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ABSTRACT OF DISSERTATION

A MESSAGE-CENTERED APPROACH TO UNDERSTANDING
YOUNG WOMEN’S DECISION-MAKING ABOUT HPV VACCINATION
The HPV vaccine represents an important step in the primary prevention of cervical
cancer, yet uptake rates for the vaccine remain below what is needed to establish "herd
immunity" from the virus. While many studies have examined both psychosocial and
communication factors affecting HPV vaccination decisions, this study adopts a unique
approach to understand the communication environment within which this health
decision happens, such as the many and sometimes conflicting messages about vaccine
efficacy and safety guiding young women's decisions. Using the message convergence
framework, this project identifies how further study of converging and diverging
messages in the communication environment in which young women make their
vaccination decision can extend research in considering optimal communication
strategies to enhance demand for HPV vaccination. In Study 1, 39 unvaccinated women
participated in qualitative interviews and were asked questions in order to understand the
important elements of the HPV vaccination communication environment that affected
their decision (i.e., common sources and content of messages, how they discussed these
messages "interacting" and influencing their decision). Study 2 builds on the findings of
Study 1 by employing an experimental design to test different message convergence
conditions on women's intent to vaccinate (e.g., what happens when a doctor and a family
member give conflicting information and recommendations about HPV vaccination?).
Three hundred and nine unvaccinated women were randomly assigned to one of nine
experimental message conditions and then assessed on behavioral intentions. Support
was found for the message convergence framework. This project represents the first
formal testing of the message convergence framework and the first time it has been used
in the health context. The findings from these studies are discussed in terms of the
implications for future cervical cancer research and prevention campaigns, as well as the
utility of the message convergence framework for other health communication research
topics in which researchers are seeking to better understand and consider the
communication environment when designing health behavior interventions.
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CHAPTER 1
HPV Vaccination
Called one of the “purest examples” of a national public health success story by
those in the public health sector, the introduction of the Pap test for the screening and
early detection of precancerous cells on the cervix has been responsible for a steady
decrease in cervical cancer deaths over the last 50 years (Edwards et al., 2005; Rust,
Satcher, Fryer, Levine, & Blumenthal, 2010). However, women remain vulnerable to
cervical cancer. In 2008, the most recent year for which national data are available,
12,410 women were diagnosed with cervical cancer and 4,008 women died from the
disease (U.S. Cancer Statistics Working Group, 2012). In Kentucky, the cervical cancer
incidence rate (8.83 per 100,000 females; 95% CI; Kentucky Cancer Registry, 2012) is
significantly higher than the U.S. rate (7.9 per 100,000 females; 95% CI; U.S. Cancer
Statistics Working Group, 2012), with 28 out of the 120 counties in Kentucky reporting
cervical cancer incidence rates higher than 12.0
With recent research revealing that 75% of cervical cancer diagnoses can be
attributed to persistent infections of Human Papillomavirus (HPV) Types 16 and 18
(NCI, 2008), the introduction of the HPV vaccine as the first primary prevention measure
against cervical cancer should also be a national public health success story.
Unfortunately, that is not the case – yet. Two HPV vaccines are available in the United
States; both protect against HPV Types 16 and 18, and both are given as three injections
over a six-month period (CDC, 2010b). The U.S. Food and Drug Administration (FDA)
approved the quadrivalent HPV vaccine Gardasil (Merck) in 2006 for females ages 9-26
years. In 2009, the FDA approved the bivalent HPV vaccine Cervarix
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(GlaxoSmithKline) for females ages 10-25 years (CDC, 2010b). Gardasil is also
approved for males ages 9-26 years because it provides protection against HPV Types 6
and 11, which cause approximately 90% of genital warts, a condition that affects both
males and females (CDC, 2010c). Awareness of the vaccine is high in the United States,
with one report showing more than 78% awareness among young adult women four years
ago (Jain et al., 2009).
Despite strong recommendations from the CDC that girls should be vaccinated at
11 or 12 years old, uptake rates (dose 1) remain low in the United States (CDC, 2010d).
Only 53.0% of adolescents aged 13 to 17 years have received dose 1 of the vaccine
(CDC, 2011). Compared to the nation, Kentucky has even lower uptake rates, with
31.0% of adolescents aged 13 to 17 years having received dose 1 (CDC, 2010a).
National rates are also low for adult women aged 19 to 26 years, who are thought of as a
“catch-up group”; only 20.7% of women in this age group have received dose 1 of the
HPV vaccine (CDC, 2012).
The three-dose schedule of the vaccine presents an additional challenge, with
adherence rates (completion of doses 2 and 3 within the appropriate time frame of sixth
months) lower than dose 1 acceptance rates. Nationally, 34.8% of adolescents aged 13
to 17 years have received doses 2 and 3 of the vaccine (CDC, 2011). In Kentucky, 19.5%
of adolescents aged 13 to 17 years have received doses 2 and 3 (CDC, 2010a). And
while no national data on adult women are currently available, it is reasonable to assume
that adherence rates are low for this group.
Even with these relatively low uptake and adherence rates since the introduction
of the first HPV vaccine in 2006, HPV incidence rates are dropping. A recent study
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compared HPV prevalence data from the pre-vaccine era (2003-2006) to the post-vaccine
era (2007-2010) and found that for some age groups, the types of HPV that are prevented
from this vaccine are decreasing in incidence (Markowitz et al., 2013). Specifically, for
females aged 14-19 years, HPV types 6, 11, 16, and 18 (all the types included in the
quadrivalent HPV vaccine, Gardasil) decreased by more than half from the prevaccination era to the post-vaccination era. This suggests that the HPV vaccine has been
especially successful at protecting younger girls and teenagers from this disease.
However, there was no decrease in the prevalence of these types of HPV among any
other age group. There are two possible reasons for this finding. First, many people in
the older age groups (up to age 59) have never been age-eligible for the HPV vaccine.
Second, sexual activity is higher among older adolescents and young adult women than
the younger age group, and therefore likelihood to contract this disease is higher.
Therefore, despite these promising findings, I argue that it’s even more important that we
focus on this “catch-up” group of young adult women (18-26 years old) who are still ageeligible for the HPV vaccine and for whom we are not seeing a drop in HPV infections in
the post-vaccination era. In addition, in the Appalachian region, which includes parts of
Kentucky, Lengerich et al. (2005) suggest that the higher cervical cancer incidence rates
are due in part to “elevated prevalence of high-risk human papillomavirus” (p. 45). In
sum, efforts to understand the HPV vaccination behaviors of young adult women,
particularly those in Kentucky, require more attention.
Research reveals a number of factors that help to explain low uptake and
adherence rates for the HPV vaccine among young adult women who are making the
decision to vaccinate on their own (compared to younger adolescents who may have the
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decision made for them by a parent). Researchers have studied young women’s
knowledge about HPV and cervical cancer and the decision to vaccinate (Cooper,
Polonec, & Gelb, 2011; Gerend & Shepherd, 2011; Kennedy, Osgood, Rosenbloom,
Feinglass, & Simon, 2011; Klug, Hukelmann, & Blettner, 2008); not surprisingly, poor
knowledge about HPV (e.g., what it is, how it causes cervical cancer, how easily it is
spread, etc.) was shown to be a barrier to vaccine uptake (Dillard & Spear, 2010; Licht et
al., 2010). Previous work has also focused on attitudes, facilitators, and barriers to
vaccination (Conroy et al., 2009; Crosby, Schoenberg, Hopenhayn, Moore, & Melhan,
2007; Daley et al., 2010; Dillard & Spear, 2010; Jain et al., 2009; Mills, Vanderpool, &
Crosby, 2011a; Patel et al., 2012; Sandfort & Pleasant, 2009; Short et al., 2010).
Consistent with social cognition models like the Theory of Reasoned Action (Fishbein &
Ajzen, 1975; Montaño & Kasprzyk, 2008), negative attitude about the vaccine was
associated with lower vaccination or vaccination intention (Daley et al., 2010; Short et
al., 2010) and positive injunctive norms were related to vaccination intention (Dillard &
Spear, 2010; Patel et al., 2012). Some of this previous research conflicts, and it remains
unclear whether a previous positive Pap test result (suggesting an increased risk for HPV)
is more (Crosby et al., 2007) or less likely (Conroy et al., 2009) to motivate young adult
women to vaccinate. Previous research also establishes demographic differences in
vaccine uptake and adherence among this population age group, such as race/ethnicity
(Bednarczyk, Birkhead, Morse, Doleyres, & McNutt, 2011; Dempsey, Cohn, Dalton, &
Ruffin, 2011; Kessels et al., 2012), education and socioeconomic status (Jain et al., 2009;
Tiro et al., 2012), and geography (Crosby, Casey, Vanderpool, Collins, & Moore, 2011;
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Franceschi, 2010).

For example, Crosby, et al. (2011) found that rural women were less

likely to get vaccinated that their urban counterparts in Kentucky.
Health communication scholars have also tackled this problem on different levels
of analysis. Some scholars have focused on interpersonal sources of influence on
vaccination decisions, such as the conversations about HPV vaccination with healthcare
providers (Cermak, Cottrell, & Murnan, 2010; Roberto, Krieger, Katz, Goei, & Jain,
2011), with family members such as mothers (Shafer, Cates, Diehl, & Hartmann, 2011),
and with female friends (Miller-Ott & Durham, 2011). Others have focused on media
sources of information about HPV vaccination and cervical cancer prevention (Briones,
Nan, Madden, & Waks, 2012; Correa & Harp, 2011; Forster, Wardle, Stephenson, &
Waller, 2010; Grantham, Ahern, & Connolly-Ahern, 2011; Quintero Johnson, Sionean, &
Scott, 2011; St. John, Pitts, & Tufts, 2010). Alternatively, some have used
communication theory and message design strategies to conduct formative research for
and to evaluate pro-HPV vaccination messages through both lab and field experiments
(Cohen & Head, 2013; Cohen et al., under contract; Kelly, Leader, Mittermaier, Hornik,
& Cappella, 2009; Krawczyk et al., 2012; Nan, 2012a, 2012b; Ngondo, 2009; Shafer et
al., 2011; St. Germaine-Madison, 2009; Vanderpool et al., 2013).
The vast amount of past research on this topic reveals many important factors that
influence a young woman’s decision to receive the HPV vaccine, and many of these
findings have been incorporated into public health campaigns to increase vaccination.
But given the relatively low uptake and adherence rates in the United States, researchers
may be missing an important avenue for studying this health behavior. No previous
research has examined the communication environment in which HPV vaccines are
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introduced to and discussed by audiences. An approach to understanding the number of
HPV vaccine messages a young woman is exposed to, the way she processes those
messages, and the effect that has on her decision to vaccinate can enhance our
understanding of HPV vaccination behaviors.
This approach may be especially prudent given the context of the vaccine’s
introduction in the United States. First, in the United States the two HPV vaccines were
approved and recommended for use in different populations (i.e., different age groups,
males and females) in stages over a few years (CDC, 2010b, 2010c). Second, given the
seemingly rapid approval of these HPV vaccines in the eyes of the public, many
individuals had questions about the safety and efficacy of this prophylactic despite
clinical trials that showed high efficacy and low rates of adverse events associated with
vaccination (Castellsague et al., 2011; Freed, Clark, Butchart, Singer, & Davis, 2010;
Gerhardus & Razum, 2010; Haupt & Sings, 2011). Third, given that HPV is a sexually
transmitted disease, a decidedly political and at times religious public discourse
developed about the HPV vaccination, especially in light of the recommendation that
girls should be vaccinated as early as nine years old (Casper & Carpenter, 2008; Gostin,
2011).
The history of HPV vaccination in the United States leads to a communication
environment in which there are “multiple messages that compete for acceptance” that
originate from a variety of sources (Sellnow, Ulmer, Seeger, & Littlefield, 2009, p. 7).
As previously stated, past studies have examined both psychosocial and communication
factors affecting HPV vaccination decisions, but no work has attempted to understand the
larger communication environment within which this health decision occurs. This
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environment includes messages originating from different sources, like friends, family
members, social media, mass media, political figures, and healthcare providers.
Additionally, the content of these messages varies. Messages may be positive and
encourage vaccination, negative and discourage vaccination, or ambiguous and cause
uncertainty. This variable communication environment around HPV vaccination,
combined with the low uptake and adherence rates for young adult women, is ripe for
study from a message convergence theoretical perspective, which takes into account how
these messages interact for young women, how they process these multiple messages, and
the effect these messages have on their vaccination decisions.
Project Overview
To address these concerns, the overarching purpose of this research project is to
employ the message convergence framework (MCF; Sellnow et al., 2009) as a lens to
understand the communication environment around HPV vaccination and the effect this
communication environment has on HPV vaccination decisions for young adult women.
Chapter 2 presents the message convergence framework, a model that outlines
how messages and message sources work together in a communication environment, as
an alternative approach to past health behavior change research traditions. Rather than
focusing on psychological predictors (e.g., attitudes, beliefs) or individual
communication predictors (e.g., a message from a friend), both of which have been
address in a plethora of previous research, the MCF considers how multiple
communication predictors may influence behavior. Additionally, exemplification theory
offers a complementary theory to the MCF in that it enhances an understanding of how
multiple messages are processed. After reviewing how these two theories can help

7

!

researchers better understand communication about HPV vaccination, the chapter
concludes with two research questions that guide Study 1 of this project.
Chapter 3 addresses the first study in this research project. Study 1 serves as
formative research for this project since this is the first time the MCF is being used in
health behavior research. Thirty-nine unvaccinated women participated in semistructured interviews about their decision not to vaccinate; women were asked to discuss
past conversations and sources of information about HPV vaccination that influenced
their decision. The study applies the MCF as a sensitizing framework for analyzing the
transcripts from these interviews, and the findings from Study 1 provide the foundation
for understanding what the HPV vaccination communication environment looks like for
young adult women. Participants identified major sources of information, the typical
messages received from those sources, and finally, participants discussed how those
messages and message sources interacted to affect their perceptions of the HPV vaccine
and their decision to vaccinate. The chapter concludes with a discussion of the findings
and limitations of Study 1.
Chapter 4 details the implications from Study 1 findings and tackles the “next
step” of addressing how young women process multiple messages about HPV
vaccination, especially in situations in which messages converge (i.e., agree), diverge
(i.e., disagree), or have mixed convergence/divergence characteristics (i.e., some parts of
the message agree and some parts disagree). While young women were able to voice
how this message interaction occurred through the recall interview technique used in
Study 1, this idea of message interaction (or, convergence) in line with the MCF has
never been empirically tested. To inform an empirical test of MCF, Study 2 borrows
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several tenets from dual-process models of message processing, especially the notion of
central and peripheral processing. In an environment of multiple messages, it would be
impossible and improbable for an individual to exert the necessary cognitive effort to
centrally process all messages. Therefore, Study 2 aims to discover what message and
source cues young adult women use when encountering persuasive HPV vaccination
communication. Specifically, Study 2 considers how perceptions of source credibility,
perceptions of argument strength, and past conversations with a source play a role in
persuasion within the context of HPV vaccination. Moving one step further, Study 2
explores the role of these variables when a young woman is confronted with more than
one message about HPV vaccination. Ultimately, the goal of Study 2 is to empirically
test the MCF in the context of HPV vaccination communication to discover under which
conditions persuasion is more likely to occur. Throughout Chapter 4, I pose research
questions and hypotheses for Study 2.
Chapter 5 describes the detailed methods and results for Study 2. Three hundred
and nine unvaccinated women were randomly assigned to one of nine message conditions
in which they received a message from a mother source and a message from a doctor
source, which was a modified approach to recreating the HPV vaccination
communication environment of multiple messages. Based on the “typical” messages
these sources use, as identified in Study 1, participants found themselves in message
conditions in which the mother/doctor messages converged, diverged, or were mixed the
on content and the recommendation to receive/not receive the HPV vaccine. Because
persuasion attempts were both positive (i.e., receive the vaccine) and negative (i.e., do
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not get the vaccine), behavioral intent to follow the source’s recommendation (i.e.,
vaccinate, do not vaccinate) served as the primary outcome measure for Study 2.
Chapter 6 includes a discussion of the overall findings from this research project,
implications for future work, and an explanation of the limitations of this project. First, I
consider how the findings from these studies can be understood in terms of the effects of
multiple sources and messages on vaccination decisions. Specifically, I address the two
main outcomes (i.e., participants perceptions of a fictitious other “Sarah’s” likelihood to
follow a source’s recommendation and participants ratings of their own likelihood to
follow a source’s recommendation) in relation to perceived source credibility, perceived
argument strength, participants’ experiences with past communication about this topic,
and the message condition they were assigned to. These findings have implications for
future cervical cancer prevention campaigns – including ones designed for the important
sources of influence (e.g., mothers, health care providers). Second, the chapter illustrates
the implications of using the MCF to understand this health topic from an ecological
perspective (rather than focusing on one or two predictors of vaccination). I argue that
this framework has utility for other health communication research topics in which
researchers seek to consider the communication environment when designing health
behavior interventions. Finally, I address the limitations for this research project which
include participant factors (e.g., all participants were college students enrolled at one
university in Kentucky) and method factors (e.g., limited formative research, struggles
with designing an effective test of the MCF).
!

Copyright © Katharine J. Head 2013

10

!

CHAPTER 2
Study 1 Theoretical Framework
What sets health communication researchers apart from other health behavior and
social science researchers is our focus on the processes and effects of communication in
changing health behavior. This includes an understanding of the health message, source
of the message, and message channels but also an understanding of the message recipient.
As noted by Witte (1995), both source variables and message variables influence whether
an audience member accepts a message and is then motivated to act on it. For example,
health communication researchers commonly value the influence of source characteristics
(Ancker et al., 2009; Clayman, Manganello, Viswanath, Hesse, & Arora, 2010) and
message characteristics (Gray & Harrington, 2011; Greene & Brinn, 2003; O'Keefe &
Jensen, 2008; Quick & Bates, 2010) on health behavior. Researchers often employ a
factorial experimental design for a message testing study by using source characteristics
(e.g., source credibility, source similarity, source likeability) combined with message
characteristics (e.g., gain-loss frame, evidence format; Anderson & McMillion, 1995;
Chaiken, 1980; Jackson, 1994; Jones, Sinclair, & Courneya, 2003; Major & Coleman,
2012; Millar & Millar, 2000) to determine which condition is most effective at changing
health behavior or predictors of health behavior. In addition to paying attention to source
and message characteristics, Witte (1995) also notes that the audience profile (i.e.,
message recipient) acts as an important predictor of whether “the message fit[s] the
audience” (p. 149). This need to focus on the audience – as well as the communication
influences – points to the importance of conducting formative work with any audience
and gathering key information like demographic and cultural variables, psychosocial
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variables, and, especially important, pre-existing beliefs and attitudes about the health
behavior. Consistent with past work in line with the health belief model and other health
behavior theories,
If individuals regard themselves as susceptible to a condition, believe that
condition would have potentially serious consequences, believe that a course of
action available to them would be beneficial in reducing either their susceptibility
to or severity of the condition, and believe the anticipated benefits of taking action
outweigh the barriers to (or costs of) action, they are likely to take action that they
believe will reduce their risks. (Champion & Skinner, 2008, p. 47)
However, in researchers’ quest to (a) gain a fine-tuned understanding of specific
communication variables and their effects on (b) a specific audience’s health behaviors
combined with (c) researchers’ methodological need to exercise control in an
experimental condition and isolate the influence of particular variables, what we may lose
is the “bigger picture” of how communication can and does play a role in changing health
behavior. In other words, the current state of persuasive health message design research
may privilege too much a micro-level understanding of communication influences on
health behavior and fail to account for the macro-level influences of many
communication influences on health behavior. Therefore, in this chapter, I will further
describe the need to consider the communication environment (rather than the effect of
one or two source/message variables) within which HPV vaccination decisions happen,
propose the message convergence framework (MCF) as the foundation for this study as
well as the secondary role of exemplification theory, and present the first set of research
questions that guide Study 1 (presented in the next chapter).
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Message Convergence Framework
We live in a world where we do not suffer from a lack of communication and we
will be exposed to many messages about any given topic. When it comes to our health
and decisions about health procedures, the importance of communication becomes even
clearer because we often make decisions based on the information we hear about the
topic. As noted by Sellnow et al. (2009), real world situations that involve risk, like a
decision about health, are “replete with technical experts providing multiple messages
that compete for acceptance” (p. 7). Many other sources, like family members, friends,
and mass media sources, also provide messages in these situations. In terms of
processing these multiple messages and multiple sources, Sellnow et al. say that the
“public must construe relevance and meaning from a given risk issue’s myriad messages
and relationships” (p. 8). Indeed, what may be missing from past persuasive health
message studies is an understanding of the communication context that represents how
people are likely to experience messages about risk, their competition and convergence,
in the real world. In other words, rather than studying how one message from one source
might influence an individual, a next step is studying source and content variables
together.
While multiple messages may focus on a central theme (i.e., cervical cancer), the
messages may differ on any number of characteristics (e.g., sender of the message,
content of the message, framing of the message, accuracy of the message, timeliness of
the message, etc.). Individuals exposed to these messages will process these multiple
messages and will try to make sense of them; that sense-making process is complicated
by how similar and different the messages are and by the individual receiver’s frame of
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reference (e.g., beliefs, attitudes, psychosocial variables, previous experience with this
health issue). On the basis of these ideas, Sellnow et al. developed the message
convergence framework (MCF) as a way to understand how messages on a similar topic
interact and affect decision-making.
Sellnow and colleagues say they developed this framework because they wanted
to take a message-centered approach in their research “as a means for understanding,
evaluating and improving risk communication” (Sellnow et al., 2009, p. 3). They argue
that “the interactive nature of risk communication, in tandem with the multiple, often
conflicting messages on any given risk issue, leads us to view risk communication as a
process of interacting arguments” (p. 10). Much like a large majority of the work in
health communication, which focuses on outcomes (i.e., changes in beliefs, attitudes, or
health behaviors), previous models of risk focused on outcomes such as financial costs,
population-level behavior trends, and from a more social scientific perspective,
psychological variables that may influence individuals’ behavior in reaction to risky
situations. Sellnow and colleagues posit that this new framework, which focuses on the
communication environment in times of risk, adds to our understanding of risk in a way
that “complements” previous models. As will be shown in the next few sections, the use
of the MCF complements existing health behavior and communication theories as well.
The message convergence framework stems from a rhetorical foundation, notably
work by Perelman and Olbrechts-Tyteca (1969). These authors posit that within a
communication environment, the following interactions occur:
•

Interaction between various arguments put forward

•

Interaction between the arguments and the overall argumentative situation
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•

Interaction between the arguments and their conclusion

•

Interaction between the arguments occurring in discourse and those that are about
the discourse (p. 460).

Sellnow and colleagues adopted this notion of argument interaction in their work.
Specifically, message convergence occurs “when distinct bodies of knowledge overlap,
resulting in some capacity of agreement” (p. 12); ultimately, a high degree of message
convergence, or overlap, is desired because it reduces uncertainty for individuals when
they are trying to make sense of a topic. In other words, when individuals hear consonant
messages from different sources over time, they can feel more certain about the
information – and, more importantly, the recommendations – contained within those
messages because the messages are essentially reinforcing each other. When message
divergence occurs and individuals encounter messages from multiple sources that contain
dissonant information, individuals engage in sense making by evaluating the competing
claims contained in various messages. As noted by Sellnow and colleagues, “observers
collect and contemplate information from a variety of sources…and discuss this
information…these discussions lead to a variety of options” or response options (p. 13).
In other words, individuals may need to exert more cognitive effort to evaluate divergent
messages because they must evaluate these competing claims.
Finally, when messages or arguments interact (i.e., individuals encounter more
than one source delivering a message about a similar topic; these messages may interact
in that they converge or diverge), individual and group level factors may affect how
much weight is given to one message (or type of message) over another. These factors
may include demographic and cultural variables, perceived credibility and similarity of
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the source delivering the message, personal relevance to the topic being communicated,
etc. (Sellnow et al., 2009). In some situations, messages may have congruence (complete
consensus or single-mindedness), mutual exclusivity (one argument “wins” over all other
arguments), dominance (one message, or message sender, is given more attention in the
public discourse), and the burden of multiple sources (the need to process the interaction
of many arguments). Figure 2.1 depicts a simple Venn diagram to illustrate how
messages from different sources (each circle) interact and have varying degrees of
convergence.
Figure 2.1
Message Convergence

Figure 2.1 Venn Diagram depicting how multiple bodies of knowledge (messages) interact,
taken from Sellnow, T. L., Ulmer, R. R., Seeger, M. W., & Littlefield, R. S. (2009).
Effective Risk Communication: A Message-Centered Approach. New York: Springer.

The MCF was developed as a framework for understanding and ultimately managing risk
about a given topic; it stems from a public relations mindset. As such, the limited amount
of previous work using this framework has centered on understanding the multiple
messages about a time of risk (i.e., a crisis) and using the MCF as a “best practices”
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approach to managing those messages for the public. For example, Sellnow, Ulmer,
Seeger, Littlefield, and Wood (2009) examined how a water company in Milwaukee dealt
with an outbreak of the disease cryptosporidiosis, which is characterized by nausea,
diarrhea, and fever, and is caused by an infestation of parasites in the water supply. They
used the MCF to understand how multiple sources, such as the water company and city
officials, were not communicating competently with each other or with the public
properly to control the situation and keep people healthy. In this case study, they were
able to identify gaps in communication, how multiple messages from different sources
were providing conflicting information, and ultimately, provide recommendations for
improving the communication in future situations.
In terms of health communication, this framework has utility in our field for at
least two major reasons. First, it can provide a novel way for health communication
scholars to understand how individuals process the variety of messages about any given
health topic to which they are exposed, how those messages interact, and how that affects
their health decision-making. While the focus of much persuasive health communication
research has been on creating and testing messages, this complementary approach allows
for the researcher to step back and examine the existing persuasive messages that an
individual may already have seen or heard. Second, for many risk and crisis
communication situations, there is a temporal element in which there is a marked
beginning and ending of messages. For example, Anthony and Sellnow (2011) examined
how Gulf Coast residents responded to different messages (and different channels, such
as local vs. national media) in the aftermath of Hurricane Katrina. Obviously, the
majority of messages for this situation were concentrated in one time period shortly
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before and for several months after the hurricane. In other words, times of risk (i.e., a
crisis) involve a temporal element that, to some extent, limits the amount of messages an
individual is exposed to as well as limits the amount of time within which an individual
must make a decision (e.g., to evacuate). On the other hand, a framework like MCF is
essential in the context of health communication in which there may be no temporal
element; people may be exposed to messages about a health topic for decades (e.g.,
smoking, exercise, the harms of drinking, whether eggs are good for you, etc.).
Exemplification Theory
What is also missing from previous work using the MCF is how multiple
messages interact to influence a person’s thoughts and actions. One theory that provides
a complementary view of this phenomenon is exemplification theory. Developed and
mostly studied in the context of mass media messages, exemplification theory helps us
understand how people receive multiple messages about a common topic and then how
an individual processes those messages and forms perceptions about the topic. While
MCF tells us that messages about a particular phenomenon can and do diverge and
converge and how that may affect an individual’s actions, exemplification theory
provides a foundation for understanding the cognitive and affective processing of those
multiple messages. This theory privileges the notion of exemplars about a topic having a
particularly strong influence on individuals’ perceptions about the general topic. For
example, why would a person pay more attention to one message compared to another?
And how does a person compare a new message to the messages they’ve already received
about this topic?

18

!

Exemplification theory provides a framework for addressing these questions.
Zillman (2002) posits that “essentially for reasons of cognitive economy, organisms had
to find ways of extracting experiential chunks from the continual flow of information
about their environments” (p. 19). A trained media scholar, Zillman was especially
interested in seeing how exposure to singular stories about a topic, which he labeled
exemplars, would affect an individual’s perceptions about the topic in general. The
theory operates with three main assumptions:
1. Comprehension, storage, and retrieval of elemental, concrete events are
generally superior to those of complex, abstract events.
2. Events of consequence attract more attention and are more vigorously
processed than irrelevant events.
3. The incidence of events of the same kind is coded, and basal quantitative
assessments are made on the ground of this coding. (Zillman, 2002, p. 2526)
The theory also relies on two cognitive processing assumptions. The representativeness
heuristic stipulates that base rate information (i.e., facts or statistics about a certain topic)
might mean less to a person than personal stories they hear about the topic. In the same
way, exemplars will vary with regard to how much they represent (or misrepresent) the
base rate information. The availability heuristic stipulates that exemplars that come to
mind quickly are more influential; access to these exemplars can be influenced by
recency and frequency of the exemplars.
Although I make the argument here that exemplification theory is a useful
complement to MCF, there are some limitations in how this theory can be used for this
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research. First, most if not all of the research on exemplification has looked at media
messages (Cox & Cox, 2001; Yu, Ahern, Connolly-Ahern, & Shen, 2010; Zillman, 1999,
2002). Scholars have given exemplars heard from interpersonal sources like friends and
family little attention. Second, exemplification research has focused solely on the
message and paid little attention to the persuasive impact of the source. One exception is
a study by Aust and Zillman (1996) in which the source, who was portraying the victim
of a crime, delivered the message in a calm manner or in an emotionally charged manner.
The emotionally charged condition elicited from participants a stronger perception of risk
to individual and that crime was a more severe issue compared to other conditions. Still,
the only source variable manipulated in this study was emotional delivery, and the
researchers failed to examine any number of other source variables that may have made a
difference in message processing. Third, and perhaps most important, exemplification
research focuses on cases or exemplars of events about other people and then studies how
the aggregation of those exemplars in the mind of an individual might affect his or her
perception of that topic. However, for many messages that one hears or sees, the
message might be directly targeted at that individual. One study by Brosius and Bathelt
(1994) hinted at this idea in a research project of five experiments using exemplification
theory as a guiding framework. Each experiment consisted of a variety of messages
about a topic and varied on vividness of language and representativeness of base rate
information. Four topics were covered on a fictitious radio program during the course of
the experiment; those topics were wine shortages in the area, replacement of coin pay
phones with credit card pay phones, type of food in a nearby university cafeteria, and the
obligatory use of classroom computers in the same nearby university. The authors claim
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they varied the topics in terms of issue involvement (the experiment was done with
university students, so the two university-related topics would be of more interest to
them), which does somewhat address the notion of messages related to the individuals.
However, other than examining the effect of general news stories about community
issues that may or may not affect an individual, this and other research has failed to
examine the exemplification of messages directed at an individual.
In the context of the current research project on message convergence dealing
with HPV vaccination, exemplification theory provides some important guidance. First,
this is one of the only communication theories that focus on processing multiple
messages and, in fact, privileges the idea that there will be multiple messages about a
topic that have some degree of similarity (i.e., they are about the same topic) but will also
differ on important variables that may make the differences in what a person decides to
do. In the case of HPV vaccination, this is relevant given the large amount of varied
information that is communicated about this topic. Second, exemplification theory does
not put limits on the amount of messages that can be considered or when those messages
were received. In fact, this theory deals specifically with aggregation of many messages
and, as noted by Zillman (2002) “closer examination of the projected longitudinal
influence [of exemplars]…seems especially important….months and perhaps years might
be more appropriate units of time…[for exemplars] to impose, if not dictate, the
perception of issues” (p. 39). As previously noted, for a health communication topic like
HPV vaccination, young women may hear many messages over a period of time. Third,
much of the research in exemplification has focused on messages or stories about risk,
which is in keeping with the current project. While a full summary of the research is not
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practical (see Zillman & Brosius, 2006 for a full review), especially given the focus on
mass media exemplars, Zillman (2006) concludes that “the involvement of just one
emotional exemplar in an otherwise highly fact-focused [environment]…is capable of
elevating assessments of risk to others and self.” (p. 227). He goes on to say that we
must be attuned to the effects of certain exemplars that draw attention to risk, change
beliefs about risk, and cause an individual to feel a greater need to act to protect
themselves from this risk. In this way, exemplification theory is perfectly suited to help
researchers understand the potential persuasive impact of one or two messages about
HPV vaccination among a milieu of other messages.
In the case of HPV vaccination, the decision to adopt or not adopt this
prophylactic innovation is a complex one that happens in a milieu of messages over time;
these messages contain information about a variety of risks such as risk of the vaccine,
risk of HPV, and risk of cervical cancer. Our previous work with young adult women in
Kentucky has revealed some interesting findings in terms of decision-making about this
vaccine situated within a communication environment full of persuasive messages
(Cohen & Head, 2013; Cohen et al., under contract; Head & Cohen, 2012; Head, Mills, &
Vanderpool, under review; Mills, Head, & Vanderpool, under review). For example,
some young women in Kentucky have reported hearing messages encouraging them to
get the HPV vaccine from a variety of sources including mothers and family members
(Mills, Head & Vanderpool, 2013), healthcare providers (Head, Vanderpool, & Mills,
2013), and mass media sources such as the Gardasil advertisements (Cohen & Head,
2013). In contrast, women also heard many negative stories about HPV vaccination. For
example, young women reported how peers discussed their personal HPV vaccination
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experience (e.g., how painful the shot was, what types of side effects they experienced)
and how that information influenced their own decision (Head & Cohen, 2012). In
another study, women attributed knowledge about dangerous side effects of the vaccine,
such as affecting a woman’s ability to have children and even women dying from the
vaccine, to mass media sources (Mills, Head, & Vanderpool, 2013). Finally, some young
women recounted conversations with mothers and healthcare providers in which they
were advised not to get the vaccine (Cohen & Head, 2013; Head & Cohen, 2012). In the
case of mothers (in this geographic area in particular), religious beliefs may affect their
willingness to believe their daughters are at risk for an STD, although some of our
research suggests mothers are more positive about vaccination for older adult daughters
(Behringer & Friedell, 2006; Kahn et al., 2009; Mills, Head, & Vanderpool, 2013). For
healthcare providers, these types of messages are consistent with other research in which
Appalachian pediatricians are less likely than non-Appalachian pediatricians to
recommend the HPV vaccine to their patients because of lower perceived susceptibility
(Krieger, Katz, Kam, & Roberto, 2011).
The cumulative findings of these and other studies are the impetus for the current
project. Young women are reporting many messages about HPV vaccination that they
hear from a variety of sources, and it is unclear what impact the accumulation of these
messages is having on vaccination decisions. Therefore, in addition to using the kind of
research described in the previous paragraph as formative research for designing
persuasive health messages (which is what it was originally used for), these findings also
suggest that researchers are missing an important component of formative work and of
the complex environment within which health decision making happens – what is the

23

!

persuasive impact of the HPV vaccination messages that young women are already
exposed to in their communication environment? In other words, how do women sort
through various existing messages from various sources and ultimately decide which
source/message to trust?
Cline (2003) addresses this notion of multiple messages well when she says health
communication should be seen as “a matrix of formal and informal communication
contexts in which planned and incidental everyday messages abound, in both mediated
and interpersonal forms” (p. 286). She goes on to argue that, especially in the case of
informal interpersonal communication, it’s important to understand how strong these
messages can be in influencing health behavior. In a case study looking at the role of
informal, interpersonal communication on HIV/AIDS behaviors (e.g., testing, disclosing
a diagnosis, negotiating condom use, etc.), Cline found that most of the desired behavior
changes by the participants were facilitated by interpersonal communication, not
mediated messages. She issues a call to fellow health communication researchers to
“attend to the sometimes more difficult-to-capture factors that influence health,” such as
those informal messages heard through interpersonal channels (p. 304). She also argues
that in doing research that pays attention to these issues, we can move away from a
researcher-initiated agenda toward a participant-centered agenda in designing our
interventions. In other words, when we understand health and health behaviors in terms
of how individuals creating meaning and communication about these topics from a
holistic perspective, we can design interventions that privilege the voice and life world of
the participant. These messages may end up being more effective, and in the case of
HPV vaccination, this may be just the approach that is needed to increase vaccine uptake.
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In sum, the MCF can be used to understand the communication environment
within which an individual makes a decision about a particular topic. This framework
has great potential for expanding researchers’ understanding of communication processes
and moving beyond studying one or two messages and their effect on individuals,
especially in the field of health communication. Additionally, exemplification theory
informs us that there are certain message characteristics that may influence an
individual’s recall and the subsequent persuasive power of that message. However,
because these theoretical frameworks have not been used in the context of health
communication about HPV vaccination specifically, formative work – in line with
Cline’s argument – needs to be done in order to understand the communication
environment around this topic beyond the previous work reported above. In other words,
to really study the way in which young women sort through various messages from
various sources – and ultimately figure out which messages and sources have the most
persuasive impact – researchers must first understand what that communication
environment looks like. Therefore, Study 1 addressed the following research questions:
RQ1: What are the common sources, message features, and message channels
that young adult women report hearing and seeing about HPV vaccination?
RQ2: How do young adult women discuss these messages interacting in a
communication context and influencing their decision to vaccinate?
To address these questions, Study 1 takes an in-depth look at how young women
discuss the messages they’ve encountered about HPV vaccination and allows researchers
to understand what the HPV vaccination communication environment looks like. Semistructured interviews with young adult unvaccinated women reveal the common sources
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and messages about HPV vaccination these individuals encounter (i.e., memorable
messages) as well their descriptions of the consonant and dissonant characteristics of
these sources and messages. Specifically, these interviews query young women about the
sources and content of existing persuasive messages - or exemplars - about HPV
vaccination. This formative work lays the foundation for better understanding HPV
vaccination communication and shaping future research and interventions for this
population.

Copyright © Katharine J. Head 2013
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CHAPTER 3
Study 1 Theoretical Framework
The primary objective of Study 1 is to better understand and explain the HPV
vaccination communication environment for young adult women. To address this
objective and the specific research questions posed in the previous chapter, I used
previously gathered interview data that was part of a larger project on various women’s
health issues and included both vaccinated and unvaccinated women. Examining only
the unvaccinated women’s responses and applying the MCF as an a posteriori
framework, I explored these young women’s recall and report of messages received about
HPV vaccination to help elucidate the communication environment within which they
decided against HPV vaccination. In the following sections, I describe the participants in
Study 1 and explain procedures for collecting and then analyzing the data. I then provide
a discussion about the findings and provide the reader with a list of limitations for this
study.
Methods
Participants and recruitment. Participants were 39 unvaccinated women who
spoke English and were between 18 and 26 years old. Women were recruited from a
large Midwestern university through two different channels: a) flyers were placed around
campus advertising the study and women were offered a $10 iTunes gift card as an
incentive for participating and b) a notice was put in the online recruitment site for
students in the Department of Communication research pool and these students were
given course credit for participating. The majority of participants were White (n = 33),
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with a minority of women from African-American (n = 4) and other racial/ethnic groups
(n = 2).
Procedures and protocol. Women contacted the principal investigator of the
main study (Dr. Elisia Cohen) through the email address listed on the campus flyer or
through the online department research sign-up system to sign up for the study and
schedule an interview time. Interviews were conducted on campus in the PI’s private
office with the door shut, and all interviews were audio recorded. Participants provided
informed consent before beginning the interview and before the audio-recording
equipment was turned on. Interviews lasted between 10 minutes and 30 minutes, and all
participants answered every question (even if their answer was “I don’t know.”).
Interviews were transcribed verbatim. Prior to analysis, the PI and I read through the
transcripts to remove any personal identifiers before analysis began and then assigned
each participant a pseudonym. All study procedures were approved by the University’s
Institutional Review Board.
The interview data used for this study was actually previously collected as part of
a larger study.

In returning to the original interview protocol and the interview data, we

realized that information germane to the current study was gathered in two ways. First,
as part of the original study, women were asked open-ended questions about knowledge,
attitudes, and vaccination decisions, which often included personal stories involving
messages and message sources. Second, women were specifically asked to recall media
messages, conversations with family/friends, and conversations with healthcare providers
about HPV vaccination. We (the PI, Bethney Wilson, a research assistant on the project,
and I) used previous literature on cancer prevention and HPV vaccination and our own
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experience in the field to identify these questions from the original interview protocol
that were germane to the current study. Specific to the MCF, we were interested in
women’s recall of messages about HPV vaccination, the sources who delivered those
messages, and how women discussed multiple messages about this topic “interacting” in
their communication environment. Related, the interview questions were open-ended and
participants were not told to put a time limit on when they heard HPV vaccination
messages; rather, they were free to discuss any and all HPV vaccine related messages
they had encountered in their lifetimes.
Data analysis. The study used a deductive data analysis technique called
provisional coding, which involves starting with a preset list of codes and allowing the
data to inform more comprehensive codes throughout the process, to analyze the
transcripts. In keeping with the theoretical framing (MCF) and the research questions
guiding the study, we (K.H. and Bethney Wilson) met to discuss the provisional list of
codes that was informed by the MCF (Sellnow et al., 2009) and our previous experience
and work in HPV vaccination and health communication (Cohen & Head, 2013; Head &
Cohen, 2012; Head, Vanderpool, & Mills, 2013; Mills, Head, & Vanderpool, 2013).
Given his expertise on the theory, we also met with Dr. Tim Sellnow to discuss the study
and ask for guidance on employing the MCF to analyze these transcripts.
In our initial reading of the transcripts, we coded for all message sources
identified by participants and all HPV vaccination messages encountered by participants,
as well as a preliminary coding of how participants discussed messages “interacting”
(i.e., when a participant discussed two or more different sources delivering an HPV
vaccination message). After this initial reading, we met to discuss more comprehensive
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theoretically-informed categories based on the tenets of MCF and returned to the
transcripts using these more developed categories. These included source characteristics
(e.g., how frequently or infrequently a source was mentioned in relation to other sources),
message characteristics (e.g., typical messages heard from each source, arguments made
within each message for or against vaccination, the vaccination recommendation within
each message), and finally, a more sensitive reading of message interaction. Specifically,
we examined and coded for whether participants expressed messages diverging or
converging and who the typical sources were in terms of message interaction. We met
frequently to discuss findings and in the final read-through of the transcripts we gathered
key exemplars for each finding.
Results
The purpose of this study was to better understand young adult women’s HPV
vaccination communication environment and specifically answer the following research
questions: 1) What are the common sources, message features, and message channels that
young adult women report hearing and seeing about HPV vaccination? and 2) how do
young adult women discuss these messages interacting in a communication context and
influencing their decision to vaccinate? Findings are discussed in the next few sections.
Primary sources of messages. Sellnow, Ulmer, Seeger, and Littlefield (2009)
claim that “there are many bodies of knowledge contributing to risk communication on
any given topic” and that each of these bodies of knowledge will address the risk in
differing ways (p. 15). To address the first research question, we describe these bodies of
knowledge and the typical messages participants recall hearing from each source, which
in essence allowed us to map out what the communication environment for HPV
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vaccination looks like. These findings included participants’ recall of the major sources
of information about HPV vaccination (including interpersonal and mediated sources), as
well as the types of content in those messages (including what the typical messages
were). Each of these sources and the content of their messages is described below and a
summary of these findings is found in Table 3.1 at the end of this section.
Mothers. One of the primary sources of HPV vaccination messages was mothers.
Typically, participants received messages warning against the HPV vaccine from their
mothers, and there were two main reasons for the warnings. First, mothers warned
against the immaturity and safety of the vaccine. Chelsea recalled a conversation with
her mother about whether she should get the vaccine, but her mother was worried with
“being the first generation of the vaccine, you know possible risks haven’t been too
widely, you know, observed.” Similarly, Celia’s mother told her “it’s good to get it but I
don’t know if they know like the long-term side effects from it yet.” Chloe’s mother
communicated her fears about the HPV vaccine by comparing it to past medications that
were later proven harmful (e.g., Diethylstilbestrol or DES, given to women in the midtwentieth century). She recalled “my mom…just said she worried about like, there have
been things out in the past where they’ve thought were okay….then it’s turned our like
it’s caused miscarriages and different things.” Similar to Celia’s and Chelsea’s mothers,
Chloe’s mother recommended waiting and said “she would rather take the chance for at
least a little bit longer until they know like absolutely for sure.”
Second, some participants reported their mothers voiced anti-vaccination
sentiments because they perceived their daughters to be sexually naïve (i.e., not sexually
active or at least not having sexual intercourse). Quinn recalled that both of her parents
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told her she didn’t need to unless she was “sexually active.” Despite reporting that she
was sexually active (and therefore at risk for HPV), Quinn followed her parents’ advice,
perhaps so that she wouldn’t have to confess to them that she was having sex. Dana
identified a conversation with her mother about vaccination in which her mother “wasn’t
concerned about it…didn’t feel like it was a priority” because her mother believed her to
be sexually naïve. While Dana was sexually naïve at the time, she had since become
sexually active (and therefore at risk for contracting HPV), but she had not decided to
receive the vaccine. Lauren reported a similar story in which her mother said “well as
long as you’re not being sexually active, then we don’t feel you need to get it.” Lauren
also said she had become sexually active after that conversation, but she had still decided
not to vaccinate. Interestingly, despite personally knowing they were at risk for HPV
because they were sexually active (all of these participants and similar others were able to
identify HPV as an STD), these women still chose not to vaccinate despite being able to
go to the university health clinic and receive the vaccine not only free of charge, but their
parents would not need to find out.
Alternatively, fewer participants recalled their mothers promoting vaccination or,
at the very least, neutrally discussing vaccination. In the cases of positive messages,
sometimes mothers cited family history of cancer or just general worry about cancer as a
risk that could be mitigated by this vaccine. Tammy said her mother “told me about it and
she was like, I…would like you to have that because cancer is prominent in our family.”
Mary remembered her mother was very encouraging and said “you should get the vaccine
so you don’t have cervical cancer later.” Some participants also recalled discussing the
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HPV vaccine with their mother, but in recalling what those conversations were like, they
did not indicate whether the conversations were positively- or negatively-valenced.
Healthcare providers. Participants also identified healthcare providers as a major
source of information about HPV vaccination. There were three types of messages that
participants recalled receiving from healthcare providers. First, compared to any other
interpersonal source identified by participants, providers tended to offer women the most
positive HPV vaccination messages and usually did so with somewhat forceful messages.
Alyssa recalled her doctor saying “how easily you could get HPV…how like you can get
it not through sex. This is just a good precaution [against cervical cancer].” (Alyssa’s
doctor was addressing the nature of transmission of HPV in that an individual need not
have full sexual intercourse to spread or contract the virus.) Chloe recalled that her
gynecologist was “very laid back” but that she was definitely “pushing it.” Bailey
remembered telling her doctor she wasn’t sexually active yet and the doctor “was like
even more excited about me having the vaccine because was like, I mean then for sure
like you would be in the clear.” She went on to say she was “really like pushing it and I
remember even her nurse like, coming in.” In these cases, despite positive
encouragement from a healthcare provider touting the benefits of this vaccine in
preventing the risk of HPV and cancer, participants decided against vaccination.
Second, some providers were pro-vaccination, but participants did not feel they
“pushed” it at all; these instances also did not result in women getting vaccinated. Vicky
remembered telling her doctor she had not received the HPV vaccine and the doctor said
“okay, well you should.’ And that’s pretty much all she said about it. It wasn’t like a
lecture.” Nina said she had gone to the gynecologist a couple of times and they always
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asked her about the HPV vaccine. When she told them she hadn’t been vaccinated, she
remembers they gave her some information in it but “they didn’t go into description.”
Sarah also indicated her doctor did not provide forceful messages; she recalled, “my
gynecologist one time asked me if I had it and asked me if I wanted it and I said no both
times and she didn’t push it any further….she did give me a pamphlet, though.” For
these unvaccinated women, it seems that neither very forceful nor more passive
recommendations by providers were enough to motivate them.
The third type of message received from providers was similar to one voiced by
mothers: Participants reported healthcare providers telling them the vaccine wasn’t
necessary because they weren’t sexually active. Rebecca recalled a conversation with her
doctor in which she asked the doctor if the vaccine was necessary: “I asked my doctor if I
needed it if I wasn’t having sex or anything and she said no.” Lindsay reported a similar
story when she asked her doctor if this vaccine was necessary for her since she wasn’t
having sex; he told her “no it wasn’t necessary but…if you want to be on the safe side
you can get it.” This type of message is particularly troubling coming from healthcare
providers who should be knowledgeable about the purpose of a vaccine – protecting
against a virus before exposure to it (i.e., before becoming sexually active and therefore
at risk for an STD).
Friends and other social acquaintances. While mothers and healthcare providers
were the dominant sources of HPV messages that these participants recalled, a few
participants reported receiving messages regarding the HPV vaccine from friends and
other social acquaintances. These messages generally involved conversations related to
the vaccine itself. Mary recalled “one of my friends said that she got it and it hurt real
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bad. It hurt real bad.” Sarah said both of her best friends got the vaccine and while “one
of them was just fine, the other one is really a[]verse to needles so she had a tough time
getting the vaccine.” On the other hand, a couple of participants reported these sources
giving them pro-vaccination messages. Teresa indicated “my best friend…she told me
that I should.” Celia said one of her friends had an abnormal Pap test and that her
healthcare provider encouraged her to get the vaccine as added protection for the future;
Celia expressed that “we were talking about that recently and about me possibly getting
it, too. She was just telling me about her experience with it.”
Gardasil mass media campaign. The majority of participants were able to recall
and identify the main theme, or catch line, from the Gardasil advertisements (i.e., “one
less”), and these commercials represented the most common mass media source. In fact,
a very common response among participants, when asked when you hear the term HPV,
what words or phrases come to mind, was “Gardasil.” While this advertisement campaign
was arguably very effective at raising awareness and knowledge about HPV and the
vaccine, many participants felt the commercials were not really targeted toward them.
Olivia described the commercial as “mothers and daughters…talking about [how] you
need to encourage your children to take the HPV vaccination.” Vicky had a similar
response to Gardasil advertisements; she said the ads were “like women and their like
young daughters going on picnics and stuff, just making sure that you get the vaccine.”
Dana remembered “it was a lot of parent, or mother and daughters together and basically
it, I feel like it targeted more the mothers instead of the daughters.” Nina described her
reaction to the advertisement by saying “it’s always girls between the ages of like 11 and
18….which is like fine I guess, but girls just go around having fun and dancing and
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climbing trees” did not motive her as a woman over 18 to act. In this sense, participants
felt these advertisements were not targeting them to take action.
Other media sources. Beyond the Gardasil media campaign, a small number of
participants reported exposure to messages related to the vaccine through other media
sources. For example, participants reported viewing news segments on the harms and
side effects of the HPV vaccine. Tammy even reported “there was a recent story in the
media about an elementary school girl getting it and then she ended up dying the same
day from it.” Participants also cited stories that encouraged people to stop getting the
vaccine, such as when Chloe said “I heard just recently in the news that something came
out where they’re actually saying that you shouldn’t have gotten it and that you need to
stop like, giving the doses.” In these few cases, women did not identify a specific news
source but rather used ambiguous terms like “news” or “media” to indicate the source.
Overwhelmingly, in these few cases the messages recalled from other media sources
were anti-vaccination in content.
Lack of messages. Participants were asked to identify the main message sources
from which they received information about HPV and the HPV vaccine. While most
participants could identify at least one message/message source, many reported receiving
vague messages and some reported not receiving any messages about the HPV vaccine
when prompted (e.g., “Can you recall a time you discussed the HPV vaccine with a
healthcare provider? Mother? Family member? Media messages?”). There are two
important points to make about the lack of HPV vaccination messages. First, participants
may not have recalled discussions they had about the HPV vaccination, particularly when
they decided not to receive it (as was the case for all women in this study). It may be that
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these discussions were brief and not something that these young women could easily
recall after they made the decision not to receive the vaccine, especially if the
conversations happened a long time ago. Alternatively, the lack of participants reporting
messages from some sources (e.g., Renee reported never discussing HPV or cervical
cancer with her gynecologist!) represent real “missed opportunities” for promoting HPV
vaccination in these women’s lives.
Second, when women reported a lack of messages and/or feeling like they weren’t
well informed about the HPV vaccination, they consistently denied searching for
information on their own. Both Sydney and Tammy reported that healthcare providers
did not give them a lot of information about the HPV vaccine beyond simply
recommending it. When asked “aside from what little she told you, have you gotten or
looked for any other information on HPV? …on cervical cancer?” they both simply
replied “no” with no explanation for why they did not research it further. Renee said she
wasn’t sure how susceptible she was to HPV and that she didn’t know “because we don’t
know a lot about it. We don’t research it as lengthy as we could and there’s not a whole
lot of information out their either.” This lack of information seeking on the part of these
women may reflect their desire to not be vaccinated in the first place; in other words, they
do not care to research it further because they have already decided against vaccination.
Table 3.1
Common HPV Vaccination Messages and Message Sources
Sourcea
Messageb
Mothers and
The vaccine could have harmful unknown side effects.
grandmothers
You are not sexually active so you do not need to vaccinate.
Additional: Positive/neutral discussion of HPV vaccination.
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Table 3.1 (continued)
Sourcea
Healthcare providers

Messageb
The HPV vaccine is a powerful tool for protecting yourself
against this STD. (Forceful recommendation)
Have you had the HPV vaccine? (Question but no
recommendation)
If you are not sexually active, you do not need to vaccinate.

Gardasil
advertisement

Raised awareness about HPV and the vaccination.

Other media outlets

The Gardasil vaccine causes serious adverse side effects.

Friends and social
acquaintances

Getting the vaccine is painful and there can be unpleasant shortterm side effects.

Messages not aimed at young adult women, but rather mothers of
young girls.

Additional: Pro-vaccination but not forceful.
Lack of messages

Could not recall discussions/exposure to HPV vaccination
messages.
Denied searching for more information about HPV vaccination
after reporting they have little information about this health
issue.

Note. aSources listed in order of most commonly reported. bMessages listed in order of
most commonly reported. Italicized verbiage represents general message content or
interpretation of message by participants, un-italicized text represents more concrete
examples of messages recalled.
Message convergence in action. Beyond simply describing the common sources
and messages about HPV vaccination, participants also described how these messages
interacted. In line with the tenets of message convergence framework, the term
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interaction describes the ways in which women explained how messages from different
sources converged or diverged on the content of the message and the recommendation for
or against vaccination. Three types of HPV vaccination message “interaction” emerged
in the findings (divergence, convergence, and still interacting), and each is described
below.
First, participants discussed examples of message divergence, in which
participants perceived conflicting information and/or recommendations about the HPV
vaccine from different sources. In an instance of divergence, Alyssa recalled, “my mom
was very against it, the shot, so she doesn’t want me to get it and so she was trying to
help me explain why I shouldn’t get it but then it was, then I went to the doctor and
she…explain[ed] why I should get it so it was kind of a decision I needed to make.” The
interaction of messages from mothers and healthcare providers – when the mother was
being unsupportive and the healthcare provider was being supportive – was the most
common instance of diverging interaction recalled by participants. A few participants
reported more than those two sources interacting and diverging. Michelle wove a story
of many sources that influenced her decision: “I would not get it unless I absolutely had
to and my parents, my mother never pressured me to get it. She said I should get it but I
never really thought about it and my gynecologist actually recommended it as well but I
just never really listened to it. And then once I started seeing the ads, I heard about it and
I was kind of a little bit more, I didn’t really want to do it. And then I had friends that got
it that started like breaking out from it; like I know a girl that like had a really bad rash
from it and stuff like that and then they were getting recalled and they were scared about
it because they had them. And I heard they are really painful and just I don’t like really
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like shots at all so.” Vicky also reported divergence about HPV vaccination from
multiple sources, but she was vague in exactly who was saying these messages: “Some
people say it’s necessary, some people are like if you want it, get it. It’s not a big deal if
you don’t get it.”
Though less common than instances of divergence, instances of convergence
were also reported by participants. These were cases in which participants perceived that
two or more sources provided similar information about the HPV vaccination and a
similar recommendation. There were two types of divergence. Participants reported
negative-valenced convergence, such that two or more sources advocated against HPV
vaccination. Penny recalled “well, I was going to get it and my mom worked in a medical
office and…so she didn’t really recommend it, [and] like, the doctor recommended not
getting it.” Other times, participants reported this negative-valenced convergence, but
did not provide details on the exact sources, suggesting that perhaps these were rumors.
Beth said, “I’ve heard some things…is it that like some girls pass out or get dizzy.
Because that’s I’ve heard that from like certain…[pause], I think there was one fatal case
but I’m not really sure about that.”
Participants very rarely reported positive-valenced convergence, in which two or
more sources advocated for vaccination. In one of those cases, Lindsay reported many
positively-valenced sources. She said, “I’ve heard about it through my doctor and I know
there’s, I mean we talked about it in health class and it was freshman year of my high, in
high school so I can barely remember what we talked about it but I know you can get a
shot for it and there’s been lots of commercials for it so I mean I’m sure it’s probably
good to get the shot but I haven’t gotten it but I do know people that have gotten it to
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prevent HPV….[and] I did talk to my grandmother about it because she had seen the
commercials, well the Gardasil and she was encouraging me to get it.” Lindsay’s
explanation of message convergence represents the best case scenario (many forms of
positive encouragement), yet this did not result in Lindsay’s vaccination.
The third type of interaction was our discovery that some participants were still in
the process of sorting through messages and evaluating them; in essence, we (and others
in the research community) may have falsely labeled these women as “unvaccinated.”
Instead, there might be two groups of “unvaccinated women” – those who are decidedly
unvaccinated and those who are still undecided. After some women discussed the
positive encouragement they received about the HPV vaccination and why they have still
chosen not to receive it, many indicated they were still thinking about it (rather than, as
we assumed, deciding against vaccination). As Nicole said, “but I don’t know because
like I don’t know if I’m going to change my mind yet…so like right now I don’t but I
don’t know about the future and so it might be a good precaution for me; I haven’t really
decided.” Alyssa also indicated she “kind of postponed it [her decision].” Celia
explained, “like I’ve talked to people but I just haven’t taken the step to go get it.”
Recognizing that women may still be mulling over their decision to vaccinate as they
process multiple messages about HPV vaccination provides an important distinction for
women whom researchers previously labeled as just unvaccinated; instead, researchers
may need to view women in stages of vaccination decision-making.
Discussion
The findings from this formative investigation using MCF to analyze women’s
discussions of HPV vaccination decisions provide strong support for continuing this
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work. These results add to our understanding of this health behavior and, germane to
communication researchers, our understandings of communication about this health
behavior. By having a clearer understanding of the communication environment within
which HPV vaccination decisions are made, communication scholars can work to test
these different messages to determine which may be the most influential. These results
provide two directions for additional research.
First, these findings point to important message sources about HPV vaccination,
as identified by young women. Mothers and healthcare providers seemed to play the
largest “roles” in these decisions for young adult women, with media and peers also
playing a part in conveying information that could affect their decision. This finding is
consistent with previous literature that shows mothers and healthcare providers are strong
influences on HPV vaccine decision-making (Conroy et al., 2009). However, what this
study adds is an understanding of the typical messages received from these different
sources, which may help us better understand how and why these sources are influential.
For example, mothers were more likely to focus on the risk of the vaccine, or the short
term risk of side effects. Alternatively, healthcare providers were more likely to focus on
the risk of cervical cancer, or the long term risk of being infected with HPV which could
cause cervical cancer. The young adult women in our study recalled healthcare providers
providing positive encouragement for vaccination more so than others. Interestingly,
participants recalled some instances in which both healthcare providers and mothers
expressed messages about no risk of HPV because a young woman wasn’t sexually active
and therefore was not in need of this vaccine. Mass media and peer sources played a
smaller role, with participants discussing risk of the vaccine messages (e.g., side effects)
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as one of the main messages received from these sources. Finally, one particularly
important finding from this study is the lack of information seeking for some of the
women who expressed uncertainty about the safety and efficacy of the HPV vaccine.
This point in particular is deserving of further study, with an eye toward developing
interventions to increase vaccination for this population.
Second, these findings provide the first report of how young women discuss the
interaction of HPV vaccination messages they’ve received. Only unvaccinated women
were included in this study because these women would be the target population for any
intervention. Understanding how they discuss various message source/content interacting
to persuade them to not receive the vaccine provides important insights for health
communication researchers and practitioners. For example, women rarely reported
positive convergence, meaning they are recalling many anti-vaccination messages in their
lives. Additionally, women most often recalled and reported conversations with their
healthcare providers and mothers, as well as how those two sources often “butted heads.”
This suggests the importance of further study on the influence of these two sources, but in
tandem (i.e., how they interact). Finally, in speaking with young women who were
unvaccinated, the finding emerged that some of these women are simply still in a state of
deciding. This is consistent with previous work by Prochaska and colleagues looking at
the stages of change behavior model and the role of decisional balance (1994). Stages of
change is a behavior model which posits that individuals progress through a series of
stages in their attempt to change a behavior and that interventions targeting individuals in
certain stages can be very effective at “moving” individuals to the next stage (Prochaska
& Velicer, 1997). Most commonly used to study behaviors that are habitual and require a
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long-term change (e.g., smoking, exercise), the model also has usefulness for a behavior
like vaccination, especially in light of the findings from the present study. Prochaska
et.al (1994) investigated the role of a construct called decisional balance situated within
the stage of change model across a variety of behaviors. Decisional balance is the idea
that an individual will scan the environment to learn about the pros and cons of a
something (e.g., a behavior) before making a decision. With regard to HPV vaccination,
understanding the ways in which communication can affect a person’s decisional balance
is an important next step.
Limitations
This study is not without limitations. First, only unvaccinated women were
included in the study. In choosing an approach for the formative work in this dissertation
project, in which there was limited time and resources, the decision to use previously
collected data and focus solely on unvaccinated women seemed the best choice. This is
because unvaccinated women would be the target of any future HPV vaccine
intervention. In addition, while a traditional approach to understanding behavior change
is to design persuasive messages based on formative work and see if behavioral
intentions or actual behavior is affected positively, an alternative approach is to
understand what messages may be influencing behavioral intentions or actual behavior
negatively. This information was gained through this approach. However, future work
may want to focus on using this same approach with vaccinated women to discover what
differences exist that may have been the impetus for vaccination. Recall that for the
participants in this study, even receiving positive-valenced convergent messages did not
result in their vaccination. Further investigating the possible differences in unvaccinated

44

!

and vaccinated young women’s HPV vaccination communication environments may lead
to some clues as to why these two groups differ on vaccination status. Additionally, in
conducting research with vaccinated, partially vaccinated and unvaccinated women, it
may be possible to develop a typology of “vaccination stages of change” that could prove
useful for future intervention attempts.
Second, this interview technique relied on self-report of messages, requiring
women to recall messages about this health topic for an undesignated amount of time.
Some participants may not have remembered messages or message sources even if they
had received messages. While definitely a limitation of the study, this self-report method
is also in keeping with the tenets of exemplification theory. If an individual easily recalls
messages about a topic, this means that this particular message is easily accessible and
perhaps has “superior influence” on the individual (Zillmann, 2002, p. 28). Alternatively,
not recalling messages about a topic from particular sources may be indicative of the low
level of influence that message has on the individual. In other words, this formative
research is perhaps strengthened by a reliance on participant recall of influential
messages, because these are the messages most ripe for study from a health behavior
change perspective. Related, the analysis was done on previously collected data and
while the interview protocol did adequately address the specific research questions for
this study, it may still be considered a limitation of this study. Specifically, in examining
the multiple sources of HPV vaccine messages, the frequency with which young women
discussed certain sources (at the expense of others) could also be due to the way in which
the questions were asked. However, given that participants did mention a variety of
sources and the weight of those sources (i.e., mothers and healthcare providers played the
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largest role compared to others) is consistent with previous work in this area, this study
can still be considered to have high external validity.
Third, all participants were recruited from one university in the same geographic
area. Previous research identifying higher risks of HPV and cervical cancer with this
population provided justification for this sample, but future work may want to focus on
other geographic areas as well as women who chose not to go to college, as there may be
important population differences.
Conclusion
The purpose of Study 1 was to gain a deeper insight of the communication
environment around HPV vaccination in order to better understand what messages and
sources are most influential. The findings allowed us to identify important sources of
information for young adult women as well as the typical messages received from these
sources. Additionally, the MCF allowed us to explore the interaction of these messages
on young women’s vaccination decisions. Continued application of the MCF can add to
our understanding of HPV vaccination decisions. However, in moving beyond
application, a next step is testing the MCF to study empirically the interaction of
messages on individuals’ behavior. In the Chapter 4, the findings from Study 1 serve as a
foundation for expanding HPV vaccination-related MCF research and Study 2 is
proposed as a message testing experiment.
!
!
!
!
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CHAPTER 4
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Given the findings from Study 1 in this project, the second part of this dissertation

project attempts to move beyond formative work outlining the communication
environment using the MCF by empirically testing the influences of multiple risk
messages on personal vaccination intentions. Although Study 1 successfully identified
HPV vaccination messages and sources of those messages, Study 2 will extend theorizing
by empirically testing these different existing messages and their influence on young
adult women to provide important information about how to best intervene within the
communication environment to change vaccination behaviors. In order to have a starting
place from which to develop interventions, researchers must identify which message and
message source is most influential, whether that’s in encouraging vaccination or in
discouraging vaccination. This chapter builds on the findings from Study 1 to explore the
rationale for Study 2 and its goals of identifying the impact of young women’s
perceptions of message content, message recommendation, and message source on their
behavioral intent.
Study 2 Theoretical Framework
A common approach to understanding, predicting, and attempting to control
health behavior change is a reliance on social cognition models of behavior. Per these
social cognition models of behavior, such as those in line with the theory of reasoned
action, we know that knowledge/beliefs and attitudes about a behavior predict behavioral
intent, which is then posited as the most direct antecedent to behavior (Montaño &
Kasprzyk, 2008). In addition to our previous work in Kentucky exploring sources of
influence on HPV vaccination, we also identified some important audience profile
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variables at play in HPV vaccination decision-making. Specifically, we found that some
women, both vaccinated and unvaccinated, have serious knowledge-attitude-practice gaps
(KAP-gaps) that suggest these women are vaccinating or not vaccinating without making
a fully informed decision (Cohen & Head, 2013). While the bias among public health
officials is that a vaccine like this one is desirable, such assumptions by officials and
vaccine program planners do not remove the need for the public to make informed
decisions about health.
Informed decisions are important for at least two reasons. First, if women rely on
what other people say about this vaccine – and act upon that information – they may not
fully understand the risks and benefits of this innovation. This is arguably an ethical
issue. Second, and related, in the case of HPV vaccination in particular, if a woman is
not making an informed decision about vaccination (e.g., just getting the vaccine because
someone suggested she should), it is not unreasonable to assume this could have an
impact on her decision to return for doses 2 and 3. In other words, these women may not
have the preexisting attitudes and beliefs that are thought to influence behavior and,
therefore, these traditional theoretical approaches to understanding health behaviors and
designing interventions based on these types of theories may not be the most appropriate
theories for understanding this behavior.
Instead, based on our work in Kentucky, it appears that for some women,
messages they receive from an important person in their life may be the reason they
decide to vaccinate (or not vaccinate). As noted in Cohen and Head (2012),
Women prompted by their mothers or doctors to get the shot often did not have
any knowledge or perceived risk of HPV. As Isabel V. expressed, “I have no idea
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what it is honestly, I got the Gardasil® shot…... my mom wanted me to … but I
don’t know anything about it.” (p. 17)
It is in this sense that researchers have demonstrated the importance of studying the
communication about this topic, in addition to understanding the beliefs and attitudes
about the health behavior. For example, in the quote above, we see that a young woman
trusted what her mother had to say about the vaccination and followed the mother’s
advice, which resulted in the young woman becoming vaccinated. From a
communication perspective, one can see that both source (in this case, the young
woman’s mother) and message (in this case, the mother’s argument for vaccination)
made the difference in this young woman’s health behavior. While this example shows
that communicative influences can positively affect behavior (i.e., Isabel decided to
vaccinate), there may be other young women who listen to influential sources telling
them not to vaccinate.
Therefore, after studying the common messages and message sources about HPV
vaccination (Study 1 of this project), the next step is for researchers to attempt to
understand the ways in which young women process these messages and make decisions
based on the information they received. In moving beyond just identifying the common
messages and message sources about HPV vaccination, which was done in Study 1 of
this project, the next step is attempting to understand how young women are processing
these messages and making decisions based off the information they receive.
Specifically, we need to focus on perceptions of source and perceptions of messages
about HPV vaccination. Recall that MCF posits that source and message content
variables (particularly how messages overlap) are important cues for an individual, and
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exemplification theory goes one step further in saying that some message content
variables may cause a message to have superior influence on an individual. Consistent
with past work on message processing, Witte (1995) notes that “although source and
message variables can be thoughtfully considered in a central route manner, they are
believed to act more often as variables that cue a person to accept a message, and thus
tend to be processed peripherally” (p. 148). In other words, rather than assuming that
individuals extensively process and analyze every message they receive, a more realistic
approach is to assume that individuals use shortcuts to process the many messages they
receive on a topic. This idea is related to the tenets of MCF and exemplification theory,
which both privilege the idea that in an environment of multiple messages, some message
factors and message source factors may operate as heuristics that stand out of offer
memorable cues, whereas others do not, suggesting that messages may be processed
differently. Understanding how and why those messages and sources have heuristic
value, in the context of the communication environment around HPV vaccination, is the
underlying purpose of Study 2. The next section delves deeper into the notion of
message processing, specifically related to certain source and message factors.
Message Processing
During the late 1970s and early 1980s, two groups of scholars were
simultaneously developing quite similar message processing models: Petty and Cacioppo
presented their elaboration likelihood model (1981, 1986) and Chaiken presented her
heuristic-systematic model of information processing (1980). These two communication
models postulate that under certain conditions, individuals may use a great amount of
cognitive effort to systematically or centrally process a persuasive communication, and in

50

!

these cases, persuasion is thought to be stronger and more lasting. Alternatively,
individuals may use minimal cognitive effort to heuristically or peripherally process a
persuasive communication and in these cases, persuasion is thought to be less strong.
While appreciable differences exist between the models (see especially, Eagly &
Chaiken, 1993, Chapter 7), the purpose and scope of this project does not necessitate
delving into those differences.
Two of the most commonly studied variables in this line of research are source
credibility and argument strength. Evidence of having relied on source credibility to
make a decision is often thought to indicate a message receiver is processing the message
peripherally, relying on the credibility of the source as a cue that they should follow the
recommendation; evidence of having assessed argument strength is thought to indicate a
message receiver is processing the message centrally, carefully scrutinizing the content
(Stiff & Mongeau, 2003). These dual-process theories are, by no doubt, impressive
models with extensive research to support these claims. However, as noted by Stiff and
Mongeau (2003), tests of models like the ELM rely on the same experimental procedure
over and over again:
The procedure involves creating two persuasive messages that advocate the same
position…one message contains strong arguments supporting the message
recommendation and the other contains weak arguments. These messages are
attributed to a highly or less expert source as they are presented to research
participants. (p. 220)
It is in this between-subjects research design that these theories have fallen short time and
again to have higher ecological validity. They fail to take into account the effect of more
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than one message on an individual’s decision to enact a behavior (i.e., be persuaded to
vaccinate or not vaccinate). While it is certainly understandable that this research design
is allows for a high degree of control in an experimental test, it fails to consider the
processing of more than one persuasive message about a topic. In other words, what we
don’t quite know is what role variables like source credibility and argument strength play
when an individual encounters different messages from more than one source as happens
in the real world. Study 2 is designed to address this gap.
Related, the tenets of the MCF (e.g., convergent messages from two different
sources are more persuasive than divergent messages from two different sources) have
not been empirically tested. As noted earlier in Study 1, this research project is the first
time the MCF has been applied to the health communication setting. What little research
has been done using the MCF in risk and crisis communication has also suffered from
methodological limitations from a reliance on the case study. As noted by Sellnow and
colleagues (2009),
The case study approach works well to identify best practices for risk
communication because individual situations are defined or isolated, relevant data
are collected about the situation, and the findings are presented in such a way that
a more complete understanding is reached regarding how messages shape
perceptions and serve to prompt particular responses from those hearing the
messages. (p. 53)
Many sources of data can be used in a case study, such as mass media messages,
interviews with key stakeholders, and news coverage. The use of case studies is limiting,
though, and while it may be appropriate to study temporal events such as a time of crisis
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and gain knowledge about best practices for similar future situations, this theory can
benefit from rigorous testing and application.
As every young social scientist learns, a defining characteristic of a strong social
scientific theory is that it must be falsifiable or testable in nature (Griffin, 2006;
Shoemaker, Tankard, & Lasorsa, 2004). Although to date, the MCF has not benefited
from empirical tests, whether in risk or health communication, it is a testable framework.
This current limitation of MCF, combined with Stiff and Mongeau’s (2003) critique of
the traditional experimental design used in most ELM-type studies, leads to the proposed
design in the current study: an experimental test of MCF in which there are messages
from more than one source that may vary on source credibility and argument strength, but
in which the true “manipulation” comes from exposing individuals to different
combinations of messages, not just message variables. In the following sections, I
separately define source credibility and argument strength and their role in the persuasion
process, and I pose several research questions and hypotheses relevant to the current
study. After examining each variable separately, I return to a discussion of the MCF and
the effect of multiple messages on message processing and persuasion, and I pose the
final research question and hypothesis addressing the first experimental test of the MCF.
Source credibility. While sources may vary or differ on any number of
characteristics, one of the most powerful source factors in persuasion is source
credibility. Especially in the case of recommendations about a health behavior (in this
case, having an injection), source credibility may serve as an important cue for
individuals. In other words, if someone you think is credible tells you to do something
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(or not do something), then you are more likely to listen to that person than if you heard
the same message from a less credible person.
O’Keefe (2002) defines source credibility in the following way: “Credibility (or,
more carefully expressed, perceived credibility) consists of the judgments made by a
perceiver (e.g., message recipient) concerning the believability of a communicator” (p.
181). Perloff (2010) explains that source credibility is made up of three characteristics or
qualities: competence is defined as the perceived knowledge or abilities of the
communicator, caring is defined as the perceived goodwill of the communicator toward
the audience, and trustworthiness is defined as the perceived honesty or character of the
communicator.
For a variety of studies in communication, including health communication,
higher source credibility consistently predicts attitude change and behavior change in the
desired direction (Pornpitakpan, 2004). On the basis of the formative work done in Study
1 of this project, two sources emerged as the most prevalent in a young women’s
communication environment about HPV vaccination: mothers and healthcare providers.
However, it was unclear how credible participants perceived these sources to be in the
context of HPV vaccination. In Study 2, which is described in more detail in the next
chapter, participants will read messages from both a mother figure and a doctor; each of
these sources will provide a recommendation in their message with regard to HPV
vaccination. Based on previous research which says that sources perceived as more
credible will be more persuasive, the following research hypothesis is posed:
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Hypothesis 1: Participants will be more likely to follow the recommendation
given by sources they perceive as higher in competence/caring/trustworthiness
than sources they perceive as lower in competence/caring/trustworthiness.
In addition to the overall effect of source credibility on persuasion, an
understanding of what type of perceived source credibility (competence, caring,
trustworthiness) has the largest persuasive impact unclear. What is clear is that both
O’Keefe and Perloff emphasize in their writings that source credibility is not so much
about the communicator as it is about the message receiver’s perception of the
communicator within a certain context. In fact, Perloff (2010) notes that “the role a
communicator plays…can determine the particular aspect of credibility that is most
important” (p. 169). While it would seem that medical competence of a trained
healthcare provider would be the most influential factor in recommendations about a
vaccine, Study 1 revealed that mothers also played an influential role. Also, recall that
for all of the women in Study 1, none of them had decided to get vaccinated. Therefore,
because it is unclear which type of source credibility may have the largest impact in the
context of HPV vaccination, the following research question is posed:
Research Question 1: Which type of source credibility (i.e., competence, caring,
trustworthiness) best predicts participants’ likelihood to follow the source’s
recommendation?
Finally, given that this study privileges the role that multiple messages from
multiple sources over time has on an individual’s health behavior, it would be negligent
to ignore the role that past communication with sources has on an individual’s perception
of similar sources in this study. While it is not possible to control for and account for all
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HPV vaccination messages from past sources within Study 2, it is possible to measure
past communication with the two sources that emerged as the most influential in Study 1:
mothers and healthcare providers. Therefore, the following research question is posed:
Research Question 2: What effect does past conversation with a source have on
participant’s perceptions of that source’s credibility (i.e., competence, caring,
trustworthiness)?
Argument strength. What do advertisers, politicians, cult leaders and health
behavior change researchers all have in common? When presenting individuals with a
persuasive message, they hope it is perceived as a strong argument. Zhao, Strasser,
Cappella, Lerman, and Fishbein (2011) define perceived argument strength as “audience
members’ perceptions of the quality, strength, and persuasiveness of the arguments
employed in a persuasive communication” (p. 50). Several researchers note that
argument strength is one of the most manipulated and studied message variables in
persuasion research, and all suggest that a message perceived as stronger will be more
persuasive (Johnson, Maio, & Smith-McLallen, 2005; Johnson, Smith-McLallen, Killeya,
& Levin, 2004; Petty & Cacioppo, 1986; Petty, Kasmer, Haugtvedt, & Cacioppo, 1987).
Because of this focused attention, as is the case in many commonly studied social
science variables, there are many different measures of argument strength (Bassili, 1996).
In reviewing those past measures and identifying the limitations, Zhao et al. (2011)
developed a new measure that accounted for a more robust assessment of perceived
argument strength. For example, they included items in their scale that addressed not
only likelihood of agreement or favorability toward an argument, which is consistent with
the dominant measure of argument strength through a thought listing technique, but also
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items that addressed perceived truth value, perceived importance, perceived confidence in
the argument’s recommendation, and a summative measure assessing individuals’
perceptions of the argument quality.
Unfortunately, the use of this more robust measure in research suffers from two
limitations. First, most likely due to the scale developers own desire to use their scale
once it was published, many of those same individuals have used the scale in their own
research that centers on one behavior – smoking (Bigsby, Cappella, & Seitz, 2012;
Falcone et al., 2011; Lee & Cappella, 2013; Lee, Cappella, Lerman, & Strasser, 2011,
2013). In addition, many of these published smoking studies appear to come from the
same large dataset, suggesting the scale has not been tested in truly different contexts.
Second, for this series of studies, the scale was used as a manipulation check for
argument strength manipulations for created messages. While this is arguably a positive
use of the scale, it fails to consider the perceived argument strength of existing persuasive
communications.
In this research project, the persuasiveness of existing messages in the
communication environment is the focus. Therefore, given previous research that
suggests arguments perceived as stronger are more persuasive and given the formative
work done in Study 1 that suggests some young women may be likely to follow
recommendations about HPV vaccination without the preexisting attitudes and beliefs
that are thought to drive behavior, the following research hypothesis is posed:
Hypothesis 2: Messages perceived as having a stronger argument (i.e., type of
risk) will be positively related to participants’ likelihood to follow the message
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recommendation (i.e., vaccinate, not vaccinate) more than arguments perceived as
weak.
Message convergence framework. Finally, in returning to the theoretical
framework of this research project, the MCF informs the main hypotheses and research
questions for Study 2. Recall from Chapter 2 that Sellnow et al. (2009) claim that “when
distinct bodies of knowledge overlap, resulting in some capacity of agreement” (p. 12),
there is message convergence. In instances of a high degree of message convergence,
individuals can feel more certain about the messages they hear and the recommendations
contained within those messages. Hence, an individual would be more likely to follow
the consonant recommendation. Alternatively, in cases of message divergence,
individuals must evaluate the claims in those messages and make choices about whom to
believe and which recommendation to follow.
The findings from Study 1 indicate that mothers and healthcare providers played
the largest role in young women’s HPV vaccination communication environment and
participants most often discussed the interaction of messages from these two sources (i.e.,
my doctor was saying this, but my mom was saying this). Additionally, Study 1 findings
revealed that mothers often voiced messages about the risk of the vaccine and
recommended against vaccination and healthcare providers often voiced messages about
the risk of cervical cancer and recommended vaccination. Findings also revealed that
both sources voiced messages about the lack of risk due to a young woman’s sexual
naivety and in these cases, both mothers and healthcare providers recommended against
vaccination.
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In designing Study 2, I used these findings from Study 1 to enhance external
validity by using these two sources in an experiment in which young adult females
receive messages from both sources. Study 2 uses these two sources (i.e., mother,
healthcare provider) and each source delivers messages within the same condition (rather
than having some participants read a message by one source and other participants read a
messages by another source). Additionally, these sources will deliver messages that
converge (agree) or diverge (disagree) on two message content variables, as informed by
Study 1: type of risk message (i.e., risk of the vaccine, risk of cervical cancer, no risk of
HPV because woman is sexually naïve) and recommendation for vaccination (i.e., receive
vaccine, do not receive vaccine). By asking women to read messages that vary on source
and content about HPV vaccination, we can extend the MCF by testing messages against
each other and determining which message combination is the most influential.
However, for the purpose of analyses and because the most likely focus of a future
intervention would be with a healthcare provider, the following hypothesis is set up to
test the likelihood of participants following the doctor’s recommendation. As such, the
hypothesis reads:
Hypothesis 3: Participants who receive messages from doctors and mothers that
converge on both recommendation and risk (i.e., Conditions 1, 5, 9) will be more
likely to follow the recommendation given by the doctor than participants who
receive messages from both sources with mixed message characteristics
(divergence on risk and convergence on recommendation; i.e., Conditions 7, 3) or
participants who receive messages from mothers and doctors that diverge on both
recommendation and risk (i.e., Conditions 2, 4, 6, 8).
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Finally, in keeping with the idea that the MCF considers the communication
environment around an issue over time (i.e., a movie reel) and not just one or two
messages at one time point (i.e., a snapshot), this study considers the effect of past
messages about HPV vaccination and their effect on current message processing. While
an analysis of all previous HPV vaccination messages from all sources is not within the
scope of the current project, it is feasible in the current study to measure the effect of
previous conversations about HPV vaccination with one of the two target sources (i.e.,
mother and doctor) on a young woman’s likelihood to follow the recommendation of the
doctor. Hence, the final research question for Study 2 is:
Research Question 3: What is the effect, if any, of past conversations with a
mother/mother figure or doctor on participants’ likelihood to follow the doctor’s
recommendation?
In sum, Study 2 is proposed as an experiment to test these common message
sources and message content variables to determine what may be the most influential
source/message combination. Rather than the common source vs. message factorial
design discussed at the beginning of this chapter, Study 2 adheres to the MCF and uses a
source/message vs. source/message design to uncover how these elements affect a
woman’s decision to vaccinate. Study 2 methods and results are detailed in the next
chapter.
!
!
!
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CHAPTER 5
Study 2
Building on the findings from Study 1 and in an effort to provide an empirical test of the
message convergence framework, Study 2 is an experiment in which participants are
randomly assigned to read messages from two difference sources (mother, healthcare
provider), that convergence, diverge or have mixed message characteristics with regard to
type of risk message and type of recommendation. As noted previously, work in HPV
vaccination promotion, specifically, and previous health persuasion research, generally,
have for the most part fallen short in empirically examining how individuals process
persuasive communications from more than one source at the same time. Study 2,
outlined in this chapter, addresses this gap.
Method
Participants and Recruitment
Participants in this study were 309 unvaccinated women ranging in age from 18 to
30 years old (M = 19.58, SD = 1.99). The university institutional review board approved
all procedures prior to study initiation. Given the 3 X 3 modified factorial design
(described below) and the desired minimum of 30 participants per cell for adequate
power (Cohen, 1988; VanVoorhis & Morgan, 2007) resulted in a desired sample size of
at least 270 participants. Recruitment of participants continued until this number was
reached and slightly exceeded for the experimental survey.
Participants were recruited in two ways. First, female students enrolled in lowerdivision communication courses were notified about this study through the Department of
Communication’s research participant pool which includes more than 3,500 students
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enrolled in general education courses from a variety of majors across the university.
Students who are a part of this research participant pool are required to complete a
research study as part of course requirements. The following study information (Table
5.1) was posted to all students on an electronic bulletin board:
Table 5.1
Study Recruitment Information
Study Information
Study Name
Communication About Women's Health
Abstract
Quick online survey about HPV vaccine and Cervical Cancer
Description
This study is a quick (no more than 15-20 minutes) survey that you can
complete at home on your own computer. We want to know your
perspectives on the HPV vaccine and cervical cancer prevention so
that we can design better health messages about these topics.
Web Study
This is an online study. Participants are not given the study URL until
after they sign up.
Eligibility
Female; between 18-30 years old; has not received the HPV vaccine
Requirements
Duration
20 minutes
Credits
1 Credits
Students who desired to participate in the study and met the eligibility
requirements enrolled in the study. A total of 279 participants were recruited through this
method. Second, women were recruited from the general campus population through
fliers posted around campus and in some sorority houses; the fliers contained the same
information listed in the SONA post above with the exception of the incentive offer of an
online $10 Target gift card or an online $10 Starbucks gift card. The flier prompted
eligible participants to email the principal researcher to complete the study. A total of 30
participants was recruited through this second recruitment method.
Although there were some significant differences between the two groups of
participants on demographic variables (see Table 5.2), there were no significant
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differences on any of the outcome variables (discussed below). Therefore, these two
groups are considered one sample from this point forward.
Table 5.2
Participant Characteristics
Combined Total
Age

19.58 (SD=1.99)

College
Classification
Freshman
Sophomore
Junior
Senior
Graduate Student
N/A

SONA
Research
Participants
19.35
(SD=1.91)

General Campus
Population

Difference

21.53 (SD=1.53)

t = -6.06 (p <.001)
X2 = 110.74 (p < .001)

53.4% (n = 165)
16.5% (n = 51)
19.4%(n = 60)
8.7% (n = 27)
0.6% (n = 2)
1.0% (n = 4)

59.8% (n = 168)
17.8% (n = 50)
16.4% (n = 46)
6.0% (n = 17)
0% (n = 0)
0% (n = 0)

0% (n = 0)
3.2% (n = 1)
45.2% (n = 14)
32.3% (n = 10)
6.5% (n = 2)
12.9% (n = 4)

Race
White/Caucasian 82.8% (n = 256)a 81.1% (n = 228) 90.3% (n = 28)
X2 = 1.60 (p = .21)
African American 10.7% (n = 33)
11.4% (n = 32) 3.2% (n = 1)
X2 = 1.97 (p = .16)
Hispanic
2.9% (n = 9)
2.5% (n = 7)
6.5% (n = 2)
X2 = 1.56 (p = .21)
Asian
5.2% (n = 16)
5.3% (n = 15)
3.2% (n = 1)
X2 = 0.27 (p = .61)
Native American 1.0% (n = 3)
1.1% (n = 3)
0% (n = 0)
X2 = 0.33 (p = .56)
Pacific Islander
0.6% (n = 2)
0.7% (n = 2)
0% (n = 0)
X2 = 0.22 (p = .64)
Other
3.6% (n = 11)
3.9% (n = 11)
0% (n = 0)
X2 = 1.26 (p = .26)
a
Note. Participants were allowed to provide multiple answers for race; therefore, each
race category is treated as a separate variable and separate chi-square tests were run to
test for differences.
Procedures
Eligible participants who signed up for the research study were directed by either
email or the student research participant pool system to an Internet survey to complete the
study. All participants read an IRB-approved consent form on the opening webpage and
were instructed that by clicking the “continue with survey” button at the bottom of the
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page, they were giving implied consent to participate in the study. A copy of the consent
form can be found in Appendix A.
As a safety measure to ensure that only eligible participants completed the
experimental section of the Internet study, participants were prevented from completing
the study if they answered “male” to the gender question or answered “18 or younger” or
“31 or older” to the age question; instead, they were directed to a page that informed
them of their ineligibility for this study and thanked them for their time. However,
despite the requirement that participants be unvaccinated, if they answered “Yes” to
receiving the HPV vaccine, they were allowed to complete a short survey about past HPV
vaccination behaviors (see Appendix B for list of questions). They were then directed to
the end of the survey where they filled out their information and were given credit for
completing the study.
There was a specific reason that these vaccinated women were allowed to
complete a portion of the survey. Some women might have honestly believed they met
the general eligibility requirement of being “unvaccinated” if they had only received
doses 1 or 2 of the 3-part HPV vaccine series. In other words, if a woman had only
received doses 1 or 2, she might believe she is eligible to complete a study about not
having the HPV vaccine (since she didn’t complete the three-dose regimen). Seventyone participants (68 participants recruited through the research participant pool and three
participants recruited through the general student population) completed the modified,
shorter version of the survey as partially vaccinated participants. However, because the
objective of the study was to examine truly unvaccinated women and their responses to
the message manipulations, and because these partially vaccinated women did not
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complete the experiment portion of the study, this group of participants is not mentioned
again.
Truly unvaccinated women completed the entire experimental survey. The
survey began with demographic questions, questions regarding attitudes and beliefs about
the HPV vaccine, questions regarding past conversations about HPV vaccination, and
questions about behavioral intent to receive the HPV vaccine. Next, participants were
randomly assigned by the Qualtrics Internet survey software to one of nine message
conditions. Finally, participants completed post-test measures including perceptions of
source credibility, perceptions of argument strength, and questions about behavioral
intent to receive the HPV vaccine. (All measures and the messages are described in
detail in the following sections.) After completing the Internet survey, all participants
were thanked for their time and were presented with a debriefing page including
information about the HPV vaccine (CDC, 2011) and information about the HPV
vaccine’s availability in the Lexington area. Finally, students eligible for the study
incentive were directed to a second “survey” asking them to enter their first name, last
name, email address, and their preference for a $10 Target gift card or a $10 Starbucks
gift card. Participants recruited through the student research participant pool were asked
to enter their first name, last name, and student ID in order to receive credit for
participating. All participants were assured that their personal information would not be
associated with their responses in the survey and the information was solely gathered in
order to deliver their gift card or course credit, respectively.
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Message Manipulations
There were nine message manipulations for the experiment embedded in the
Qualtrics Internet survey. As noted earlier, the Qualtrics program randomly assigned
participants to one message condition and then directed participants to the post-test
measures. When participants reached the message stimuli section of the Internet survey,
they first read a prompt that set up a story about a young woman named Sarah who was
thinking about getting the HPV vaccine. The prompt read:
Now, we want you to read a story about a young woman who is
deciding whether to get the HPV vaccine. She hears information about
the vaccine from a couple of different sources, which may influence her
decision. Please read Sarah's story and respond to the questions.
Sarah is a 20 year old sophomore at the University of
Kentucky. She has had sex a couple of times while in college, although
she has not told her mother or doctor that she is sexually active.
She is trying to decide whether she should get the HPV
vaccine. She knows that HPV is a common sexually transmitted disease
among college-aged women. She also knows that a vaccine is available
to protect against the types of HPV known to cause cervical cancer.
Sarah hears messages about the HPV vaccine from both her
doctor and her mother.
After reading this prompt, participants were instructed to click “Next” (and
randomly assigned to one of the message conditions) to read the messages from the
doctor and mother. Message conditions varied on type of message received from mother
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source (short-term risk of HPV vaccination, long-term risk of cervical cancer, or no risk
of HPV infection) and type of message received from doctor source (short-term risk of
HPV vaccination, long-term risk of cervical cancer, or no risk of HPV infection). To
clarify, participants received a message from both the mother and doctor source; to
control for order effects, participants were randomly assigned to receive the mother or
doctor message first. As a secondary check of order effects, a series of t-tests were run to
determine if there were any significant differences on the major experimental variables of
interest in the study (i.e., those measured in the posttest: perceptions of source credibility,
perceptions of argument strength and the likelihood to follow recommendation outcome
variables). No significant differences were found for any of these variables between
groups that read the mother message first or groups that read the doctor message first.
Table 5.3 provides information on the content of the messages; the choice of sources and
the content of the messages in this experiment were informed by the formative research
conducted in Study 1.
Table 5.3
Experiment Messages
Message Type
Short-term Risk

Content of Message
Argument
Recommendation
You may experience side effects from the I don’t think you
vaccine like a fever or rash, especially
should get the vaccine.
because it is new.

Long-term Risk

There is the risk of you getting HPV and
it turning into cervical cancer later in
life.

I think you should get
the vaccine.

No Risk

You aren’t sexually active, so there is no
risk of you getting HPV in the first place.

I don’t think you
should get the vaccine.
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The created message conditions resulted in a 3 x 3 design, presented below in
Table 5.4. Each condition is numbered to facilitate discussion. As is described later,
message conditions 1, 5, and 9 converge on risk and recommendation; message
conditions 3 and 7 diverge on risk but converge on recommendation; and message
conditions 2, 4, 6, and 8 diverge on risk and recommendation.
Table 5.4
Factorial Design

Mother

Short-term Risk
Long-term Risk
No Risk

Short-term Risk
1
4
7

Healthcare Provider
Long-term Risk
2
5
8

No Risk
3
6
9

Measures
The survey for this study can be found in Appendix B; however, only items
relevant to the main dissertation study and that address the hypotheses and research
questions described in Chapter 4 are presented in detail here. These items are basic
demographics (presented in the “Participants and Recruitment” section above), the
control variables of past conversations about HPV vaccination with both mother/mother
figures and healthcare providers, independent variables of interest (including the stimulirelated measures of perceived source credibility and perceived argument strength), and
outcome variables including behavioral intention to receive the HPV vaccine. In
addition, several computed variables are discussed below, such as the type of past
conversations about HPV vaccination with mother/mother figures and healthcare
providers, type of message stimuli convergence, and likelihood to follow the message
recommendation with regard to HPV vaccination receipt.
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Past Conversations. Participants’ past conversations about HPV vaccination
with their mothers/mother figures and healthcare providers were measured. This measure
included two parts. First, each participant was asked if she had ever discussed HPV
vaccination with the two sources of interest in this study (have you ever discussed HPV
vaccination with a healthcare provider? have you ever discussed HPV vaccination with
your mom or a mother figure in your life?); the response items for these questions were
(a) yes or (b) no. If a participant answered yes, she was then asked to indicate what that
source advised her to do (did the provider (a) recommend that you receive the HPV
vaccine or (b) recommend that you not receive the HPV vaccine?; did your mom (or
mother figure) (a) recommend that you receive the HPV vaccine or (b) recommend that
you not receive the HPV vaccine?). Descriptive statistics for this variable are presented
in Table 5.5 below.
Table 5.5
Past HPV Vaccination Conversations
Self-Reported Past Conversation with Mother
No
Yes
Recommended vaccination
Did not recommend vaccination
Self-Reported Past Conversation with Doctor
No
Yes
Recommended vaccination
Did not recommend vaccination

Percent

Frequency

40.1%
58.7%
59.6%
40.4%

n = 125
n = 183
n = 109
n = 74

48.1%
51.0%
89.3%
10.1%

n = 150
n = 159
n = 142
n = 16

For the purpose of analysis, two ordinal variables representing the nature of past
conversations were created: one for past conversation with a participant’s mother/mother
figure and one for past conversations with a healthcare provider. Participants who
reported no past conversations were given the value of 0, participants who reported past
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conversations with a recommendation to not receive the HPV vaccine were given the
value of -1, and participants who reported past conversations with a recommendation to
receive the HPV vaccine were given the value of +1. Therefore, every participant had
two past conversation scores, one that reflected the nature of her conversations with her
mother/mother figure and one that reflected the nature of her conversations with her
healthcare provider.
Source Credibility. Each participant’s perception of source credibility was
measured using a seven-point semantic differential scale (McCroskey & Teven, 1999).
Source credibility is composed of three separate subscales and each subscale has its own
set of items: competence ( intelligent/unintelligent, untrained/trained, inexpert/expert,
informed/uninformed, incompetent/competent, and bright/stupid); caring (cares about
me/doesn't care about me, has my interests at heart/doesn't have my interests at heart,
self-centered/not self-centered, concerned with me/not concerned with me,
insensitive/sensitive, and not understanding/understanding); and trustworthiness
(honest/dishonest, untrustworthy/trustworthy, honorable/dishonorable, moral/immoral,
unethical/ethical, and phony/genuine). Because each participant read messages from both
a mother source and a doctor source, each participant answered these questions twice.
Scores on the three separate subscales are presented separately for each source below.
Included in these sections are descriptions of dichotomizing each subscale into high and
low values using a median split (MacCallum, Zhang, Preacher, & Rucker, 2002).
Detailed descriptive statistics (including scores on each credibility scale for each
condition) are presented in Table 5.6 for the mother source and Table 5.7 for the doctor
source.
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Mother competence. Exploratory factor analysis (principal components) revealed
a unidimensional solution to the mother competence subscale. The six competence items
were averaged (M = 3.91, SD = 1.25) to compute a reliable (! = 0.84) perceived mother
competence scale, where higher scores indicate that participants perceived the mother
source to be more competent. Using a median split (Md = 3.83), scores on the perceived
mother competence scale were dichotomized into a new variable; participants who rated
the mother’s competence at or below 3.83 were labeled as perceived low mother
competence and participants who rated the mother’s competence above 3.83 were labeled
as perceived high mother competence.
Mother caring. Exploratory factor analysis (principal components) revealed a
unidimensional solution to the mother caring scale. The six caring items were averaged
(M = 5.23, SD = 1.26) to compute a reliable (! = 0.85) perceived mother caring scale,
where higher scores indicate that participants perceived the mother source to be more
caring. Using a median split (Md = 5.33), scores on the perceived mother caring scale
were dichotomized into a new variable; participants who rated the mother’s caring at or
below 5.33 were labeled as perceived low mother caring and participants who rated the
mother’s caring above 5.33 were labeled as perceived high mother caring.
Mother trustworthiness. Exploratory factor analysis (principal components)
revealed a unidimensional solution to the mother trustworthiness scale. The six
trustworthiness items were averaged (M = 5.18, SD = 1.18) to compute a reliable (! =
0.89) perceived mother trustworthiness scale, where higher scores indicate that
participants perceived the mother source to be more trustworthy. Using a median split
(Md = 5.17), scores on the perceived mother trustworthiness scale were dichotomized
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into a new variable; participants who rated the mother’s trustworthiness at or below 5.17
were labeled as perceived low mother trustworthiness and participants who rated the
mother’s trustworthiness above 5.17 were labeled perceived high mother trustworthiness.
Doctor competence. Exploratory factor analysis (principal components) revealed
a unidimensional solution to the doctor competence scale. The six competence items
were averaged (M = 5.45, SD = 1.47) to compute a reliable (! = 0.92) perceived doctor
competence scale, where higher scores indicate that participants perceived the doctor
source to be more competent. Using a median split (Md = 5.83), scores on the perceived
doctor competence scale were dichotomized into a new variable; participants who rated
the doctor’s competence at or below 5.83 were labeled as perceived low doctor
competence and participants who rated the doctor’s competence above 5.83 were labeled
as perceived high doctor competence.
Doctor caring. Exploratory factor analysis (principal components) revealed a
unidimensional solution to the doctor caring scale. The six caring items were averaged
(M = 4.86, SD = 1.23) to compute a reliable (! = 0.88) perceived doctor caring scale,
where higher scores indicate that participants perceived the doctor source to be more
caring. Using a median split (Md = 4.83), scores on the perceived doctor caring scale
were dichotomized into a new variable; participants who rated the doctor’s caring at or
below 4.83 were labeled as perceived low doctor caring and participants who rated the
doctor’s caring above 4.83 were labeled as perceived high doctor caring.
Doctor trustworthiness. Exploratory factor analysis (principal components)
revealed a unidimensional solution to the doctor trustworthiness scale. The six
trustworthiness items were averaged (M = 5.23, SD = 1.24) to compute a reliable (! =
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0.92) perceived doctor trustworthiness scale, where higher scores indicate that
participants perceived the doctor source to be more trustworthy. Using a median split
(Md = 5.17), scores on the perceived doctor trustworthiness scale were dichotomized into
a new variable; participants who rated the doctor’s trustworthiness at or below 5.17 were
labeled as perceived low doctor trustworthiness and participants who rated the doctor’s
trustworthiness above 5.17 were labeled as perceived high doctor trustworthiness.
Table 5.6
Mother Source Credibility Descriptive Statistics
Type of
Condition
Credibility
Perceived
Mother
Competence

Perceived
Mother
Caring

!

Overall – All Conditions
Mom Short-term Risk
Condition 1
2
3
Mom Long-term Risk
4
5
6
Mom Lack of Risk (No Sex)
7
8
9
Overall – All Conditions
Mom Short-term Risk
Condition 1
2
3
Mom Long-term Risk
4
5
6
Mom Lack of Risk (No Sex)
7
8
9

!
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Reliability
(!)
.84
.87

.89

.75

.85
.89

.80

.86

Mean
Score
(M)
3.91
3.60
3.80
3.27
3.74
4.81
4.69
4.84
4.92
3.32
3.49
3.18
3.29
5.23
5.02
4.91
4.94
5.21
6.11
6.08
6.16
6.12
4.55
4.77
4.42
4.47

Standard
Deviation
(SD)
1.25
1.21
1.22
1.17
1.20
1.09
.94
1.10
1.25
.88
.88
.90
.86
1.26
1.24
1.34
1.23
1.16
.78
.74
.75
.87
1.17
1.01
1.44
1.00
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Table 5.6 (continued)
Perceived
Overall – All Conditions
Mother
Mom Short-term Risk
Trustworthiness
Condition 1
2
3
Mom Long-term Risk
4
5
6
Mom Lack of Risk (No Sex)
7
8
9
Table 5.7
Doctor Source Credibility Descriptive Statistics
Type of
Condition
Credibility
Perceived
Doctor
Competence

Perceived
Doctor
Caring

!

Overall – All Conditions
Doctor Short-term Risk
Condition 1
4
7
Doctor Long-term Risk
2
5
8
Doctor Lack of Risk (No Sex)
3
6
9
Overall – All Conditions
Doctor Short-term Risk
Condition 1
4
7
Doctor Long-term Risk
2
5
8
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.89
.92

.91

.85

Reliability
(!)
.92
.94

.92

.90

.88
.89

.88

5.18
4.90
4.93
4.83
4.94
5.92
5.83
5.95
5.97
4.73
4.98
4.73
4.50

Mean
Score
(M)
5.45
5.23
5.22
5.33
5.14
6.30
6.27
6.28
6.37
4.81
5.01
5.14
4.29
4.86
4.71
4.70
4.76
4.68
5.41
5.31
5.33
5.59

1.18
1.17
1.22
1.15
1.16
.94
.89
.93
1.02
1.05
.91
1.12
1.07

Standard
Deviation
(SD)
1.47
1.50
1.56
1.61
1.36
.96
.97
1.10
.80
1.46
1.40
1.58
1.29
1.23
1.20
1.41
1.18
.99
1.11
1.15
1.08
1.11
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Table 5.7 (continued)
Doctor Lack of Risk (No Sex)
3
6
9
Perceived
Overall – All Conditions
Doctor
Doctor Short-term Risk
Trustworthiness
Condition 1
4
7
Doctor Long-term Risk
2
5
8
Doctor Lack of Risk (No Sex)
3
6
9

.86

.92
.94

.92

.91

4.45
4.65
4.63
4.07
5.23
5.01
5.02
5.05
4.95
5.84
5.68
5.96
5.90
4.83
4.96
5.13
4.41

1.19
1.20
1.29
.98
1.24
1.28
1.44
1.17
1.25
1.00
1.02
.90
1.07
1.20
1.22
1.36
.92

Argument Strength. A modified version of the perceived argument strength
scale developed by Zhao et al. (2011) was used to identify participants’ perceptions of the
message argument strength. The scale contains two parts. First, participants responded
to five statements/questions about the target argument using a four-point Likert type scale
where 1 = strongly disagree and 4 = strongly agree; items included the following: (a) the
statement is a reason for ___ that is believable, (b) the statement is a reason for ___ that
is convincing, (c) the statement gives a reason for ___ that is important to me, (d) the
statement put thoughts in my mind about wanting/not wanting to___, and (e) overall, how
much do you agree or disagree with the statement? Second, participants responded to the
following question using a four-point Likert-type scale where 1 = very weak and 4 = very
strong: Is the reason the statement gave for ____ a strong or weak reason? Scores are
averaged to calculate an overall perceived argument strength score.
Before presenting the descriptive analysis for this scale, three important points are
worth making. First, participants responded using this scale twice, once in reference to
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the mother message they read and once in reference to the doctor message they read.
Therefore, each participant has a perceived mother argument strength score and a
perceived doctor argument strength score. (Note that to ensure participants were
responding to the correct argument, the specific message [e.g., the mother message] was
listed at the top of the page as participants answered the questions in this scale.) Second,
because participants were randomly assigned to one of three different messages from
each source, only one-third of participants (n=103) responded to each different message.
In other words, 103 participants read the mother’s short-term risk message, 103
participants read the mother’s long-term risk message, and 103 participants read the
mother’s no risk message. This was also the case for the doctor messages. Regardless of
the message read, a higher score indicates a participant believed the message contained a
stronger argument, and therefore these different versions of the scale are comparable.
However, because the arguments were part of the experimental manipulation and were
completed by different individuals randomly assigned to that message condition, scores
are left separate for each argument type for the purpose of analysis; see the Message
Manipulations section above to review the content of the arguments. Third, as seen in the
scale statements/questions above, there are blanks where the researcher must indicate the
message outcome participants must respond to. On the basis of message condition (i.e.,
whether the source recommended the HPV vaccination or whether the source
recommended not getting the HPV vaccination), participants were directed to respond to
the appropriate message recommendation outcome on the argument strength scale. For
example, if participants read a message in which the recommended outcome was to not
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get the HPV vaccine, the first scale item read, “the statement is a reason for not getting
the HPV vaccine that is believable.”
In sum, there are six different versions of this scale that were answered in this
study, but each participant only answered two of them. Descriptive data analyses for
these scales are presented below and the information is presented visually in Table 5.8.
Mother short-term risk message perceptions (n = 103). Exploratory factor
analysis (principal components) revealed a unidimensional solution to the argument
strength scale for participants’ perceptions of the short-term risk message delivered by
the mother source. The six argument strength items were averaged (M = 2.27, SD = 0.62)
to compute a reliable (! = 0.88) perceived mother short-term risk message argument
strength scale, where higher scores on the scale indicate that participants perceived the
mother short-term risk message as a stronger argument.
Doctor short-term risk message (n = 103). Exploratory factor analysis (principal
components) revealed a unidimensional solution to the argument strength scale for
participants’ perceptions of the short-term risk message delivered by the doctor source.
The six argument strength items were averaged (M = 2.67, SD = 0.79) to compute a
reliable (! = 0.91) perceived doctor short-term risk message argument strength scale,
where higher scores on the scale indicate that participants perceived the doctor short-term
risk message to be a stronger argument.
Mother long-term risk message (n = 103). Exploratory factor analysis (principal
components) revealed a unidimensional solution to the argument strength scale for
participants’ perceptions of the long-term risk message delivered by the mother source.
The six argument strength items were averaged (M = 3.15, SD = 0.56) to compute a
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reliable (! = 0.86) perceived mother long-term risk message argument strength scale,
where higher scores indicate that participants perceived the mother long-term risk
message to be a stronger argument.
Doctor long-term risk message (n = 103). Exploratory factor analysis (principal
components) revealed a unidimensional solution to the argument strength scale for
participants’ perceptions of the long-term risk message delivered by the doctor source.
The six argument strength items were averaged (M = 3.39, SD = 0.55) to compute a
reliable (! = 0.86) perceived doctor long-term risk message argument strength scale,
where higher scores indicate that participants perceived the doctor long-term risk
message to be a stronger argument.
Mother no risk message (n = 103). Exploratory factor analysis (principal
components) revealed a unidimensional solution to the argument strength scale for
participants’ perceptions of the no risk message delivered by the mother source. The six
argument strength items were averaged (M = 2.05, SD = 0.70) to compute a reliable (! =
0.88) perceived mother no risk message argument strength scale, where higher scores
indicate that participants perceived the mother no risk message to be a stronger argument.
Doctor no risk message (n = 103). Exploratory factor analysis (principal
components) revealed a unidimensional solution to the argument strength scale for
participants’ perceptions of the no risk message delivered by the doctor source. The six
argument strength items were averaged (M = 2.50, SD = 0.81) to compute a reliable (! =
0.90) perceived doctor no risk message argument strength scale, where higher scores
indicate that participants perceived the doctor no risk message to be a stronger argument.

78

!

Table 5.8
Argument Strength Descriptive Statistics
ArguRecommenReliabilCondiment
dation
ity
tion
(!)
Mother Do not vaccinate .88
Overall
short1
term risk
2
3
Doctor Do not vaccinate .91
Overall
short1
term risk
4
7
Mother Vaccinate
.86
Overall
long4
term risk
5
6
Doctor Vaccinate
.86
Overall
long2
term risk
5
8
Mother Do not vaccinate .88
Overall
no risk
7
8
9
Doctor Do not vaccinate .90
Overall
no risk
3
6
9

Mean Score
(M)

Standard
Deviation (SD)

2.27
2.36
2.24
2.20
2.67
2.77
2.59
2.67
3.15
3.10
3.17
3.20
3.39
3.35
3.27
3.54
2.05
1.99
2.02
2.13
2.50
2.70
2.47
2.32

.620
.633
.636
.600
.79
.857
.890
.610
.563
.644
.481
.560
.546
.600
.583
.420
.697
.565
.808
.700
.807
.751
.850
.800

Behavioral Intent
Vaccine receipt. There were two vaccine receipt intent measures that served as
outcome variables for this study. First, each participant was asked what she believed the
character in the story, Sarah, would do regarding HPV vaccination (how likely do you
think Sarah would be to get the vaccine?). Second, participants were asked what they
would do regarding HPV vaccination after reading Sarah’s story (in thinking about what
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you read today [i.e., the messages from Sarah’s mother and doctor], how likely are you
to get the vaccine?). For both of these questions, participants responded using a fourpoint Likert-type scale where 1 = very unlikely and 4 = very likely. Higher scores on
each of these measures indicated that participant believed Sarah/she would be more likely
to get the vaccine.
Likelihood to follow the recommendation within the message. Because many
of the research questions and hypotheses sought to identify the likelihood to follow the
recommendation offered in the messages (rather than intent to get the vaccine), a
secondary outcome measure was calculated called likelihood to follow recommendation.
Each participant answered questions related to her beliefs about how likely Sarah would
be to get the vaccine and how likely she personally would be to get the vaccine
(discussed in the “Vaccine receipt” section above). These variables were recoded into
four “likelihood to follow recommendation” variables through a multi-step calculation.
First, each condition was coded for whether the mother source recommended to get or to
not get the vaccine. The same was done for each condition regarding the doctor’s
recommendation. Next, the message conditions were nominally coded for whether or not
the source recommended the vaccine. Each message condition in which the mother
recommended to get the vaccine (conditions 4, 5, and 6) was coded as a 1. Each message
condition in which the mother recommended not getting the vaccine (conditions 1, 2, 3,
7, 8, and 9) was coded as a 2. Similarly, each message condition in which the doctor
recommended to get the vaccine (conditions 2, 5, and 8) was coded as a 1. Each message
condition in which the doctor recommended not getting the vaccine (conditions 1, 3, 4, 6,
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7 and 9) was coded as a 2. See Table 5.9 below for the message conditions and type of
recommendation from each source.
Table 5.9
Recommendations by Sources for Each Message Condition
Condition
Mother says…
Get it
Don’t Recommendation Get it
get it
Score
1
*
2
2
*
2
*
3
*
2
4
*
1
5
*
1
*
6
*
1
7
*
2
8
*
2
*
9
*
2

Doctor says…
Don’t Recommendation
get it
Score
*
2
1
*
2
*
2
1
*
2
*
2
1
*
2

Recall that participants answered two vaccine receipt intention questions (i.e.,
how likely do you think Sarah would be to get the vaccine? and in thinking about what
you read today [i.e., the messages from Sarah’s mother and doctor], how likely are you
to get the vaccine?) and that for both of these questions, participants responded using a
four-point Likert type scale where 1 = very unlikely and 4 = very likely. Scores for these
questions, combined with the recommendation from each source in each message
condition, were used to calculate four new outcome variables, [Sarah or Participant]
likelihood to follow [mother’s or doctor’s] recommendation. For conditions in which the
mother source recommended to get the vaccine, the values associated with the original
vaccine receipt intent measure (1 = very unlikely 2 = somewhat unlikely, 3 = somewhat
likely, and 4 = very likely) were used as the new values for the likelihood to follow
recommendation variable because following the recommendation to get the vaccine (i.e.,
following the mom’s advice) and being more likely to get the vaccine (i.e., a higher
score) would be the same. In other words, for conditions in which the mother
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recommended getting the vaccine, participants’ scores on the behavioral intent measure
(likelihood to get the vaccine) were simply copied for the new likelihood to follow
recommendation outcome variable. For conditions in which the mother recommended
not getting the vaccine, the values were recoded into the opposite value (1 = 4, 2 = 3, 3 =
2, and 4 = 1) because if a participant read a message where the mother source
recommended to not get the vaccine, yet the participant selected that Sarah/she would be
very likely to get it, then this would result in the participant’s believing Sarah/she would
be very unlikely to follow the recommendation. The data transformation (or, recoding) is
displayed below in Table 5.10. This process resulted in four new variables (Sarah’s
likelihood to follow mother recommendation, Participant’s likelihood to follow mother
recommendation, Sarah’s likelihood to follow doctor recommendation, and Participant’s
likelihood to follow doctor recommendation), which served as the primary outcome
variables for most of the analyses.
Table 5.10
Recoding of Likelihood Outcome Variables

Recoded into
Sarah’s/Participant’s Sarah’s/Participant’s Likelihood Sarah’s/Participant’s to Follow
Likelihood to Get
to Follow Mother
Doctor Recommendation
Vaccine (Original
Recommendation
Scores on
Conditions
Conditions
Conditions
Conditions
Behavioral Intent
Where Mother Where Mother Where Doctor Where Doctor
Measure)
Says Get
Says Not Get
Says Get
Says Not Get
Vaccine
Vaccine
Vaccine
Vaccine
1 = very unlikely
1 = very
4 = very
1 = very
4 = very
unlikely
unlikely
unlikely
unlikely
2 = somewhat
2 = somewhat 3 = somewhat 2 = somewhat 3 = somewhat
unlikely
unlikely
unlikely
unlikely
unlikely
3 = somewhat likely 3 = somewhat 2 = somewhat 3 = somewhat 2 = somewhat
likely
likely
likely
likely
4 = very likely
4 = very likely 1 = very likely 4 = very likely 1 = very likely
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Finally, for each of the four the new likelihood to follow recommendation
variables created above, a final dichotomized variable for each likelihood outcome was
created. If a participant scored 1 or 2 on the likelihood to follow the recommendation,
this was recoded into 1 for “not likely.” If a participant scored a 3 or 4 on the likelihood
to follow the recommendation, this was recoded into a 2 for “likely.”

Results
Hypothesis 1
Hypothesis 1 predicted that participants will more likely follow the
recommendation given by sources they perceive as higher in
credibility/caring/trustworthiness than sources they perceive as lower in
credibility/caring/trustworthiness. A series of t-tests was run to test this hypothesis.
Given that there are four different likelihood to follow recommendation variables and
three different types of source credibility for each source (competence, caring, and
trustworthiness for both mother and doctor), the total number of t-tests run was 12.
Results are reported below and in Table 5.11 (for Sarah’s likelihood to follow
recommendation from both sources) and Table 5.12 (for participant likelihood to follow
recommendation from both sources).
Source credibility and Sarah’s likelihood to follow mother’s recommendation.
Results showed no significant differences for perceived mother competence, t (304) =
0.80, p = 0.42 (Mlow = 2.86, Mhigh = 2.83) or perceived mother caring, t (304) = 0.46, p =
0.64 (Mlow = 2.87, Mhigh = 2.83). However, there was a significant difference for
perceived mother trustworthiness, t (304) = 2.07, p = 0.04 (Mlow = 2.80, Mhigh = 2.89).
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Therefore, Hypothesis 1 was partially supported for the outcome variable Sarah’s
likelihood to follow mother’s recommendation. Participants were more likely to believe
that Sarah would follow the mother’s recommendation when they perceived the mother
source to have higher trustworthiness, but they were not more likely to believe that Sarah
would follow the mother’s recommendation due to perceived higher mother competence
or mother caring. In order to better see the distribution of scores, results in Table 5.11
(and Table 5.12) also present the percentage of participants who chose very unlikely,
somewhat unlikely, somewhat likely and very likely for likelihood to follow the
recommendation, situated within the high and low source credibility conditions.
Source credibility and Sarah’s likelihood to follow doctor’s recommendation.
Results showed no significant differences for perceived doctor competence, t (303) =
0.20, p = 0.84 (Mlow = 2.91, Mhigh = 2.85), perceived doctor caring, t (303) = 0.62, p =
0.54 (Mlow = 2.90, Mhigh = 2.81), or perceived doctor trustworthiness, t (303) = 0.56, p =
0.57 (Mlow = 2.87, Mhigh = 2.86). Therefore, Hypothesis 1 was not supported for the
outcome variable Sarah’s likelihood to follow the doctor’s recommendation. Participants
were not more likely to believe that Sarah would follow the doctor’s recommendation
regardless of how they perceived the doctor’s competence, caring, or trustworthiness.
Table 5.11
Hypothesis 1 Results for Source Credibility and Sarah’s Likelihood
Sarah’s Likelihood to Follow Recommendation
Very
Somewhat
Somewhat
Very Likely
unlikely
unlikely
likely
Mother
% (n)
Competence
Low
50% (4)
45.9% (45)
40.6% (54)
55.2% (37)
M = 2.96 (SD = .69)
High
50% (4)
54.1% (53)
59.4% (79)
44.8% (30)
M = 4.95 (SD = .81)
!
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Table 5.11 (continued)
Caring
Low
M = 4.18 (SD = .86)
High
M = 6.25 (SD = .56)
Trustworthiness
Low
M = 4.23 (SD = .71)
High
M = 6.19 (SD = .58)
Doctor
Competence
Low
M = 4.01 (SD = 1.04)
High
M = 6.52 (SD = .50)
Caring
Low
M = 3.91 (SD = .71)
High
M = 5.93 (SD = .69)
Trustworthiness
Low
M = 4.18 (SD = .74)
High
M = 6.28 (SD = .59)

50% (4)

54.1% (53)

39.8% (53)

61.2% (41)

50% (4)

45.9% (45)

60.2% (80)

38.8% (26)

25.0% (2)

39.8% (39)

51.5% (68)

52.2% (35)

75.0% (6)

60.2% (59)

48.5% (64)

47.8% (32)

33.3% (3)

54.4% (49)

42.9% (60)

54.5% (36)

66.7% (6)

45.6% (41)

57.1% (80)

45.5% (30)

11.1% (1)

53.3% (48)

45.7% (64)

51.5% (34)

88.9% (8)

46.7% (42)

54.3% (76)

48.5% (32)

22.2% (2)

52.2% (47)

42.9% (60)

53.0% (35)

77.8% (7)

47.8% (43)

57.1% (80)

47.0% (31)

Source credibility and participant’s likelihood to follow mother’s
recommendation. Results showed significant differences for perceived mother
competence, t (306) = -3.58, p < 0.001 (Mlow = 2.46, Mhigh = 2.84), perceived mother
caring, t (306) = -2.42, p = 0.02 (Mlow = 2.51, Mhigh = 2.76), and perceived mother
trustworthiness, t (306) = 1.93, p = 0.05 (Mlow = 2.49, Mhigh = 2.80). Participants were
more likely to follow the mother’s recommendation when they perceived the mother
source to have higher competence, higher caring, and higher trustworthiness. Therefore,
Hypothesis 1 was fully supported for the outcome variable participant’s likelihood to
follow mother’s recommendation.
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Source credibility and participant’s likelihood to follow doctor’s
recommendation. Results showed significant differences for perceived doctor
competence, t (305) = -3.57, p < 0.001 (Mlow = 2.38, Mhigh = 2.80), perceived doctor
caring, t (305) = -2.85, p = 0.005 (Mlow = 2.48, Mhigh = 2.78), and perceived doctor
trustworthiness, t (305) = -2.87, p = 0.004 (Mlow = 2.46, Mhigh = 2.78). Participants were
more likely to follow the doctor’s recommendation when they perceived the doctor
source to have higher competence, higher caring, and higher trustworthiness. Therefore,
Hypothesis 1 was fully supported for the outcome variable participant’s likelihood to
follow doctor’s recommendation.
Table 5.12
Hypothesis 1 Results for Source Credibility and Participant’s Likelihood
Participant’s Likelihood to Follow Recommendation
Very unlikely
Somewhat
Somewhat
Very Likely
p-value
unlikely
likely
Mother
Competence
Low
54.1% (20)
58.0% (58)
41.3% (45)
29.0% (18) 0.001
M = 2.96 (SD = .69)
High
45.9% (17)
42.0% (42)
58.7% (64)
71.0% (44)
M = 4.95 (SD = .81)
Caring
Low
54.1% (20)
57.0% (57)
48.6% (53)
35.5% (22) 0.02
M = 4.18 (SD = .86)
High
45.9% (17)
43.0% (43)
51.4% (56)
64.5% (40)
M = 6.25 (SD = .56)
Trustworthiness
Low
37.8% (14)
41.4% (41)
54.1% (59)
51.6% (32) 0.05
M = 4.23 (SD = .71)
High
62.2% (23)
58.6% (58)
45.9% (50)
48.4% (30)
M = 6.19 (SD = .58)
Doctor
Competence
Low
M = 4.01 (SD = 1.04)
High
M = 6.52 (SD = .50)

64.3% (27)

59.1% (52)

41.7% (50)

36.8% (21)

35.7% (15)

40.9% (36)

58.3% (70)

63.2% (36)
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Table 5.12 (continued)
Caring
Low
M = 3.91 (SD = .71)
High
M = 5.93 (SD = .69)
Trustworthiness
Low
M = 4.18 (SD = .74)
High
M = 6.28 (SD = .59)

54.8% (23)

59.1% (52)

45.8% (55)

33.3% (19)

45.2% (19)

40.9% (36)

54.2% (65)

66.7% (38)

59.5% (25)

55.7% (49)

42.5% (51)

36.8% (21)

40.5% (17)

44.3% (39)

57.5% (69)

63.2% (36)

Research Question 1
Research Question 1 asked which type of source credibility (competence, caring,
trustworthiness) best predicts following the source’s recommendation. Research
Question 1 was answered using a multiple regression analysis. Because there were four
dependent or criterion variables that need to be tested, four multiple regression analyses
were run. The four dependent variables are Sarah’s likelihood to follow mother
recommendation, Participant’s likelihood to follow mother recommendation, Sarah’s
likelihood to follow doctor recommendation, and Participant’s likelihood to follow doctor
recommendation. Due to high correlation between some of the source credibility
predictor variables, all source credibility variables were mean-centered to reduce the risk
of multi-collinearity in the regression analyses (Chatterjee & Hadi, 2006).
First, a multiple regression was performed on the dependent variable Sarah’s
likelihood to follow mother recommendation using the three mother source credibility
predictor variables (perceived mother competence, perceived mother caring, and
perceived mother trustworthiness). The model was not statistically significant, F (3, 302)
= 0.23, p = 0.87, R2 = .002. Therefore, the answer to Research Question 1 is that no type
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of mother source credibility significantly predicts participant’s perception of Sarah’s
likelihood to follow mother recommendation.
Second, a multiple regression was performed on the dependent variable
Participant’s likelihood to follow mother recommendation using the three mother source
credibility predictor variables (perceived mother competence, perceived mother caring,
and perceived mother trustworthiness). The model was statistically significant, F (3,
304) = 6.27, p < .001, R2 = .05.

One of the three predictor variables significantly

predicted participant’s likelihood to follow mother recommendation: perceived mother
competence ! = .19, p = .02. Therefore, the answer to Research Question 1 is that
perceived mother competence is the only type of source credibility that significantly
predicts Participant’s likelihood to follow mother recommendation.
Third, a multiple regression was performed on the dependent variable Sarah’s
likelihood to follow doctor recommendation using the three doctor source credibility
predictor variables (perceived doctor competence, perceived doctor caring, and
perceived doctor trustworthiness). The model was not statistically significant, F (3, 301)
= 0.99, p = 0.40, R2 = .01. Therefore, the answer to Research Question 1 is that no type
of doctor source credibility significantly predicts participant’s perception of Sarah’s
likelihood to follow doctor recommendation.
Fourth, a multiple regression was performed on the dependent variable
Participant’s likelihood to follow doctor recommendation using the three doctor source
credibility predictor variables (perceived doctor competence, perceived doctor caring,
and perceived doctor trustworthiness). The model was statistically significant, F (3, 303)
= 7.97, p < .001, R2 = .06.

However, only two of the three predictor variables were
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significant predictors of Participant’s likelihood to follow doctor recommendation:
perceived doctor competence ! = .23, p = .04 and perceived doctor caring ! = .22, p =
.048. Therefore, the answer to Research Question 1 is that perceived doctor competence
best predicts Participant’s likelihood to follow doctor recommendation, followed by
perceived doctor caring.
Research Question 2
Research Question 2 asked what effect does past conversation with a source have
on participant’s perceptions of source credibility. A one-way analysis of variance was
used to assess mean differences between perceptions of mother and doctor competence,
caring, and trustworthiness based on the types of past conversations participants had with
these sources (past conversation recommending no vaccination, no past conversation,
past conversation recommending vaccination).
Perceived mother credibility. A one-way ANOVA indicated no significant
differences in participants’ ratings of perceived mother competence across the three
different past mother conversation scenarios, F (2, 305) = 2.61, p = .075, "2 = .02. A
one-way ANOVA indicated a significant difference in participants’ ratings of perceived
mother caring across the three different past conversation scenarios, F (2, 305) = 4.95, p
= .008, "2 = .03. Specifically, LSD post hoc tests indicated that past mother conversation
recommending no vaccination (M = 5.63) differed significantly (p = .05) from no past
mother conversation (M = 5.10) and past mother conversation recommending
vaccination (M = 5.12). A one-way ANOVA indicated a significant difference in
participants’ ratings of perceived mother trustworthiness across the three different past
conversation scenarios, F (2, 305) = 6.74, p = .001, "2 = .04. Specifically, LSD post hoc
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tests indicated that past mother conversation recommending no vaccination (M = 5.61)
differed significantly (p = .05) from no past mother conversation (M = 5.04) and past
mother conversation recommending vaccination (M = 5.06). Therefore, the answer to
Research Question 2 is that the type or nature of past conversation about HPV
vaccination with a mother or mother source affects participants’ ratings of perceived
mother caring and perceived mother trustworthiness. Specifically, participants rated the
mother source in the message as more caring and more trustworthy if they personally had
a past conversation with their mother or mother figure in which she recommended against
vaccination than if they had a past conversation with their mother or mother figure in
which she recommended to get the vaccine or in situations in which the participants had
no past conversation with their mother or mother figure.
Perceived doctor credibility. A one-way ANOVA indicated significant
differences in participants’ ratings of perceived doctor competence across the three past
conversation scenarios, F (2, 303) = 3.53, p = .03, "2 = .02. Specifically, LSD post hoc
tests indicated that past doctor conversation recommending no vaccination (M = 6.22)
differed significantly (p = .05) from no past doctor conversation (M = 5.28). A one-way
ANOVA indicated a significant difference in participants’ ratings of perceived doctor
caring across the three different past conversation scenarios, F (2, 303) = 6.32, p = .002,
"2 = .04. Specifically, LSD post hoc tests indicated that past doctor conversation
recommending no vaccination (M = 5.73) differed significantly (p = .05) from no past
doctor conversation (M = 4.67) and past doctor conversation recommending vaccination
(M = 4.95). A one-way ANOVA indicated a significant difference in participants’ ratings
of perceived doctor trustworthiness across the three different past conversation scenarios,
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F (2, 303) = 4.97, p = .008, "2 = .03. Specifically, LSD post hoc tests indicated that past
doctor conversation recommending no vaccination (M = 6.07) differed significantly (p =
.05) from no past doctor conversation (M = 5.08) and past doctor conversation
recommending vaccination (M = 5.28). Therefore, the answer to Research Question 2 is
that the type or nature of past conversation with a doctor affects participants’ ratings of
perceived doctor competence, perceived doctor caring, and perceived doctor
trustworthiness. Participants rated the doctor source in the message as more competent if
they personally had a previous conversation with a doctor who recommended against
vaccination than if they reported no past conversations with a doctor. Also, participants
rated the doctor as more caring and more trustworthy if they personally had a past
conversation with a doctor who recommended against vaccination than if they had a past
conversation with their own doctor in which s/he recommended to get the vaccine or in
situations in which the participants had no past conversation with a doctor.
Hypothesis 2
Hypothesis 2 predicted that messages with greater perceived argument strength
will be positively related to participants’ likelihood to follow the message
recommendation. Hypothesis 2 was analyzed using zero-order correlation between each
type of perceived argument strength and the likelihood to follow recommendation
variables. Results are described in detail below and presented in Table 5.13 at the end of
this section.
Participants’ ratings of Sarah’s likelihood to follow mother recommendation was
positively correlated with perceived mother long-term risk message argument strength, r
(96) = .28, p < .01. Sarah’s likelihood to follow mother recommendation was not
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significantly correlated with perceived mother short-term risk message argument strength
or perceived mother no risk message argument strength. Therefore, Hypothesis 2 is
supported for the perceived mother long-term risk message argument strength:
Participants who perceived the mother’s long-term risk message as stronger were more
likely to believe Sarah would follow the mother’s recommendation.
The participant’s likelihood to follow mother recommendation was positively
correlated with perceived mother short-term risk message argument strength, r (103) =
.33, p < .01 and perceived mother long-term risk message argument strength, r (97) =
.58, p < .01, but was not significantly correlated with perceived mother no risk message
argument strength. Therefore, Hypothesis 2 is supported for perceived mother shortterm risk message argument strength and perceived mother long-term risk message
argument strength: Participants who perceived the mother’s short-term risk message and
long-term risk messages as stronger were more likely to follow the mother’s
recommendation.
Participants’ ratings of Sarah’s likelihood to follow doctor recommendation was
positively correlated with perceived doctor long-term risk message argument strength, r
(99) = .21, p < .05, but were not significantly correlated with perceived doctor short-term
risk message argument strength or perceived doctor no risk message argument strength.
Therefore, Hypothesis 2 is supported for perceived doctor long-term risk message
argument strength: Participants who perceived the doctor’s long-term risk message as
stronger were more likely to follow the doctor’s recommendation.
The participant’s likelihood to follow doctor recommendation was positively
correlated with perceived doctor short-term risk message argument strength, r (97) = .40,
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p < .01, perceived doctor long-term risk message argument strength, r (99) = .51, p < .01,
and perceived doctor no risk message argument strength, r (94) = .33, p < .01.
Therefore, Hypothesis 2 is supported for perceived doctor short-term risk message
argument strength, perceived doctor long-term risk message argument strength, and
perceived doctor no risk message argument strength: Participants who perceived all three
doctor messages as stronger were more likely to follow the doctor’s recommendation.
Table 5.13
Hypothesis 2 Correlations between Likelihood and Argument Strength
Mother
Mother
Mother
Doctor
shortlongno risk
shortterm
term
term
**
Sarah’s likelihood to
.057
.284
-.061
follow mother
recommendation
Participant’s likelihood
.329**
.582**
.127
to follow mother
recommendation
Sarah’s likelihood to
.149
follow doctor
recommendation
Participant’s likelihood
.398**
to follow doctor
recommendation

Doctor
longterm

Doctor
no risk

.208*

-.105

.506**

.332**

Note. **Correlation is significant at the 0.01 level; *Correlation is significant at the 0.05
level.
Hypothesis 3 and Research Question 3
Hypothesis 3 predicted that participants who receive messages from doctors and
mothers that converge on both recommendation and risk (i.e., Conditions 1, 5, 9) will be
more likely to follow the recommendation given by the doctor than participants who
receive messages from both sources with mixed message characteristics (divergence on
risk and convergence on recommendation; i.e., Conditions 7, 3) or divergent message
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characteristics (divergence on both recommendation and risk; i.e., Conditions 2, 4, 6, 8).
In addition, Research Question 3 asked, what is the effect of past conversations with a
source on likelihood to follow the doctor’s recommendation? Hypothesis 3 and Research
Question 3 were tested for the outcome variables Sarah’s likelihood to follow the doctor’s
recommendation and Participant’s likelihood to follow the doctor’s recommendation.
The decision was made to focus these final analyses on the participants’ likelihood to
follow a doctor’s recommendation for two reasons: a) formative work revealed that
doctors were more likely to voice pro-vaccination messages, and so focusing on
likelihood to follow a doctor’s recommendation is the most advantageous for promoting
this behavior and b) the focus of future intervention efforts based on the findings from
this study might more easily be directed toward doctors rather than mothers.
First, a 3 X 3 (mother argument type X doctor argument type) between-subjects
univariate ANOVA tested the effects of the type of convergence on Sarah’s likelihood to
follow the doctor’s recommendation. Past conversation with mother and past
conversation with doctor were entered as covariates. Put simply, Hypothesis 3 predicted
that messages that converge from both sources on both recommendation and risk will be
more effective than mixed convergence messages, and that mixed convergence messages
will be more effective than messages that diverge. Support for this hypothesis would be
indicated by a significant mother argument type by doctor argument type interaction.
The overall model was significant, F (8, 305) = 10.70, p <.001, "2 = .22. More
specifically, the two-way interaction term (mother argument type X doctor argument
type) was statistically significant for Sarah’s likelihood to follow the doctor’s
recommendation, F (4, 305) = 15.03, p <.001, "2 = .17.
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Post-hoc tests on individual mean differences for each message condition were
not appropriate and would not provide a clear report of the mean differences or
adequately address Hypothesis 3 because the conditions were grouped together in the
hypothesis according to type of message convergence. Therefore, a follow-up one-way
ANOVA on Sarah’s likelihood to follow the doctor’s recommendation was conducted
across the three difference types of convergence (convergence on recommendation and
risk, mixed convergence/divergence on recommendation and risk, divergence on
recommendation and risk). This analysis was significant: F (2, 305) = 28.99, p <.001, "2
= .16. Participants indicated that they more likely believed Sarah would follow the
doctor’s recommendation in message conditions where there was convergence on
recommendation and risk (M = 3.21, SD = 0.79), followed by mixed message conditions
(M = 3.03, SD = 0.78), and finally divergent message conditions (M = 2.52, SD = 0.64).
LSD post-hoc tests on this analysis revealed that the message convergence conditions as
a group were significantly greater (p = .05) than the divergent message conditions, and
the mixed message conditions as a group were significantly greater (p = .05) than
divergent message conditions. Therefore, Hypothesis 3 was nearly fully supported,
except for the lack of a significant difference between convergence conditions and mixed
conditions. Results for these analyses are displayed visually in Table 5.14 and Table
5.15.
Past conversations with both doctor and mother were entered as covariates in the
model, and the analysis revealed that participants’ perceptions of Sarah’s likelihood to
follow the doctor’s recommendation did not vary in relation to past conversation with
doctor or past conversation with mother or mother figure. Therefore, the answer to
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Research Question 3 is no, past conversations with a mother or doctor about HPV
vaccination do not have an effect on participant’s perceptions of Sarah’s likelihood to
follow the doctor’s recommendation.
Table 5.14
Sarah’s Likelihood to Follow Doctor’s Recommendation by Message Condition a
Doctor
short term risk
long term risk
no risk
do not get
get vaccinated
do not get
vaccinated
vaccinated
Mother short term
1
2
3
risk
Convergence on risk
Divergence on
Divergence on risk
do not get
and
risk and
but convergence on
vaccinated
recommendation
recommendation
recommendation
b
M = 3.30
M = 2.60
M = 2.94
SD = 0.84
SD = 0.60
SD = 0.80
long term
4
5
6
risk
Divergence on risk
Convergence on
Divergence on risk
get
and
risk and
and
vaccinated
recommendation
recommendation
recommendation
M = 2.36
M = 3.26
M = 2.18
SD = 0.60
SD = 0.71
SD = 0.58
no risk
7
8
9
do not get
Divergence on risk
Divergence on
Convergence on risk
vaccinated
but convergence on
risk and
and
recommendation
recommendation
recommendation
M = 3.11
M = 2.91
M = 3.05
SD = 0.69
SD = 0.57
SD = 0.80
Note. aThe message conditions are shaded according to type of message convergence:
convergent message conditions are unshaded, mixed message conditions are shaded light
gray, and divergent message conditions are shaded dark gray. bThe likelihood to follow
recommendation variable was measured on a 4-point scale, with higher scores indicating
a participant is more likely to follow the doctor recommendation.
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Table 5.15
Sarah’s Likelihood to Follow Doctor’s Recommendation by Convergence Type
95% Confidence Interval
for Mean
Convergence
Message
Lower
Upper
Type
Conditions
N
Mean
SD
Bound
Bound
Converge on All
1 5 9
102
3.21
.79
3.05
3.36
Mixed
7 3
69
3.03
.75
2.85
3.21
Diverge on All
2 4 6 8
135
2.52
.64
2.41
2.63
Total
306
2.86
.78
2.77
2.95
Second, a 3 X 3 (mother argument type X doctor argument type) betweensubjects univariate ANOVA tested the effects of the type of convergence on Participant’s
likelihood to follow the doctor’s recommendation. Past conversation with mother and
past conversation with doctor were entered as covariates. The overall model was
significant, F (8, 307) = 2.07, p < .05, "2 = .05. However, the two-way interaction term
(mother argument type X doctor argument type) was not statistically significant. Similar
to the process followed for the first outcome variable, a follow-up one-way ANOVA
indicated significant differences on Participant’s likelihood to follow the doctor’s
recommendation across the three difference types of convergence (convergence on
recommendation and risk, mixed convergence/divergence on recommendation and risk,
divergence on recommendation and risk), F (2, 305) = 3.10, p <.05, "2 = .02. Participants
indicated that they would be more likely to follow the doctor’s recommendation in
message conditions in which there was convergence on recommendation and risk (M =
2.79, SD = 0.91), followed by mixed message conditions (M = 2.65, SD = 0.90), and
finally divergent message conditions (M = 2.49, SD = 0.96). LSD post-hoc tests on this
analysis revealed that message convergence conditions as a group were significantly
greater (p = .05) than divergent message conditions. Therefore, Hypothesis 3 was
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partially supported. Results for these analyses are displayed visually in Table 5.16 and
Table 5.17.
Past conversations with both doctor and mother were entered as covariates in the
model, and the analysis revealed that participants’ perceptions of Participant’s likelihood
to follow the doctor’s recommendation did significantly vary in relation to past
conversation with mother, F (1, 305) = 10.27, p <.01 Therefore, the answer to Research
Question 3 is past conversations with a mother does have an effect on Participant’s
likelihood to follow the doctor’s recommendation.
Figure 5.16
Participant’s Likelihood to Follow Doctor’s Recommendation by Message Condition a
Doctor
short term risk
long term risk
no risk
do not get
get vaccinated
do not get
vaccinated
vaccinated
Mother short term
1
2
3
risk
Convergence on risk
Divergence on
Divergence on risk
do not get
and
risk and
but convergence on
vaccinated
recommendation
recommendation
recommendation
M = 2.83b
M = 2.63
M = 2.66
SD = 0.94
SD = 0.88
SD = 0.97
long term
4
5
6
risk
Divergence on risk
Convergence on
Divergence on risk
get
and
risk and
and
vaccinated
recommendation
recommendation
recommendation
M = 2.35
M = 2.85
M = 2.15
SD = 1.01
SD = 0.86
SD = 0.94
no risk
7
8
9
do not get
Divergence on risk
Divergence on
Convergence on risk
vaccinated
but convergence on
risk and
and
recommendation
recommendation
recommendation
M = 2.65
M = 2.79
M = 2.69
SD = 0.85
SD = 0.91
SD = 0.96
Note. aThe message conditions are shaded according to type of message convergence:
convergent message conditions are unshaded, mixed message conditions are shaded light
gray, and divergent message conditions are shaded dark gray. bThe likelihood to follow
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recommendation variable was measured on a 4-point scale, with higher scores indicating
a participant is more likely to follow the doctor recommendation.

Table 5.17
Participant’s Likelihood to Follow Doctor’s Recommendation by Convergence Type
95% Confidence
Interval for Mean
Convergence
Message
Lower
Upper
Type
Conditions
N
Mean
SD
Bound
Bound
Converge on All
1 5 9
103
2.79
.91
2.61
2.97
Mixed
7 3
69
2.65
.90
2.43
2.87
Diverge on All
2 4 6 8
136
2.49
.96
2.32
2.65
Total
308
2.62
.94
2.52
2.73
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CHAPTER 6
Discussion
!

The purpose of Study 2 was to provide an experimental test of the MCF in the

context of HPV vaccination. This was the first empirical test of the MCF, and the results
provide support for the main tenets of the theory. Specifically, in Study 2, participants
heard messages from both a mother source and a doctor source; these two messages
converged on the type of risk message and recommendation provided, diverged on the
type of risk message and recommendation provided, or were mixed in the type of risk
message and recommendation provided. Participants were then asked to indicate their
perceptions of each source’s credibility, their perceptions of the strengths of each
argument (i.e., message), and finally, their likelihood and their perceptions of Sarah’s
likelihood to follow each source’s recommendation. In this discussion chapter, I first
discuss some of the major implications of Study 2 findings. Next, I discuss the limitations
of Study 2 including methodological and external validity considerations. Finally, I
conclude the chapter with some ideas for future research and health interventions.
Implications
The goal of this study was to answer three hypotheses and three research
questions that explored the persuasive effects of perceptions of source credibility,
perceptions of argument strength, and the effect of different types of message
convergence. The data presented in Chapter 5 provide some evidentiary support to
address these hypotheses and research questions. To address the findings that were
concordant and discordant with the hypotheses and research questions, the following
sections examine in detail four main discussion points or implications.
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First, the main outcomes in this study were participants’ perceptions of Sarah’s
likelihood to follow recommendations from the doctor and mother source and
participants personal likelihood to follow recommendations from the doctor and mother
source. There were some key differences between participants’ responses to Sarah’s
likelihood to follow a recommendation and their personal likelihood to follow a
recommendation. To address these differences, I first describe the overall findings for
Sarah’s likelihood to follow a recommendation and reserve the remainder of the
discussion section to focus on participants’ personal likelihood outcome variables. Table
6.1 offers detail to the reader of each hypothesis or research question, and the findings for
each outcome variable (Sarah’s likelihood to follow a recommendation and participant’s
likelihood to follow a recommendation).
Recall Hypothesis 1 predicted that participants would more likely follow the
recommendation given by sources they perceive as higher in
credibility/caring/trustworthiness than sources they perceive as lower in
credibility/caring/trustworthiness, Research Question 1 asked which type of source
credibility (competence, caring, trustworthiness) best predicts following the source’s
recommendation, and Hypothesis 2 predicted that messages with greater perceived
argument strength will be positively related to participants’ likelihood to follow the
message recommendation. Results show that both source credibility and argument
strength did not have significant main effects (with some minor exceptions) on
participants’ ratings of Sarah’s likelihood to follow recommendations. This may suggest
that, in evaluations of what an “other” would do, certain cues like source credibility and
argument strength are not important message processing variables for individuals. In
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other words, in terms of the ELM, participants are not relying on perceptions of higher
source credibility or perceptions of stronger arguments as reasons for another person to
follow a source’s recommendation.
Alternatively, these data indicate participants’ ratings of Sarah’s likelihood to
follow a source’s recommendation were almost fully explained by message convergence.
There were significant differences between message convergent and divergent conditions
and between mixed message conditions and divergent message conditions and these
differences were in the hypothesized direction. It may be that, in the case of evaluating
what an “other” would do, the message convergence acted as a processing cue for
participants, such that when messages converged, participants assumed that Sarah would
follow the doctor’s recommendation because it agreed with the mother’s risk message
and recommendation. Compared to convergent and mixed message conditions in which
scores were at or above 3.0, in message divergent conditions (see Figure 5.1 in Chapter
5), participants’ scores on Sarah’s likelihood to follow the doctor recommendation
generally hovered around the 2.5 mark on the 4-point scale; this suggests “neutral
territory” in that participants’ average scores were in the mid-point of the scale. This
may indicate uncertainty in what Sarah would be likely to do, suggesting that divergent
conditions do create a level of dissonance for participants. An alternate explanation is
that such uncertainty was not due to dissonance, but rather the inability for participants to
evaluate which message source would be more compelling for Sarah in the context of
divergent recommendations. However, this idea needs to be further explored.
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Table 6.1
Sarah and Participant Comparison of Findings
Hypothesis/Research
a
Question
Test
Sarah
H1a: Young women will be t-test
Partially supported
more likely to follow
Higher
mother recommendation if
trustworthiness
perceived higher
predicts more likely
credibility.
to follow.
H1b: Young women will be t-test
more likely to follow doctor
recommendation if
perceived higher
credibility.

Not supported

RQ1a: Which type of
source credibility best
predicts following mother’s
recommendation?
RQ1b: Which type of
source credibility best
predicts following doctor’s
recommendation?

Multiple
Regression

Not able to
answer/Model not
significant

Multiple
Regression

Not able to
answer/Model not
significant

RQ2a: What is the effect of
past conversations with
mother on perceived
mother credibility?

One-way
ANOVA

N/A

RQ2b: What is the effect of
past conversations with
doctor on perceived doctor
credibility?

One-way
ANOVA

N/A

!
!
!
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b

Participant
Fully supported
Higher competence,
caring, and
trustworthiness
predict more likely
to follow.
Fully supported
Higher competence,
caring, and
trustworthiness
predict more likely
to follow.
Perceived mother
competence is only
significant predictor
Perceived doctor
competence and
perceived doctor
caring significant
predictors
Perceived mother
caring and perceived
mother
trustworthiness
higher if past
conversation
recommended no
vaccine.
Perceived doctor
competence, caring,
and trustworthiness
higher if past
conversation
recommended no
vaccine

!

Table 6.1 (continued)!
H2a: Young women will
be more likely to follow
mother’s recommendations
in messages perceived as
strong.

Bivariate
correlation

H2a: Young women will
be more likely to follow
doctor’s recommendations
in messages perceived as
strong.

Bivariate
correlation

H3: Young women will
follow doctor’s
recommendation more in
convergent message
conditions than in mixed
and more in mixed
conditions than in divergent
conditions.
RQ3: What is the effect of
past conversations with a
source on likelihood to
follow doctor’s
recommendation?

Partially supported
Participants more
likely to follow
recommendation in
stronger long-term
risk message, but
not in other
message conditions

Partially supported
Participants more
likely to follow
recommendation in
stronger long-term
risk message
c
Univariate
Nearly Fully
ANOVA
Supported
Participants
followed
recommendations
more in convergent
conditions than in
mixed conditions
and divergent
conditions
Entered as
Not able to
Covariates in answer/Not
ANOVA
significant
covariates

Partially supported
Participants more
likely to follow
recommendations in
stronger short-term
and stronger longterm risk message,
but not in no risk
message condition
Fully supported
Participants more
likely to follow
recommendations in
(all) arguments they
perceive as stronger
Partially Supported
Participants followed
recommendations
more in convergent
conditions than in
divergent conditions

Past conversations
with mother has an
effect on
participant’s
likelihood to follow
doctor’s
recommendation
Note a The Sarah column represents the outcome Sarah’s likelihood to follow a
recommendation. b The Participant column represents the outcome Participant’s
likelihood to follow a recommendation. c Please see Chapter 5 Results section for a
detailed description of why these hypotheses are labeled “nearly fully supported;” space
limitations in the table prevent a thorough description.
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Second, source credibility and argument strength proved important predictors of
participants’ personal likelihood to follow a source’s recommendation. Participants were
more likely to follow a source’s recommendation (both mother and doctor) when they
perceived the source to be more competent, caring, and trustworthy, and when they
perceived the argument the source was making to be strong. However, recall that
individuals read messages from both sources at the same time and therefore it may be
unclear what role source credibility and argument strength played in how individuals
processed these messages. In past message testing studies, it has been typical for
participants to read a message from one source and then evaluate that individual source’s
credibility (Stiff & Mongeau, 2003). By asking participants to read messages from two
sources at the same time and then evaluate each source’s credibility, it may be that
participants made comparisons in their mind that also reflected upon their credibility
assessments. Did these source variables act as peripheral cues, such that a more credible
source acted as a cue for a participant to follow that recommendation rather than a less
credible source?
Alternatively, given that individuals read messages from both sources at the same
time, did source credibility prompt individuals to centrally process the source attributes?
Past research says that while source credibility typically serves as a peripheral cue, it can
act as a central cue in some instances in which source credibility is important in the
decision (O’Keefe, 2002). I would posit that in cases in which two sources are “pitted”
against each other, like what was done in Study 2, source credibility serves more as a
central processing cue. However, future research needs to examine this idea using
measures such as thought listing tasks that assess central processing. Additionally, the
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role of argument strength, often relied on as an indicator of central processing, needs
further examining in the context of multiple messages. Even if it is true that an
individual believes a message is strong (and the source is credible), she may still choose
not to follow the recommendation given by that particular source if she is confronted with
a message and recommendation from another source that is also argumentatively strong
and credible.
Third, recall that Research Question 2 asked what effect does past conversation
with a source have on participant’s perceptions of source credibility. Results revealed
that past conversations with a source had an effect on a participant’s perceptions of
source credibility and likelihood to follow a recommendation from that “same” source.
In other words, past conversations about HPV vaccination matter, lending support to the
notion that the communication environment around an issue (e.g., HPV vaccination)
should be seen more as a movie reel and not a snapshot of one point in time.
Specifically, the type of past conversation revealed that participants reacted to messages
from a similar source (in this case, Sarah’s mother and doctor) in different ways. By
that, I mean that participants perceived a source’s credibility in different ways depending
on their past communication with a source. For example, the mother source (regardless
of message condition) was perceived as more caring and more trustworthy if the
participant had personally discussed HPV vaccination with her mother in the past and the
mother had recommended against vaccination, than if participants had past conversations
in which the participant’s mother had recommended for vaccination or if no past
conversations had occurred. It is unclear why this is the case. However, one possible
explanation can be drawn from the study sample itself. Because the women in the study
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were unvaccinated, if the participants had personally discussed HPV vaccination in the
past, she clearly had considered vaccination and chosen not to vaccinate. In asking
participants to consider the credibility of the mother source in the scenario, it may be that
participants considered mothers who chose to discuss vaccination with their daughters,
even though this was a hypothetical scenario with “Sarah’s” mother, as more caring and
trustworthy because they cared enough to talk about it. After all, this finding was
significant regardless of the recommendation in the message scenarios (i.e., the mother
recommending to get the vaccine or recommending not to get the vaccine).
The same pattern was seen for past conversations with a doctor; the doctor source
in this experiment was perceived as more competent, more caring, and more trustworthy
if a participant had personally discussed HPV vaccination with her own doctor in the past
and that doctor had recommended against vaccination. In the case of doctors, the same
possible explanation for mothers may be at play. In sum, this study revealed that past
conversations with a source do have an impact on a person’s processing of current
messages, lending support to the idea that individuals process current risk messages
through a personal frame of reference (Sellnow, Ulmer, Seeger, & Littlefield, 2009). This
frame of reference includes an individual’s past exposure to messages about the topic
whether from the same or a similar source. However, future research is needed to further
examine the effect of past communication about a health topic on an individuals’
processing of current communication about the same topic.
Fourth, this first test of the message convergence framework revealed support for
the model. The model’s main proposition, that message convergence by multiple sources
will lead participants to be more persuaded to follow the recommendation, now has
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empirical support. There are a variety of cognitive functions that may be at work to
explain why convergence provides the strongest behavioral intention effect. For
example, in the case of likelihood to follow a doctor’s recommendation in Study 2,
participants may have seen the mother’s message as reinforcing what the doctor was
saying and therefore felt more assured that the behavior the doctor was advocating was
indeed possible. Alternatively, much like participants’ ratings of Sarah’s likelihood to
follow the doctor’s recommendation in divergent message conditions, participants’
average scores on their likelihood to follow the doctor’s recommendation in divergent
conditions were in the 2.15-2.79 range, suggesting a potential level of uncertainty in
whether they should follow the recommendation. This was also the case in mixed
message conditions; participants’ scores ranged from 2.65-2.66. Recall that in these
“mixed” conditions, participants read messages that diverged on the type of risk (i.e., the
short term risk of getting the vaccine or the lack of risk of becoming infected with HPV)
but converged on recommendation (i.e., do not get vaccinated). Despite the fact that
there wasn’t a significant difference between convergent and mixed conditions or
divergent and mixed conditions on this outcome variable, mean directions suggest that
the mixed message conditions do fall between convergent and divergent conditions. This
may be the most interesting finding and one that needs further exploration – a convergent
recommendation is not the only part of the message that’s important – participants may
also need a convergent message (or argument) for why they should follow this
convergent recommendation.
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Limitations
There were many limitations to Study 2 that deserve attention and that readers
should be aware of as they consider the results of this project. I will organize the
limitations around experimental design, measurement and related data analysis issues,
and finally, external validity threats.
First, perhaps the most difficult part of designing Study 2 was identifying how to
test the MCF. This was the first test of MCF and there was little guidance in the research
literature for designing an experiment like this one. The experimental design used in this
message testing study was somewhat unusual compared to other persuasive health
message testing studies in three ways. First, even though several of the hypotheses and
research questions concerned the effect of each source (i.e., mother and healthcare
provider), in every message condition, the participants read messages from both sources.
In other words, source was not a manipulated variable in the factorial design but it was an
IV of interest. Second, and related, the message manipulation came in the form of type
of argument (3 levels; short term risk of vaccine, long term risk of cervical cancer, and
lack of risk) and the type of recommendation (2 levels; recommends get the vaccine,
recommends against vaccination) from each source. However, in the manipulation of the
second independent variable (type of recommendation), it was necessary to expose
participants to the negative recommendation in more than one experimental condition
(i.e., participants read a negative recommendation in both short term risk argument and
lack of risk argument). Because of this, a true factorial design was not possible because
one of the IVs (recommendation type) was represented in more than one “column” of the
message matrix usually associated with a factorial design. See Table 5.4 for a visual
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depiction of these message conditions. Related, the type of risk messages tested in this
study differed in terms of the locus of risk (i.e., risk of the vaccine, risk of cervical
cancer, and lack of risk for contracting HPV); this is something that could have been
addressed in a more sensitive manner in the data analysis in order to control for these
differences. Third, the main hypothesis concerning the experimental message testing
concerned the convergence/divergence of messages in each experimental condition and
not the usual main or interaction effects of individual or combined IVs, thus further
making a test of this true factorial design not necessary. Despite these unusual
conditions, I believe that this experimental design did allow for an adequate first test of
the message convergence framework. Future research should attempt to conduct more
sophisticated tests of the model.
Second, because of little guidance in the published literature on research design,
the data analysis required some extra work, such as recoding a number of variables and
creating a number of variables after data collection occurred in order to fully address the
research questions and hypotheses. For example, in most if not all persuasion and health
behavior change research, the outcome variable is behavioral intention to adopt the
behavior. Here, this study design initially used a behavioral intention outcome measure
(i.e., intention to vaccinate), which is common in vaccination studies. However, the true
outcome in message convergence research should be likelihood or intention to follow a
message recommendation, whatever that may be. Therefore, the vaccination intention
measure that participants answered had to be recoded into a likelihood to follow the
recommendation measure.
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Related, I could have conducted more sophisticated analyses on source credibility,
argument strength, and the role of past communication about HPV vaccination. For
example, participants’ past conversations about HPV vaccination with both their own
mothers and their own healthcare providers was measured and each individual’s past
conversation types (i.e., type of past conversation with a mother, type of past
conversation with a doctor) were entered as covariates in the ANOVA testing the
different message conditions on likelihood to follow the doctor’s recommendation
outcome. However, a combined variable reflecting whether the type of past conversation
with a mother converged or diverged with the type of past conversation with a doctor
may have been a more interesting covariate to test in the model. Additionally,
measuring more than just past communication with these two sources and their effect on
participants’ message processing may have provided a more fitting test of the MCF,
which seeks to consider all possible communication about a topic. Despite this, the
number of participants in this study limited the feasibility of testing interactions among
many covariates and I made the decision instead to test the main propositions in the
model (i.e., convergence or divergence among two sources) at the expense of these more
detailed nuances (i.e., the effect of a more thorough examination of past communication
on message processing). Future work should strive to investigate important covariates,
as informed by formative work around the behavior of interest.
Related, there were also a number of measurement limitations. First, two of the
variables measured in this study may have lacked a strong conceptual fit. As previously
mentioned, the main outcome variable (likelihood to follow a recommendation) was
recoded from a vaccine behavioral intention measure. In addition, the past conversation
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measure only measured the type of past conversation (no past conversation, past
conversation recommending no vaccination, and past conversation recommending
vaccination). This suggests that participants only had one past conversation with each of
these sources and therefore this measure did not capture the extent of past conversation
(e.g., one conversation, multiple conversations), nor did it measure the quality of the
conversation (e.g., whether the source was deemed credible, whether participants
believed the argument was strong). The measure also failed to include other sources of
past conversations or communication about HPV vaccination (which were identified in
Study 1). Additionally, to simplify the study design, only the two most important sources
identified in Study 1 for HPV vaccination information (i.e., mother and doctor) were
tested in Study 2.
There also may have been a number of potentially important variables that were
not measured, and therefore I was unable to see if they made a significant difference in an
individual’s processing of HPV vaccination messages. For example, a participant’s
personal sexual history could have had an impact on her processing of the messages she
received in the experimental scenario, which identified that Sarah was not a virgin but
that her mother and doctor (the sources of the messages for the experiment) did not know
this. In fact, one of the messages that participants received from the doctor and/or mother
concerned the lack of risk of contracting HPV because the source believed that Sarah was
a virgin. Other important variables of interest to this study that were not measured and/or
not included in analyses include attitudes and beliefs about vaccinations in general, other
cervical cancer-related behaviors like Pap testing and HPV testing history, geographic
location of participants (as well as where they grew up, if it is different from their current
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location), religious and political beliefs, and family communication norms (which may
reveal why a participant would follow a family member’s recommendation more than a
non-family member like a doctor). In addition, there may have been other important
covariates that may have proven important if they had been included in the study and
future research, including more formative work on what variables may be important to
include, is needed.
Finally, given the applied nature of this research project, I would be remiss to not
discuss external validity considerations. The sample for Study 2 was young adult
unvaccinated women from Kentucky, which limits the generalizability of the findings
beyond this population. However, there are also several strengths to this sample. First,
the formative work completed in Study 1, which informed the experimental messages in
Study 2, was conducted with a similar sample (young adult unvaccinated women from
Kentucky); therefore the findings are highly generalizable to this particular population.
Second, and related, both studies used unvaccinated women, which would be a relevant
target population for any HPV vaccination uptake intervention. Third, the geographic
focus in Kentucky is important given the previously discussed high cervical cancer rates
and relatively low HPV vaccination rates. Another external validity consideration is the
medium used in this message testing study. The stimulus was text-based. A more
realistic test may have been to use video messages of each source delivering a message.
However, the text-based messages allowed for the study to be easily completed on the
Internet and it also allowed for participants to be reminded of the source and message
when answering each question (i.e., as a reminder, participants saw the “mother” message
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at the top of the screen while they filled out the mother source credibility and mother
argument strength measures; the same held true for the “doctor” message).
Future Directions
There are two areas for future research with regard to this study. The first is in
regard to research and intervention design for increasing HPV vaccination among young
adult women. The findings from Study 2 reveal important information about how
messages from different sources have an effect on likelihood to receive the HPV vaccine.
While single-source and single-message research is valuable in helping us understand
communication influences, this study reveals that researchers need to move beyond single
message research designs to consider multiple communication influences. Perhaps the
most important piece of information that was learned (or, confirmed) in this study is that
recommendations for health behaviors do not happen in a vacuum. Moving forward,
developing more sensitive understandings of these multiple recommendations and
teaching healthcare providers how to talk to patients will help us to better increase HPV
vaccine uptake. Elder, Ayala, and Harris (1999) suggest a number of provider counseling
actions informed by health behavior change theories, including having the provider “elicit
from the patient potential cues he/she is exposed to on a daily basis” such as media
messages as well as “determine whether family members and friends endorse the
behavior [and]… highlight these endorsements if they exist” (p. 278). In this way,
healthcare providers can capitalize on message convergence being an effective method of
behavior change and work to help the patient “see” the message convergence in their
communication environment.
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However, in cases in which patients may be receiving conflicting or divergent
messages and recommendations (or, alternatively, no messages) from others in their
communication environment, the provider’s actions for encouraging vaccination are less
clear. Despite this, healthcare providers cannot know a patient’s history with regard to
HPV vaccination communication unless they elicit that information from the patient.
Perhaps starting the HPV vaccination conversation by simply asking “what have you
heard about this vaccine?” is a good first step in opening up the dialogue and learning
what patients have heard. Such a conversation will help healthcare providers better
assess what past messages a patient has received. This is especially relevant to the
population of young adult women, who may still be influenced by their mother and other
family members when it comes to health, even though they are over 18 and are most
likely making independent health decisions. For example, healthcare providers can enlist
the use of others in the patient’s life to encourage behavior change. Elder, Ayala, and
Harris (1999) note that “support for change can be elicited from family members or close
friends” and doctors can “invite key family members into a discussion with the patient”
to help reinforce the benefits of behavior change (p. 280).
The second major implication for future research is that this framework (MCF)
and this research design (examining the effect of more than one persuasive message)
should be tested in other health communication contexts. Given the significant findings
shown here, it is reasonable to assume that other “controversial” health behaviors may
benefit from a message convergence framework analysis. For example, consider the
topic of voluntary mastectomies due to testing positive for the BRCA gene. Angelina
Jolie made national headlines when she shared her personal story around this decision
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(Jolie, 2013), but it’s something that thousands of women may deal with at some point in
their lives. This is a behavior for which there may be multiple messages about the topic –
some encouraging, some discouraging – and better understanding how a woman sorts
through these messages can allow health communication scholars to better design
messages and social support programs for women who find themselves in a similar
situation. Another health topic that may benefit from this analysis is breast feeding.
While this is a decision that is easy for some women, others may find it difficult to decide
to breast feed (or decide to continue to breast feed) due to the messages they receive
about this behavior from spouses, parents, in-laws, peers, rude people in public, etc.
Surprisingly, there is little published communication research on the discourse around
breastfeeding (Foss, 2013; Gray, 2013). In sum, while it is clear that these two research
ideas center specifically on women’s health (a personal research bias, I admit!), any
health behavior in which an individual may receive conflicting messages from different
sources over time about what to do regarding a health issue is a ripe area for study from
this framework.
Conclusion
The purpose of this research project was to better understand the communication
environment about HPV vaccination and how multiple messages from different sources
interact to influence HPV vaccination decisions. The project contained two studies. In
Study 1, the message convergence framework was used to analyze interviews with
unvaccinated young adult women who discussed past messages they received about HPV
vaccination and the effect those messages had on their HPV vaccine decision. In Study
2, the findings from Study 1 were used to design an experiment to test these typical
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messages and message sources and determine in which conditions (convergence,
divergence, or mixed) a participant was more likely to follow a recommendation. In sum,
this research project succeeded in achieving its objectives. We now have a clearer idea of
what the HPV vaccination communication environment “looks” like for young adult
women, and we have a better understanding of how multiple HPV vaccination messages
influence decision-making.

Copyright © Katharine J. Head 2013
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Appendix A
Consent Form
Consent to Participate in a Research Study
Understanding Patient Perspectives on Cervical Cancer Prevention
WHY ARE YOU BEING INVITED TO TAKE PART IN THIS RESEARCH?
You are being invited to take part in a research study about your perspectives on cervical
cancer prevention. You are being invited to take part in this research study because you
are a female between the ages of 18 and 30 years old. If you choose to take part in this
study, you will be one of about 300 women to do so in the Lexington area.

WHO IS DOING THE STUDY?
The person in charge of this study is Katharine Head (Principal Investigator, PI) of the
University of Kentucky’s Department of Communication. She is a doctoral student and
is being guided in this research by Dr. Elisia Cohen.

WHAT IS THE PURPOSE OF THIS STUDY?
This research study will help Katharine better understand young adult women’s
perspectives on cervical cancer prevention. All answers to your questions will be kept
confidential. In addition, you understand that all information from the study will be used
only for research purposes. Although you may not get personal benefit from taking part
in this research study, your responses may help us understand more about how young
women like you communicate about cervical cancer prevention.
ARE THERE REASONS YOU SHOULD NOT TAKE PART IN THIS STUDY?
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If you are under 18 years of age or over 30 years of age you will not be able to participate
in this study. There are questions of a sensitive nature included in the study, mostly
about issues related to women’s health and wellbeing. Your responses will be kept
confidential. Although we have tried to minimize the number of sensitive questions that
we ask, some questions may make you upset or feel uncomfortable or embarrassed, and
you may choose not to answer them. If some questions do upset you, we can tell you
about some people who may be able to help you with these feelings.

WHERE IS THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT
LAST?
You will need to complete one web-based survey for the study which will take
approximately 15-20 minutes to complete. This survey will be completed at your
convenience on a computer.

WHAT WILL YOU BE ASKED TO DO?
You will be asked to answer questions on a web-based survey (on the computer). These
questions will ask about your knowledge, thoughts, and feelings about cervical cancer
prevention and women’s health. As part of the survey, you will also be asked to respond
to a scenario about cervical cancer prevention. You will complete this survey at your
own convenience (for example, on your home computer). After reading this informed
consent statement and agreeing to participate in the study, you can proceed to completing
this web-based survey.
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WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS?
To the best of our knowledge, the things you will be doing have no more risk of harm
than you would experience in everyday life. The only possible risks to you are any
discomfort or embarrassment you might feel answering some of the survey questions. If
so, we can tell you about some people who may be able to help you with these
feelings. However, this risk should be no greater than what you would experience in
everyday conversations with other people such as yourself about these issues. In addition
to the risks listed above, you may experience a previously unknown risk or side effect.
WILL YOU BENEFIT FROM TAKING PART IN THIS STUDY?
There is no guarantee that you will get any benefit from taking part in this
study. However, some people have experienced increased knowledge and understanding
about cervical cancer prevention and women’s health after participating in similar
studies. Your willingness to take part, however, may in the future help society as a whole
better understand this research topic.

DO YOU HAVE TO TAKE PART IN THE STUDY?
If you decide to take part in the study, it should be because you really want to
volunteer. You have a choice about whether or not to complete the survey, and if you do
participate, you are free to skip any questions or discontinue at any time. As a student, if
you decide not to take part in this study, you may want to choose to participate in other
research projects to fulfill course requirements.
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IF YOU DON’T WANT TO TAKE PART IN THE STUDY, ARE THERE OTHER
CHOICES?
If you do not want to take part in this research study, you can withdraw from the
study. Participants who signed up for this study to earn Communication research credit
for their Communication course(s) can choose to earn their required research credit by
signing up for other research projects offered by the Department of Communication.

WHAT WILL IT COST YOU TO PARTICIPATE?
There are no direct costs associated with taking part in the study.

WILL YOU RECEIVE ANY REWARDS FOR TAKING PART IN THIS STUDY?
For students enrolled in lower level Communication courses and who signed up as part of
the SONA Research Recruitment System, you will receive course credit for
participating. Specifically, you will receive one (1) research credit. This credit will be
granted to you at the conclusion of your participation. For participants who signed up as
a volunteer to participate in this study, you will receive a $10 gift card to the business of
your choice (Target or Starbucks) for participation in this study.

WHO WILL SEE THE INFORMATION THAT YOU GIVE?
We will make every effort to keep private all research records that identify you to the
extent allowed by law. We may be required to show some study information, such as
information that identifies you, to people who need to be sure we have done the research
correctly. These would be people from such organizations as the University of Kentucky.
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Your name will not be attached to any of the materials that you complete during the
study. Please be aware, while we make every effort to safeguard your data once received
from the online survey/data gathering company, given the nature of online surveys, as
with anything involving the Internet, we can never guarantee the confidentiality of the
data while still on the survey/data gathering company’s servers, or while en route to
either them or us. It is also possible the raw data collected for research purposes may be
used for marketing or reporting purposes by the survey/data gathering company after the
research is concluded, depending on the company’s Terms of Service and Privacy
policies.
Your information will be combined with information from other people taking part in the
study. When we write about the study to share it with other researchers, we will write
about the combined information we have gathered. You will not be personally identified
in these written materials. We may publish the results of this study; however, we will
keep your name and other identifying information private as it will not be linked to your
responses. This study is confidential. However, it should be noted that researchers can
be forced by law to tell people who are not connected with the study, including the
courts, about your participation.

CAN YOUR PARTICIPATION IN THE STUDY END EARLY?
If you decide to take part in the study, you still have the right to decide at any time that
you no longer want to continue. You also may skip any question that you do not wish to
answer. You will not be treated differently if you decide to skip questions or stop taking
part in the study.
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WHAT IF YOU HAVE QUESTIONS, SUGGESTIONS, CONCERNS, OR
COMPLAINTS?
Before you decide whether to accept this invitation to take part in the study, please ask
any questions (by contacting Katharine Head through email at katharine.head@uky.edu)
that might come to mind now. Later, if you have questions, suggestions, concerns, or
complaints about the study, you can contact the investigator, Katharine Head, at
katharine.head@uky.edu. If you have any questions about your rights as a volunteer in
this research, contact the staff in the Office of Research Integrity at the University of
Kentucky at 859-257-9428 or toll free at 1-866-400-9428. Thank you in advance for
your assistance with this important project.
IMPLIED CONSENT
Below, please select "Continue" if you would like to complete the survey. By choosing to
complete the web-based survey, you are providing implied consent to participate in the
research project. You may print this consent form for your records or the researcher will
provide a paper copy for you at your request.
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Experimental Survey
Internet Survey Questions
Note: Questions include the variable label (Gender), followed by the question/directions
that were given to the participant for that question (What is your gender?), followed by
the answer choices as well as what value each variable level was given (1 = Male, 2 =
Female). A link to login to the actual online survey, which may provide a better
understanding of the flow of the survey, can be provided upon request.
Gender What is your gender?
! Male (1)
! Female (2)
ClgClass What is your college classification?
! Freshman (1)
! Sophomore (2)
! Junior (3)
! Senior (4)
! Graduate Student (5)
! Does not apply (6)
Race What is your race?
! White/Caucasian (1)
! African American (2)
! Hispanic (3)
! Asian (4)
! Native American (5)
! Pacific Islander (6)
! Other (7)
Age How old are you?
! 17 or younger (17)
! 18 (18)
! 19 (19)
! 20 (20)
! 21 (21)
! 22 (22)
! 23 (23)
! 24 (24)
! 25 (25)
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26 (26)
27 (27)
28 (28)
29 (29)
30 (30)
31 or older (31)

RcvdHPVvac Have you received the HPV vaccine?
! Yes (1)
! No (2)
(If yes, participant proceeds to page 3; if no, participant proceeds to page 5.)
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[If yes, received HPV vaccine…]
Howmany How many doses (shots) of the HPV vaccine have you received?
! One dose (1)
! Two doses (2)
! Three doses (3)
Age1stdose At what age did you receive the first dose (shot) of the HPV vaccine?
! Under 10 (10)
! 11 (11)
! 12 (12)
! 13 (13)
! 14 (14)
! 15 (15)
! 16 (16)
! 17 (17)
! 18 (18)
! 19 (19)
! 20 (20)
! 21 (21)
! 22 (22)
! 23 (23)
! 24 (24)
! 25 (25)
! 26 (26)
HS1stdose Were you in high school when you received the first dose (shot) of the HPV
vaccine?
! Yes (1)
! No (2)
LivSit What was your living situation when you received the first dose (shot) of the HPV
vaccine?
! Living at home with parents (1)
! Living away from home (2)
! Other (please explain): (3) ____________________
Hlthcre1st At the time you received the first dose (shot) of the HPV vaccine, what type of
healthcare program or payment type did you use?
! Private insurance (for example, your parent’s insurance) (1)
! Private pay (for example, paying for health services like the vaccine on your own) (2)
! Public assistance (for example, Medicaid or the Vaccines For Children [VFC]
program) (3)
! Other (please explain): (4) ____________________
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! Don't know (5)
HlthcreNOW What type of healthcare program or payment type do you use now?
! Private insurance (for example, your parent’s insurance) (1)
! Private pay (for example, paying for health services like the vaccine on your own) (2)
! Public assistance (for example, Medicaid or the Vaccines For Children [VFC]
program) (3)
! Other (please explain): (4) ____________________
! Don't know (5)
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HPVBelfs What are your general thoughts on the HPV vaccine?
Strongly
Somewhat
Somewhat
Disagree (1)
Disagree (2)
Agree (3)
The HPV
!
!
!
vaccine might
cause short term
problems, like
fever. (1)
The HPV
!
!
!
vaccine might
cause short term
problems, like
pain at the
injection site.
(2)
The HPV
!
!
!
vaccine might
cause short term
problems, like a
rash. (3)
The HPV
!
!
!
vaccine is being
pushed to make
money for drug
companies. (4)
The HPV
!
!
!
vaccine might
cause longlasting health
problems that
we don’t yet
know about. (5)
If a teenage girl
!
!
!
gets the HPV
vaccine, she
may be more
likely to have
sex. (6)
I think the HPV
!
!
!
vaccine is
unsafe. (7)
Teenage girls
!
!
!
are too young to
get a vaccine
for a sexually
transmitted
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Strongly Agree
(4)
!

!

!

!

!

!

!
!

!

disease like
HPV. (8)
HPVEffect
How effective
do you think
the HPV
vaccine is in
preventing an
HPV infection?
(1)
How effective
do you think
the HPV
vaccine is in
preventing
cervical cancer?
(2)

Slightly
Effective (1)
!

Moderately
Effective (2)
!

Very Effective
(3)
!

Extremely
Effective (4)
!

!

!

!

!

[Participants who answered yes to receiving HPV vaccine finish the survey at this point.]
CnvDoc Have you ever discussed HPV vaccination with a healthcare provider?
! Yes (1)
! No (2)
[If yes, participant proceeds to next two questions; if no, participant skips next two
questions.]
RecDoc Did the provider...
! Recommend that you receive the HPV vaccine. (1)
! Recommend that you not receive the HPV vaccine. (2)
InfoDoc What types of information did the healthcare provider tell you about the
vaccine? Please describe.
CnvMom Have you ever discussed HPV vaccination with your mom or a mother figure in
your life?
! Yes (1)
! No (2)
[If yes, participant proceeds to next two questions; if no, participant skips next two
questions.]
RecMom Did your mom (or mother figure)...
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! Recommend that you receive the HPV vaccine. (1)
! Recommend that you not receive the HPV vaccine. (2)
InfoMom What types of information did your mom (or mother figure) tell you about the
vaccine? Please describe.
BlfsGetVc1 Please indicate how much you agree or disagree with the following
statements about getting the HPV vaccine
Strongly
Somewhat
Somewhat
Strongly Agree
Disagree (1)
Disagree (2)
Agree (3)
(4)
I absolutely will
!
!
!
!
not get the HPV
vaccine. (1)
I would
!
!
!
!
consider getting
the HPV
vaccine if I had
more
information
about it. (2)
I would get the
!
!
!
!
HPV vaccine if
it wasn’t so
expensive. (3)
I would get the
!
!
!
!
HPV vaccine if
I had time in my
busy schedule.
(4)
I don’t have
!
!
!
!
enough
information
about the HPV
vaccine to
decide whether
to get it. (5)
The HPV
!
!
!
!
vaccine is so
new that I want
to wait a while
before deciding
if I should get
it. (6)
Because I’m not
!
!
!
!
sexually active
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right now, I
don’t need the
HPV vaccine.
(7)
GetVacTim1 Are you seriously thinking of getting the HPV vaccine?
! Yes, I would probably get the HPV vaccine today. (4)
! Yes, I would probably get the HPV vaccine within the next 30 days. (1)
! Yes, I would probably get the HPV vaccine within the next 6 months. (2)
! No, I am not thinking of getting the HPV vaccine in the future. (3)
STIMULUS
Now, we want you to read a story about a young women who is deciding whether to get
the HPV vaccine. She hears information about the vaccine from a couple of different
sources, which may influence her decision. Please read Sarah's story and respond to the
questions.
Sarah is a 20 year old sophomore at the University of Kentucky. She has had sex a
couple of times while in college, although she has not told her mother or doctor that she
is sexually active.
She is trying to decide whether she should get the HPV vaccine. She knows that HPV is
a common sexually transmitted disease among college-aged women. She also knows that
a vaccine is available to protect against the types of HPV known to cause cervical cancer.
Sarah hears messages about the HPV vaccine from both her doctor and her mother.
At this point, participants are randomly assigned to message condition. Within each
message condition, participants are randomly assigned to read the mother or doctor
message first.
Argument Strength Indicate how much you agree or disagree with the following
statements.
Strongly
Somewhat
Somewhat
Strongly Agree
Disagree (1)
Disagree (2)
Agree (3)
(4)
The
!
!
!
!
mother’s/doctor’s
statement is a
reason for not
getting the HPV
vaccine/for
getting the HPV
vaccine that is
believable. (1)
131

!

The
mother’s/doctor’s
statement is a
reason for not
getting the HPV
vaccine/for
getting the HPV
vaccine that is
convincing. (2)
The
mother’s/doctor’s
statement gives a
reason for not
getting the HPV
vaccine/for
getting the HPV
vaccine that is
important to me.
(3)
The
mother’s/doctor’s
statement put
thoughts in my
mind for not
wanting to get
the HPV
vaccine/for
wanting to get
the HPV vaccine.
(4)
Overall, how
much do you
agree or disagree
with what Sarah's
mother/Sarah’s
doctor had to say
about the HPV
vaccine? (5)

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

Somewhat
Weak (2)
!

Somewhat
Strong (3)
!

Very Strong
(4)
!

Argument Strength_Reason
Very Weak (1)
Is the reason
Sarah's
mother/Sarah’s
doctor gave for

!
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not getting the
HPV vaccine/for
getting the HPV
vaccine a strong
or weak reason?
(1)
Credibility On the scales below, indicate your feelings about Sarah's mother/Sarah’s
doctor in this story.
1 (1)
2 (2)
3 (3)
4 (4)
5 (5)
6 (6)
7 (7)
Intelligent:
!
!
!
!
!
!
!
Unintelligent
(1)
Untrained:
!
!
!
!
!
!
!
Trained (2)
Cares about
!
!
!
!
!
!
!
Sarah: Doesn't
care about
Sarah (3)
Honest:
!
!
!
!
!
!
!
Dishonest (4)
Has Sarah's
!
!
!
!
!
!
!
interests at
heart: Doesn't
have Sarah's
interests at
heart (5)
Untrustworthy:
!
!
!
!
!
!
!
Trustworthy
(6)
Inexpert:
!
!
!
!
!
!
!
Expert (7)
Self-centered:
!
!
!
!
!
!
!
Not selfcentered (8)
Concerned
!
!
!
!
!
!
!
about Sarah:
Not concerned
about Sarah
(9)
Honorable:
!
!
!
!
!
!
!
Dishonorable
(10)
Informed:
!
!
!
!
!
!
!
Uninformed
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(11)
Moral:
Immoral (12)
Incompetent:
Competent
(13)
Unethical:
Ethical (14)
Insensitive:
Sensitive (15)
Bright: Stupid
(16)
Phony:
Genuine (17)
Not
understanding:
Understanding
(18)

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

SarahGetVc
How likely do
you think Sarah
would be to get
the vaccine? (1)

Very Unlikely
(1)
!

Somewhat
Unlikely (2)
!

Somewhat
Likely (3)
!

Very Likely (4)

Very Unlikely
(1)
!

Somewhat
Unlikely (2)
!

Somewhat
Likely (3)
!

Very Likely (4)

!

YouGetVc
In thinking
about what you
read today (i.e.,
the messages
from Sarah's
mother and
doctor), how
likely are you
to get the
vaccine? (1)

BlfsGetVc2 Please indicate how much you agree or disagree with the following
statements about getting the HPV vaccine.
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I absolutely will
not get the HPV
vaccine. (1)
I would
consider getting
the HPV
vaccine if I had
more
information
about it. (2)
I would get the
HPV vaccine if
it wasn’t so
expensive. (3)
I would get the
HPV vaccine if
I had time in my
busy schedule.
(4)
I don’t have
enough
information
about the HPV
vaccine to
decide whether
to get it. (5)
The HPV
vaccine is so
new that I want
to wait a while
before deciding
if I should get
it. (6)
Because I’m not
sexually active
right now, I
don’t need the
HPV vaccine.
(7)

Strongly
Disagree (1)
!

Somewhat
Disagree (2)
!

Somewhat
Agree (3)
!

Strongly Agree
(4)
!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

!

GetVacTim2 Are you seriously thinking of getting the HPV vaccine?
! Yes, I would probably get the HPV vaccine today. (4)
! Yes, I would probably get the HPV vaccine within the next 30 days. (1)
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! Yes, I would probably get the HPV vaccine within the next 6 months. (2)
! No, I am not thinking of getting the HPV vaccine in the future. (3)
Thank you for completing this study! We really appreciate it! We would like to
leave you with some information, in case you would like to learn more about the HPV
vaccine and where in Lexington you can get it. The following information about the
HPV vaccine is taken directly from the Centers for Disease Control and Prevention
(“CDC”) website.
Why is the HPV vaccine important? Genital HPV is a common virus that is passed
from one person to another through direct skin-to-skin contact during sexual activity.
Most sexually active people will get HPV at some time in their lives, though most will
never even know it. HPV infection is most common in people in their late teens and early
20s. There are about 40 types of HPV that can infect the genital areas of men and women.
Most HPV types cause no symptoms and go away on their own. But some types can
cause cervical cancer in women and other less common cancers— like cancers of the
anus, penis, vagina, and vulva and oropharynx (back of throat including base of tongue
and tonsils). Other types of HPV can cause warts in the genital areas of men and women,
called genital warts. Genital warts are not life-threatening. But they can cause emotional
stress and their treatment can be very uncomfortable. Every year, about 12,000 women
are diagnosed with cervical cancer and 4,000 women die from this disease in the U.S.
About 1% of sexually active adults in the U.S. have visible genital warts at any point in
time.
Which girls/women should receive HPV vaccination? HPV vaccination is
recommended with either vaccine for 11 and 12 year-old girls. It is also recommended for
girls and women age 13 through 26 years of age who have not yet been vaccinated or
completed the vaccine series; HPV vaccine can also be given to girls beginning at age 9
years.
Will sexually active females benefit from the vaccine? Ideally females should get
the vaccine before they become sexually active and exposed to HPV. Females who are
sexually active may also benefit from vaccination, but they may get less benefit. This is
because they may have already been exposed to one or more of the HPV types targeted
by the vaccines. However, few sexually active young women are infected with all HPV
types prevented by the vaccines, so most young women could still get protection by
getting vaccinated.
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How effective are the HPV vaccines? The vaccines target the HPV types that
most commonly cause cervical cancer. One of the vaccines (Gardasil) also protects
against the HPV types that cause most genital warts. Both vaccines are highly effective in
preventing the targeted HPV types, as well as the most common health problems caused
by them. The vaccines are less effective in preventing HPV-related disease in young
women who have already been exposed to one or more HPV types. That is because the
vaccines prevent HPV before a person is exposed to it. HPV vaccines do not treat
existing HPV infections or HPV-associated diseases.
How safe are the HPV vaccines? Both vaccines have been licensed by the Food
and Drug Administration (FDA). The CDC has approved these vaccines as safe and
effective. Both vaccines were studied in thousands of people around the world, and these
studies showed no serious safety concerns. Side effects reported in these studies were
mild, including pain where the shot was given, fever, dizziness, and nausea. Vaccine
safety continues to be monitored by CDC and the FDA. More than 46 million doses of
HPV vaccine have been distributed in the United States as of June 2012. Fainting, which
can occur after any medical procedure, has also been noted after HPV vaccination.
Fainting after any vaccination is more common in adolescents. Because fainting can
cause falls and injuries, adolescents and adults should be seated or lying down during
HPV vaccination. Sitting or lying down for about 15 minutes after a vaccination can help
prevent fainting and injuries.
The HPV vaccine is available at the University of Kentucky University Health
Service (859-323-5823) and the Lexington-Fayette County Public Health Department
((859-252-2371).

137

!

References
Ancker, J. S., Carpenter, K. M., Greene, P., Hoffman, R., Kukafka, R., Marlow, L. A. V.,
Quillin, J. M. (2009). Peer-to-peer communication, cancer prevention, and the
internet. Journal of Health Communication, 14, 38-46. doi:
10.1080/10810730902806760
Anderson, R. B., & McMillion, P. Y. (1995). Effects of similar and diversified modeling
on African American women's efficacy expectations and intentions to perform
breast self-examination. Health Communication, 7, 327-343.
Anthony, K. E., & Sellnow, T. L. (2011). Information acquisition, perception, preference,
and convergence by Gulf Coast residents in the aftermath of the Hurricane
Katrina crisis. Argumentation and Advocacy, 48, 81-96.
Aust, C. F., & Zillmann, D. (1996). Effects of victim exemplification in television news
on viewer perception of social issues. Journalism & Mass Communication
Quarterly, 73, 787-803. doi: 10.1177/107769909607300403
Bassili, J. N. (1996). Meta-judgmental versus operative indexes of psychological
attributes: The case of measures of attitude strength. Journal of Personality and
Social Psychology, 71, 637-653. doi: 10.1037/0022-3514.71.4.637
Bednarczyk, R.A., Birkhead, G. S., Morse, D.L., Doleyres, H., & McNutt, L. (2011).
Human papillomavirus vaccine uptake and barriers: Association with perceived
risk, actual risk and race/ethnicity among female students at a New York State
university, 2010. Vaccine, 29, 3138-3143. doi: 10.1016/j.vaccine.2011.02.045
Behringer, B., & Friedell, G. H. (2006). Appalachia: Where place matters in health.
Preventing Chronic Disease, 3, 1-4.

138

!

Bigsby, E., Cappella, J. N., & Seitz, H. H. (2012). Efficiently and effectively evaluating
public service announcements: Additional evidence for the utility of perceived
effectiveness. Communication Monographs, 80, 1-23. doi:
10.1080/03637751.2012.739706
Briones, R., Nan, X., Madden, K., & Waks, L. (2012). When vaccines go viral: An
analysis of HPV vaccine coverage on YouTube. Health Communication, 27, 478485. doi: 10.1080/10410236.2011.610258
Casper, M. J., & Carpenter, L. M. (2008). Sex, drugs, and politics: the HPV vaccine for
cervical cancer. Sociology of Health & Illness, 30, 886-899. doi: 10.1111/j.14679566.2008.01100.x
Castellsague, X., Munoz, N., Pitisuttithum, P., Ferris, D., Monsonego, J., Ault, K., Saah,
A. (2011). End-of-study safety, immunogenicity, and efficacy of quadrivalent
HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of
age. British Journal of Cancer, 105, 28-37.
doi: http://www.nature.com/bjc/journal/v105/n1/suppinfo/bjc2011185s1.html
CDC. (2010a). Estimated vaccination coverage with selected vaccines among adolescents
aged 13-17 years, by state and local areas. From
http://www.cdc.gov/vaccines/stats-surv/nisteen/data/tables_2009.htm.
CDC. (2010b). FDA licensure of bivalent human papillomavirus vaccine (HPV2,
Cervarix) for use in females and updated HPV vaccination recommendations from
the Advisory Committee on Immunization Practices (ACIP). Morbidity and
Mortality Weekly Report, 59, 626-629.

139

!

CDC. (2010c). FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4,
Gardasil) for use in males and guidance from the Advisory Committee on
Immunization Practices (ACIP). Morbidity & Mortality Weekly Report, 59, 630632.
CDC. (2010d). Human Papillomavirus (HPV). From http://www.cdc.gov/hpv/
CDC. (2012). National, state, and local area vaccination coverage among adolescents
aged 13-17 years -- United States, 2011. MMWR: Morbidity & Mortality Weekly
Report, 61, 671-677.
CDC. (2012). Adult vaccination coverage - United States, 2010. Morbidity and Mortality
Weekly Report, 61, 66-72.
Cermak, M., Cottrell, R., & Murnan, J. (2010). Women's knowledge of HPV and their
perceptions of physician educational efforts regarding HPV and cervical cancer.
Journal of Community Health, 35, 229-234. doi: 10.1007/s10900-010-9232-y
Chaiken, S. (1980). Heuristic versus systematic information processing and the use of
source versus message cues in persuasion. Journal of Personality and Social
Psychology, 39, 752-766.
Champion, V. L., & Skinner, C. S. (2008). The health belief model. In K. Glanz, B. K.
Rimer & K. Viswanath (Eds.), Health behavior and health education: Theory,
research, and practice (4th ed.). (pp. 45-65). San Francisco, CA US: Jossey-Bass.
Chatterjee, S., & Hadi, A. S. (2006). Regression analysis by example. Hoboken, NJ: John
Wiley & Sons, Inc.
Clayman, M. L., Manganello, J. A., Viswanath, K., Hesse, B. W., & Arora, N. K. (2010).
Providing health messages to Hispanics/Latinos: Understanding the importance of

140

!

language, trust in health information sources, and media use. Journal of Health
Communication, 15, 252-263. doi: 10.1080/10810730.2010.522697
Cline, R. J. W. (2003). Everyday interpersonal communication and health. In T. L.
Thompson, A. M. Dorsey, K. I. Miller & R. Parrott (Eds.), Handbook of Health
Communication (pp. 285-313). Mahwah, NJ: Lawrence Erlbaum Associates.
Cohen, E. L., & Head, K. J. (2013). Identifying knowledge-attitude-practice gaps to
enhance HPV vaccine diffusion. Journal of Health Communication, published
online first.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.).
Hillsdale, NJ: Lawrence Erlbaum Associates.
Conroy, K., Rosenthal, S. L., Zimet, G. D., Jin, Y., Bernstein, D. I., Glynn, S., & Kahn, J.
A. (2009). Human papillomavirus vaccine uptake, predictors of vaccination, and
self-reported barriers to vaccination. Journal of Women's Health, 18, 1679-1686.
doi: 10.1089/jwh.2008.1329
Cooper, C. P., Polonec, L., & Gelb, C. A. (2011). Women's knowledge and awareness of
gynecologic cancer: A multisite qualitative study in the United States. Journal of
Women's Health, 20, 517-524. doi: 10.1089/jwh.2011.2765
Correa, T., & Harp, D. (2011). Women matter in newsrooms: How power and critical
mass relate to the coverage of the HPV vaccine. Journalism & Mass
Communication Quarterly, 88, 301-319.
Cox, D., & Cox, A. D. (2001). Communicating the consequences of early detection: The
role of evidence and framing. Journal of Marketing, 65, 91-103. doi:
10.2307/3203469

141

!

Crosby, R. A., Casey, B. R., Vanderpool, R. C., Collins, T., & Moore, G. R. (2011).
Uptake of free HPV vaccination among young women: A comparison of rural
versus urban rates. The Journal of Rural Health, 27, 380-384. doi:
10.1111/j.1748-0361.2010.00354.x
Crosby, R. A., Schoenberg, N., Hopenhayn, C., Moore, G., & Melhan, W. (2007).
Correlates of intent to be vaccinated against human papillomavirus: An
exploratory study of college-aged women. Sexual Health, 4, 71-73.
Daley, E. M., Vamos, C. A., Buhi, E. R., Kolar, S. K., McDermott, R. J., Hernandez, N.,
& Fuhrmann, H. J. (2010). Influences on Human Papillomavirus vaccination
status among female college students. Journal of Women's Health 19, 1885-1891.
doi: 10.1089/jwh.2009.1861
Dempsey, A., Cohn, L., Dalton, V., & Ruffin, M. (2011). Worsening disparities in HPV
vaccine utilization among 19-26 year old women. Vaccine, 29, 528-534.
Dillard, J. P., & Spear, M. E. (2010). Knowledge of human papillomavirus and perceived
barriers to vaccination in a sample of US female college students. Journal of
American College Health, 59,186-190. doi: 10.1080/07448481.2010.493189
Eagly, A. H., & Chaiken, S. (1993). The psychology of attitudes. Fort Worth, TX:
Harcourt Brace & Company.
Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, Elizabeth, Ries,...
Pickle, L. W. (2005). Annual report to the nation on the status of cancer, 1975–
2002, featuring population-based trends in cancer treatment. Journal of the
National Cancer Institute, 97,1407-1427. doi: 10.1093/jnci/dji289

142

!

Elder, J. P., Ayala, G. X., & Harris, S. (1999). Theories and intervention approaches to
health-behavior change in primary care. American Journal of Preventive
Medicine, 17, 275-284. doi: 10.1016/S0749-3797(99)00094-X
Falcone, M., Jepson, C., Sanborn, P., Cappella, J. N., Lerman, C., & Strasser, A. A.
(2011). Association of BDNF and COMT genotypes with cognitive processing of
anti-smoking PSAs. Genes, Brain and Behavior, 10, 862-867. doi:
10.1111/j.1601-183X.2011.00726.x
Fishbein, Martin, & Ajzen, I. (1975). Belief, attitude, intention, and behavior: An
introduction to theory and research. Reading, Mass: Addison-Wesley
Forster, A., Wardle, J., Stephenson, J., & Waller, J. (2010). Passport to promiscuity or
lifesaver: press coverage of HPV vaccination and risky sexual behavior. Journal
of Health Communication, 15, 205-217. doi: 10.1080/10810730903528066
Foss, K. A. (2013). “That's not a beer bong, it's a breast pump!” Representations of
breastfeeding in prime-time fictional television. Health Communication, 28, 329340. doi: 10.1080/10410236.2012.685692
Franceschi, S. (2010). Monitoring HPV16/18 immunisation in England and elsewhere.
British Journal Of Cancer, 103, 157-158. doi: 10.1038/sj.bjc.6605758
Freed, G. L., Clark, S. J., Butchart, A. T., Singer, D. C., & Davis, M. M. (2010). Parental
vaccine safety concerns in 2009. Pediatrics, 125, 654-659. doi:
10.1542/peds.2009-1962
Gerend, M. A., & Shepherd, J. E. (2011). Correlates of HPV knowledge in the era of
HPV vaccination: A study of unvaccinated young adult women. Women &
Health, 51, 25-40. doi: 10.1080/03630242.2011.540744

143

!

Gerhardus, A., & Razum, O. (2010). A long story made too short: Surrogate variables
and the communication of HPV vaccine trial results. Journal of Epidemiology and
Community Health, 64, 377-378. doi: 10.1136/jech.2009.090183
Gostin, L. O. (2011). Mandatory HPV vaccination and political debate. Journal of the
American Medical Association, 306, 1699-1700. doi: 10.1001/jama.2011.1525
Grantham, S., Ahern, L., & Connolly-Ahern, C. (2011). Merck's One Less campaign:
Using risk message frames to promote the use of Gardasil® in HPV prevention.
Communication Research Reports, 28, 318-326. doi:
10.1080/08824096.2011.616243
Gray, J. B. (2013). Feeding on the web: Online social support in the breastfeeding
context. Communication Research Reports, 30, 1-11.
doi: 10.1080/08824096.2012.746219
Gray, J. B., & Harrington, N. G. (2011). Narrative and framing: A test of an integrated
message strategy in the exercise context. Journal of Health Communication, 16,
264-281. doi: 10.1080/10810730.2010.529490
Greene, K., & Brinn, L. S. (2003). Messages influencing college women's tanning bed
use: Statistical versus narrative evidence format and a self-assessment to increase
perceived susceptibility. Journal of Health Communication, 8, 443. doi:
10.1080/10810730390233271
Griffin, E. (2006). A first look at communication theory (6th ed.). New York, NY US:
McGraw-Hill.

144

!

Haupt, R. M., & Sings, H. L. (2011). The efficacy and safety of the quadrivalent human
papillomavirus 6/11/16/18 vaccine Gardasil. Journal of Adolescent Health, 49,
467-475. doi: 10.1016/j.jadohealth.2011.07.003
Head, K. J., & Cohen, E. L. (2012). Young women’s perspectives on cervical cancer
prevention in Appalachian Kentucky. Qualitative Health Research, 22, 476-487.
doi: 10.1177/1049732311425053
Head, K. J., Vanderpool, R. C., & Mills, L. A. (2013). Health care providers' perspectives
on low HPV vaccine uptake and adherence in Appalachian Kentucky. Public
Health Nursing, published online first, doi: 10.1111/phn.12044
Jackson, L. D. (1994). Maximizing treatment adherence among back-pain patients: An
experimental study of the effects of physician-related cues in written medical
messages. Health Communication, 6, 173-180.
Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L. (2009). Human
papillomavirus (HPV) awareness and vaccination initiation among women in the
United States, National Immunization Survey--Adult 2007. Preventive Medicine,
48, 426-431. doi: 10.1016/j.ypmed.2008.11.010
Johnson, B. T., Smith-McLallen, A., Killeya, L. A., & Levin, K. D. (2004). Truth or
consequences: Overcoming resistance to persuasion with positive thinking. In E.
S. Knowles & J. Linn (Eds.), Resistance and persuasion (pp. 215-233). Mahwah,
NJ: Lawrence Erlbaum Associates.
Johnson, B. T., Maio, G. R., & Smith-McLallen, A. (2005). Communication and attitude
change: Causes, processes, and effects. In D. Albarracin, B. T. Johnson & M. P.

145

!

Zanna (Eds.), The handbook of attitudes (pp. 617-669). Mahwah, NJ: Lawrence
Erllbaum Associates.
Jolie, A. (2013, May 14). My medical choice, The New York Times, p. A25.
Jones, L. W., Sinclair, R. C., & Courneya, K. S. (2003). The effects of source credibility
and message framing on exercise intentions, behaviors, and attitudes: An
integration of the elaboration likelihood model and prospect theory. Journal of
Applied Social Psychology, 33, 179-196. doi: 10.1111/j.15591816.2003.tb02078.x
Kahn, J. A., Ding, L., Bin, H., Zimet, G. D., Rosenthal, S. L., & Frazier, A. L. (2009).
Mothers' intention for their daughters and themselves to receive the Human
Papillomavirus vaccine: A national study of nurses. Pediatrics, 123, 1439-1445.
doi: 10.1542/peds.2008-1536
Kelly, B. J., Leader, A. E., Mittermaier, D. J., Hornik, R. C., & Cappella, J. N. (2009).
The HPV vaccine and the media: How has the topic been covered and what are
the effects on knowledge about the virus and cervical cancer? Patient Education
and Counseling, 77, 308-313. doi: 10.1016/j.pec.2009.03.018
Kennedy, S., Osgood, R., Rosenbloom, L., Feinglass, J., & Simon, M. (2011).
Knowledge of human papillomavirus among publicly and privately insured
women. Journal of Midwifery & Women's Health, 56, 481-487. doi:
10.1111/j.1542-2011.2011.00040.x
Kentucky Cancer Registry (2012). Age-adjusted invasive cancer incidence rates in
Kentucky: Cervix Uteri 2006-2010. Retrieved from http://www.cancerrates.info/ky/index.php

146

!

Kessels, S. J. M., Marshall, H. S., Watson, M., Braunack-Mayer, A. J., Reuzel, R., &
Tooher, R. L. (2012). Factors associated with HPV vaccine uptake in teenage
girls: A systematic review. Vaccine, 30, 3546-3556. doi:
10.1016/j.vaccine.2012.03.063
Klug, S. J., Hukelmann, M., & Blettner, M. (2008). Knowledge about infection with
human papillomavirus: a systematic review. Preventive Medicine, 46, 87-98.
Krawczyk, A., Lau, E., Perez, S., Delisle, V., Amsel, R., & Rosberger, Z. (2012). How to
inform: Comparing written and video education interventions to increase human
papillomavirus knowledge and vaccination intentions in young adults. Journal of
American College Health, 60, 316-322. doi: 10.1080/07448481.2011.615355
Krieger, J. L., Katz, M. L., Kam, J. A., & Roberto, A. (2011). Appalachian and nonAppalachian pediatricians’ encouragement of the human papillomavirus vaccine:
Implications for health disparities. Women's Health Issues, doi:
10.1016/j.whi.2011.07.005
Lee, S., & Cappella, J. N. (2013). Distraction effects of smoking cues in antismoking
messages: Examining resource allocation to message processing as a function of
smoking cues and argument strength. Media Psychology, 16, 154-176. doi:
10.1080/15213269.2012.755454
Lee, S., Cappella, J. N., Lerman, C., & Strasser, A. A. (2011). Smoking cues, argument
strength, and perceived effectiveness of antismoking PSAs. Nicotine & Tobacco
Research, 13, 282-290.
Lee, S., Cappella, J. N., Lerman, C., & Strasser, A. A. (2013). Effects of smoking cues
and argument strength of antismoking advertisements on former smokers' self-

147

!

efficacy, attitude, and intention to refrain from smoking. Nicotine & Tobacco
Research, 15, 527-533. doi: 10.1093/ntr/nts171
Lengerich, E. J., Tucker, T. C., Powell, R. K., Colsher, P., Lehman, E., Ward, A. J.,
Wyatt, S. W. (2005). Cancer incidence in Kentucky, Pennsylvania, and West
Virginia: Disparities in Appalachia. Journal of Rural Health, 21, 39-47.
Licht, A. S., Murphy, J. M., Hyland, A. J., Fix, B. V., Hawk, L. W., & Mahoney, M. C.
(2010). Is use of the human papillomavirus vaccine among female college
students related to human papillomavirus knowledge and risk perception?
Sexually Transmitted Infections, 86, 74-78.
MacCallum, R. C., Zhang, S., Preacher, K. J., & Rucker, D. D. (2002). On the practice of
dichotomization of quantitative variables. Psychological Methods, 7, 19-40. doi:
10.1037/1082-989X.7.1.19
Major, L. H., & Coleman, R. (2012). Source credibility and evidence format: Examining
the effectiveness of HIV/AIDS messages for young African Americans. Journal
of Health Communication, 17, 515-531. doi: 10.1080/10810730.2011.635771
Markowitz, L. E., Hariri, S., Lin, C., Dunne, E. F., Steinau, M., McQuillan, G., & Unger,
E. R. (2013). Reduction in human papillomavirus (HPV) prevalence among
young women following HPV vaccine introduction in the United States, national
health and nutrition examination surveys, 2003–2010. Journal of Infectious
Diseases. doi: 10.1093/infdis/jit192
McCroskey, J. C., & Teven, J. J. (1999). Goodwill: A reexamination of the construct and
its measurement. Communication Monographs, 66, 90-103. doi:
10.1080/03637759909376464

148

!

Millar, M. G., & Millar, K. U. (2000). Promoting safe driving behaviors: The influence of
message framing and issue involvement. Journal of Applied Social Psychology,
30, 853-866. doi: 10.1111/j.1559-1816.2000.tb02827.x
Miller-Ott, A. E., & Durham, W. T. (2011). The role of social support in young women's
communication about the genital HPV vaccine. Women's Studies in
Communication, 34, 183-201. doi: 10.1080/07491409.2011.618239
Mills, L. A., Head, K. J., & Vanderpool, R. C. (2013). HPV vaccination among young
adult women: A perspective from appalachian Kentucky. Preventing Chronic
Disease, 10, E17. doi: 10.5888/pcd10.120183
Mills, L. A., Vanderpool, R. C., & Crosby, R. A. (2011b). Sexually related behaviors as
predictors of HPV vaccination among young rural women. Journal of Women's
Health, 20, 1909-1915. doi: 10.1089/jwh.2011.3000
Montaño, D. E., & Kasprzyk, D. (2008). Theory of reasoned action, theory of planned
behavior, and the integrated behavioral model. In K. Glanz, B. K. Rimer & K.
Viswanath (Eds.), Health behavior and health education: Theory, research, and
practice (4th ed.). (pp. 67-96). San Francisco, CA US: Jossey-Bass.
Nan, X. (2012a). Communicating to young adults about HPV Vaccination: Consideration
of message framing, motivation, and gender. Health Communication, 27, 10-18.
doi: 10.1080/10410236.2011.567447
Nan, X. (2012b). Relative persuasiveness of gain- versus loss-framed human
papillomavirus vaccination messages for the present- and future-minded. Human
Communication Research, 38, 72-94. doi: 10.1111/j.1468-2958.2011.01419.x

149

!

Natioanl Cancer Institute (NCI). (2008). Human Papillomaviruses and cancer: Questions
and answersfact sheet. Retrieved from
http://www.cancer.gov/cancertopics/factsheet/Risk/HPV
Ngondo, P. (2009). Threat vs. efficacy messages: An analysis of the HPV vaccination
campaign. Paper presented at the annual National Communication Association.
O'Keefe, D. (2002). Persuasion: Theory & research (2nd ed.). Thousand Oaks, CA:
Sage.
O'Keefe, D., & Jensen, J. (2008). The persuasiveness of gain- and loss-framed messages
for encouraging disease detection: A meta-analytic review. Paper presented at the
annual International Communication Association.
Patel, D. A., Zochowski, M., Peterman, S., Dempsey, A. F., Ernst, S., & Dalton, V. K.
(2012). Human papillomavirus vaccine intent and uptake among female college
students. Journal of American College Health, 60, 151-161. doi:
10.1080/07448481.2011.580028
Perelman, C., & Olbrechts-Tyteca, L. (1969). The new rhetoric: A treatise on argument.
Notre Dame, IN: University of Notre Dame Press.
Perloff, R. M. (2010). The Dynamics of Persuasion: Communication and Attitudes in the
21st Century. New York: Routledge.
Petty, R., & Cacioppo, J. (1981). Attitudes and persuasion: Classic and contemporary
approaches. Dubuque, IA: Wm. C. Brown.
Petty, R. E., Kasmer, J. A., Haugtvedt, C. P., & Cacioppo, J. T. (1987). Source and
message factors in persuasion: A reply to stiff's critique of the elaboration
likelihood model. Communication Monographs, 54, 233-249.

150

!

Pornpitakpan, C. (2004). The persuasiveness of source credibility: A critical review of
five decades' evidence. Journal of Applied Social Psychology, 34, 243-281. doi:
10.1111/j.1559-1816.2004.tb02547.x
Prochaska, J. O., & Velicer, W. F. (1997). The transtheoretical model of health behavior
change. American Journal of Health Promotion, 12, 38-48. doi: 10.4278/08901171-12.1.38
Prochaska, J. O., Velicer, W. F., Rossi, J. S., Goldstein, M. G., Marcus, B. H., Rakowski,
W., Rossi, S. R. (1994). Stages of change and decisional balance for 12 problem
behaviors. Health Psychology, 13, 39-46. doi: 10.1037/0278-6133.13.1.39
Quick, B. L., & Bates, B. R. (2010). The use of gain- or loss-frame messages and efficacy
appeals to dissuade excessive alcohol consumption among college students: A test
of psychological reactance theory. Journal of Health Communication, 15, 603628. doi: 10.1080/10810730.2010.499593
Quintero J., Jessie, S. C., & Scott, A. M. (2011). Exploring the presentation of news
information about the HPV vaccine: A content analysis of a representative sample
of U.S. newspaper articles. Health Communication, 26, 491-501. doi:
10.1080/10410236.2011.556080
Roberto, A. J., Krieger, J. L., Katz, M. L., Goei, R., & Jain, P. (2011). Predicting
pediatricians' communication with parents about the human papillomavirus
(HPV) Vaccine: An application of the theory of reasoned action. Health
Communication, 26, 303-312. doi: 10.1080/10410236.2010.550021
Rust, G., Satcher, D., Fryer, G. E., Levine, R. S., & Blumenthal, D. S. (2010).
Triangulating on success: Innovation, public health, medical care, and cause-

151

!

specific US Mortality rates over a half century (1950–2000). American Journal Of
Public Health, 100, S95-S104. doi: 10.2105/ajph.2009.164350
Sandfort, J. R., & Pleasant, A. (2009). Knowledge, attitudes, and informational behaviors
of college students in regard to the human papillomavirus. Journal of American
College Health, 58, 141-149. doi: 10.1080/07448480903221368
Sellnow, T. L., Ulmer, R. R., Seeger, M. W., & Littlefield, R. S. (2009). Effective risk
communication: A message-centered approach. New York: Springer.
Shafer, A., Cates, J. R., Diehl, S. J., & Hartmann, M. (2011). Asking mom: Formative
research for an HPV vaccine campaign targeting mothers of adolescent girls.
Journal of Health Communication, 16, 988-1005. doi:
10.1080/10810730.2011.571343
Shoemaker, P.J., Tankard, J.W., & Lasorsa, D. L. (2004). How to build social science
theories. Thousand Oaks, CA: Sage.
Short, M. B., Rosenthal, S. L., Sturm, L., Black, L., Loza, M., Breitkopf, D., & Zimet, G.
D. (2010). Adult women's attitudes toward the HPV vaccine. Journal of Women's
Health (15409996), 19, 1305-1311. doi: 10.1089/jwh.2009.1471
St. Germaine-Madison, N. (2009). Localizing medical information for U.S. Spanishspeakers: The CDC campaign to increase public awareness about HPV. Technical
Communication, 56, 235-247.
St. John Iii, B., Pitts, M., & Tufts, K. A. (2010). Disconnects between news framing and
parental discourse concerning the state-mandated HPV vaccine: Implications for
dialogic health communication and health literacy. Communication & Medicine,
7, 75-84. doi: 10.1558/cam.v7i1.75

152

!

Stiff, J. B., & Mongeau, P. A. (2003). Persuasive communication (2nd ed.). New York:
The Guilford Press.
Tiro, J. A., Tsui, J., Bauer, H.M., Yamada, E., Kobrin, S., & Breen, N. (2012). Human
Papillomavirus vaccine use among adolescent girls and young adult women: An
analysis of the 2007 California health interview survey. Journal of Women's
Health, 21, 656-665. doi: 10.1089/jwh.2011.3284
U.S. Cancer Statistics Working Group. (2012). United States cancer statistics: 1999-2008
incidence and mortality web-based report. Atlanta: U.S. Department of Health
and Human Services, Centers for Disease Control and Prevention and National
Cancer Institute.
Vanderpool, R. C., Cohen, E. L., Crosby, R. A., Jones, M. G., Bates, W., Casey, B. R., &
Collins, T. (2013). "1-2-3 Pap" intervention improves HPV vaccine series
completion among Appalachian women. Journal of Communication, 63, 95-115.
doi: 10.1111/jcom.12001
VanVoorhis, C. R. W., & Morgan, B. L. (2007). Understanding power and rules of thumb
for determining sample sizes. Tutorials in Quantitative Methods for Psychology,
3, 43-50.
Witte, K. (1995). Fishing for success: Using the persuasive health message framework to
generate effective campaign messages. In E. Maibach & R. L. Parrott (Eds.),
Designing health messages: Approaches from communication theory and public
health practice. (pp. 145-166). Thousand Oaks, CA US: Sage Publications, Inc.
Yu, N., Ahern, L. A., Connolly-Ahern, C., & Shen, F. (2010). Communicating the risks
of fetal alcohol spectrum disorder: Effects of message framing and

153

!

exemplification. Health Communication, 25, 692-699. doi:
10.1080/10410236.2010.521910
Zhao, X., Strasser, A., Cappella, J. N., Lerman, C., & Fishbein, M. (2011). A measure of
perceived argument strength: Reliability and validity. Communication Methods &
Measures, 5, 48-75. doi: 10.1080/19312458.2010.547822
Zillmann, D. (2002). Exemplification theory of media influence. In J. Bryant & D.
Zillmann (Eds.), Media effects: Advances in theory and research (pp. 19-41).
Mahwah, NJ: Lawrence Erlbaum Associates.
Zillmann, D. (2006). Exemplification effects in the promotion of safety and health.
Journal of Communication, 56, S221-S237. doi: 10.1111/j.14602466.2006.00291.x

154

!

Vita
Katharine J. Head

Education
M.A., Communication, Texas A&M University, December 2008
B.A., Communication, Texas A&M University, December 2006

Professional Academic Experience
Fall 2009-Present

Graduate Teaching Assistant in Communication, University
of Kentucky

Fall 2008-Fall 2009

Grant Project Manager, Department of Veteran Affairs

Spring 2007-Summer 2008

Graduate Teaching Assistant in Communication, Texas
A&M University

Awards/Honors
University of Kentucky:
Carozza Graduate Fellowship for Excellence in Health Communication, Fall 2012
Sypher Memorial Graduate Research Scholarship, Spring 2012
Graduate Teaching Excellence Award, Fall 2010
Michael S. Shelton Top Student Paper, Kentucky Communication Association, Fall 2010
R. Lewis Donohew Graduate Fellowship in Health Communication, Fall 2009.

Texas A&M:
“Good Egg” Award (Departmental Citizenship Award), Spring 2008
Lambda Pi Eta, inducted member, Spring 2006

155

!

Professional Publications
Cohen, E. L., & Head, K. J. (2013). Identifying knowledge-attitude-practice gaps to
enhance HPV vaccine diffusion. Published online first in Journal of Health
Communication. doi: 10.1080/10810730.2013.778357
Head, K. J. & Noar, S. M. (2013). Facilitating progress in health behavior theory
development and modification: The reasoned action approach as a case study.
Published online first in Health Psychology Review, doi:
10.1080/17437199.2013.778165
Head, K. J., Vanderpool, R. C., & Mills, L. A. (2013). Health care providers' perspectives
on low HPV vaccine uptake and adherence in Appalachian Kentucky. Published
online first in Public Health Nursing, doi: 10.1111/phn.12044
Mills, L. A., Head, K. J., & Vanderpool, R. C. (2013). HPV vaccination among young
adult women: A perspective from Appalachian Kentucky. Preventing Chronic
Disease, 10, E17. doi: 10.5888/pcd10.120183
Head, K. J. ,& Cohen, E. L. (2012). Young women’s perspectives on cervical cancer
prevention in Appalachian Kentucky. Qualitative Health Research, 22, 476-487.
doi: 10.1177/1049732311425053
Jameson, J. P., Farmer, M. S., Head, K. J., Fortney, J., & Teal, C. R. (2011). VA
community mental health service providers’ utilization of and attitudes towards
telemental health care: The gatekeeper’s perspective. The Journal of Rural
Health, 27, 425-432. doi: 10.1111/j.1748-0361.2011.00364.x
Noar, S. M., & Head, K. J. (2011). Trends in the research and practice of health
communication campaigns. Sociology Compass, 5, 426-438. doi: 10.1111/j.17519020.2011.00379.x

156

